Gene.Name	Census.Gene	Drug.Name	Mutation	Orig_AA	Position_AA	Mut_AA	Gen.Mutation	Gen_mutated_from	Gen_mutated_to	Primary.Tissue	Histology	Histology.Subtype.1	Histology.Subtype.2	Zygosity	Transcript_info	mut_col	aln_posn	cosmic_id	cosmic_aa	cosmic_posn	uniprot_id	uniprot_aa	uniprot_posn	conc_pfam	Acc	UniprotAA	Uniprot_Pos	Pfam_AA	Pfam_Pos	mut_in_uniprot	conc_col	orth_25	orth_50	orth_75	orth_100	all_homs_25	all_homs_50	all_homs_75	all_homs_100	excl_para_25	excl_para_50	excl_para_75	excl_para_100	spec_para_25	spec_para_50	spec_para_75	spec_para_100	bpsh_25	bpsh_50	bpsh_75	bpsh_100	bpso_25	bpso_50	bpso_75	bpso_100
KIT	Yes	Imatinib	T670I	T	670	I	2009C>T	C	T	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Homozygous	ENST00000288135.5	KIT_T_670	670	KIT	T	670	P10721	T	670	P10721_T_670	P10721	T	670	l	77	T670I	P10721/T670I	-3.21372	-3.61	-4.07085	-3.06475	-1.69942	-0.73517	-0.29682	-0.27338	-1.91451	-0.43354	-0.20002	-0.12691	-4.41323	-0.99524	-0.62606	0.45647	-3.86569	-4.28669	-1.91173	-0.20553	-3.15078	-3.33921	-3.90805	-4.70736
EGFR_ENST00000454757	No	Gefitinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	EGFR_ENST00000454757_T_745	790	EGFR_ENST00000454757	T	745	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
EGFR	Yes	Gefitinib	T790M	T	790	M	?	?	NA	lung	carcinoma	squamous_cell_carcinoma	NS	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
EGFR	Yes	Gefitinib	T790M	T	790	M	?	?	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
KIT	Yes	Imatinib	V654A	V	654	A	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000288135.5	KIT_V_654	654	KIT	V	654	P10721	V	654	P10721_V_654	P10721	V	654	v	61	V654A	P10721/V654A	-3.0421	-3.91067	-4.28896	-4.96082	-5.97083	-6.55487	-4.62666	-4.76232	-6.07968	-6.51538	-4.42426	-4.7495	-3.86516	-4.78749	-4.69194	-5.04105	-3.59732	-4.43669	-5.88686	-5.92714	-2.94308	-3.67093	-4.14688	-4.77469
ABL1_ENST00000318560	No	Imatinib	T315I	T	315	I	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_T_315	315	ABL1_ENST00000318560	T	315	P00519	T	315	P00519_T_315	P00519	T	315	l	77	T315I	P00519/T315I	-3.83824	-3.89394	-4.90879	-4.39264	-5.08085	-3.009	-2.99728	-3.29298	-2.37856	-2.70226	-2.83383	-3.19426	-4.73256	-2.3655	-2.63879	-1.93584	-3.83098	-6.27019	-6.31943	-2.10314	-2.96885	-3.82882	-5.20793	-4.18032
ABL1_ENST00000318560	No	Imatinib	G250E	G	250	E	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_G_250	250	ABL1_ENST00000318560	G	250	P00519	G	250	P00519_G_250	P00519	G	250	e	9	G250E	P00519/G250E	-6.10879	-6.25099	-7.27815	-4.42786	-2.11968	1.3822	1.76775	2.03896	1.61495	4.00556	3.01981	3.23876	-1.32824	-0.68916	-0.68473	-0.08813	-6.14112	-5.31538	-2.08641	-2.08598	-4.79607	-6.15321	-7.55871	-6.7245
ABL1_ENST00000318560	No	Imatinib	Y253H	Y	253	H	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_Y_253	253	ABL1_ENST00000318560	Y	253	P00519	Y	253	P00519_Y_253	P00519	Y	253	f	12	Y253H	P00519/Y253H	-4.89532	-4.98695	-5.85466	-6.40595	-7.04709	-5.54449	-3.47977	-3.44568	-3.6467	-4.56531	-2.75965	-2.89919	-3.78921	-4.06068	-3.91027	-3.18392	-4.90827	-5.82537	-7.37698	-7.52041	-4.13495	-4.92132	-6.08031	-6.33863
EGFR	Yes	Tyrosine kinase inhibitor - NS	T790M	T	790	M	?	?	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
EGFR_ENST00000454757	No	Gefitinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000454757.6	EGFR_ENST00000454757_T_745	790	EGFR_ENST00000454757	T	745	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
ABL1_ENST00000318560	No	Tyrosine kinase inhibitor - NS	T315I	T	315	I	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_T_315	315	ABL1_ENST00000318560	T	315	P00519	T	315	P00519_T_315	P00519	T	315	l	77	T315I	P00519/T315I	-3.83824	-3.89394	-4.90879	-4.39264	-5.08085	-3.009	-2.99728	-3.29298	-2.37856	-2.70226	-2.83383	-3.19426	-4.73256	-2.3655	-2.63879	-1.93584	-3.83098	-6.27019	-6.31943	-2.10314	-2.96885	-3.82882	-5.20793	-4.18032
ABL1_ENST00000318560	No	Tyrosine kinase inhibitor - NS	E255K	E	255	K	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_E_255	255	ABL1_ENST00000318560	E	255	P00519	E	255	P00519_E_255	P00519	E	255	k	14	E255K	P00519/E255K	-3.87752	-3.98692	-3.77258	-4.51827	-4.65119	-0.99294	-0.54953	-0.75458	-2.32244	-0.55667	-0.25813	-0.51514	-3.73023	-2.35155	-1.56173	-0.72175	-3.89441	-4.42775	-2.57996	-3.09774	-2.98345	-3.90263	-3.87545	-4.32295
ALK_ENST00000642122	No	Crizotinib	L128M	L	128	M	382C>A	C	A	lung	carcinoma	adenocarcinoma	NS	Homozygous	ENST00000642122.1	ALK_ENST00000642122_L_128	1196	ALK_ENST00000642122	L	128	Q9UM73	L	1196	Q9UM73_L_1196	Q9UM73	L	1196	l	77	L1196M	Q9UM73/L1196M	-2.10714	-3.04155	-2.93754	-0.65705	1.58653	2.74448	2.99869	3.18813	2.09569	2.92517	3.12183	3.29347	0.72507	0.39472	1.81289	1.8037	-3.29014	-2.42223	-1.1506	0.19169	-1.87869	-2.94667	-3.37793	-3.58831
PDGFRA	Yes	Imatinib	D842V	D	842	V	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000257290.9	PDGFRA_D_842	842	PDGFRA	D	842	P16234	D	842	P16234_D_842	P16234	D	842	e	147	D842V	P16234/D842V	-4.31564	-5.1395	-5.72083	-6.23429	-7.50222	-5.58834	-3.17398	-2.56912	-7.12687	-5.66214	-2.91303	-2.5456	-6.35691	-7.44297	-7.97849	-6.78856	-5.04194	-6.07278	-4.61315	-1.093	-4.28226	-5.10224	-5.65105	-5.81161
EGFR	Yes	Gefitinib	T790M	T	790	M	2369C>T	C	T	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
KIT	Yes	Imatinib	T670I	T	670	I	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000288135.5	KIT_T_670	670	KIT	T	670	P10721	T	670	P10721_T_670	P10721	T	670	l	77	T670I	P10721/T670I	-3.21372	-3.61	-4.07085	-3.06475	-1.69942	-0.73517	-0.29682	-0.27338	-1.91451	-0.43354	-0.20002	-0.12691	-4.41323	-0.99524	-0.62606	0.45647	-3.86569	-4.28669	-1.91173	-0.20553	-3.15078	-3.33921	-3.90805	-4.70736
ABL1_ENST00000318560	No	Dasatinib	T315I	T	315	I	?	?	NA	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	Unknown	ENST00000318560.5	ABL1_ENST00000318560_T_315	315	ABL1_ENST00000318560	T	315	P00519	T	315	P00519_T_315	P00519	T	315	l	77	T315I	P00519/T315I	-3.83824	-3.89394	-4.90879	-4.39264	-5.08085	-3.009	-2.99728	-3.29298	-2.37856	-2.70226	-2.83383	-3.19426	-4.73256	-2.3655	-2.63879	-1.93584	-3.83098	-6.27019	-6.31943	-2.10314	-2.96885	-3.82882	-5.20793	-4.18032
KIT	Yes	Imatinib	N822K	N	822	K	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Unknown	ENST00000288135.5	KIT_N_822	822	KIT	N	822	P10721	N	822	P10721_N_822	P10721	N	822	k	153	N822K	P10721/N822K	-3.43164	-4.65104	-5.21801	-4.95388	-4.84253	-2.03841	-1.844	-1.6082	-4.85631	-1.78246	-1.69447	-1.44971	-4.70887	-4.01165	-3.0352	-0.87894	-4.196	-4.44176	-2.84777	-2.514	-3.33111	-4.31337	-5.02839	-4.78265
KIT	Yes	Imatinib	V654A	V	654	A	1961T>C	T	C	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Unknown	ENST00000288135.5	KIT_V_654	654	KIT	V	654	P10721	V	654	P10721_V_654	P10721	V	654	v	61	V654A	P10721/V654A	-3.0421	-3.91067	-4.28896	-4.96082	-5.97083	-6.55487	-4.62666	-4.76232	-6.07968	-6.51538	-4.42426	-4.7495	-3.86516	-4.78749	-4.69194	-5.04105	-3.59732	-4.43669	-5.88686	-5.92714	-2.94308	-3.67093	-4.14688	-4.77469
EGFR	Yes	Erlotinib	T790M	T	790	M	?	?	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
EGFR	Yes	Tyrosine kinase inhibitor - NS	T790M	T	790	M	?	?	NA	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
BTK_ENST00000618050	No	Acalabrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Unknown	ENST00000618050.4	BTK_ENST00000618050_C_481	481	BTK_ENST00000618050	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
BTK_ENST00000618050	No	Ibrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Unknown	ENST00000618050.4	BTK_ENST00000618050_C_481	481	BTK_ENST00000618050	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
EGFR	Yes	Osimertinib	L718Q	L	718	Q	2153T>A	T	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_L_718	718	EGFR	L	718	P00533	L	718	P00533_L_718	P00533	L	718	l	7	L718Q	P00533/L718Q	-5.05825	-5.64597	-6.05984	-7.36659	-6.36485	-7.36319	-7.88834	-9.14273	-6.4587	-6.85261	-7.91901	-8.63806	-2.97989	-4.1502	-4.92061	-5.49016	-5.11756	-5.85864	-7.27968	-8.23138	-4.99883	-5.39418	-5.67361	-7.19663
EGFR	Yes	Afatinib	C797S	C	797	S	?	?	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_C_797	797	EGFR	C	797	P00533	C	797	P00533_C_797	P00533	C	797	e	84	C797S	P00533/C797S	-6.10543	-6.64002	-6.96375	-2.21228	-7.28074	-5.17489	-1.99234	-1.36406	-7.39063	-3.56928	-2.02928	-1.47672	-3.7615	-5.10149	-5.84303	-2.46042	-6.15484	-6.83722	-5.65101	-2.29663	-6.04365	-6.40311	-6.66681	-2.05142
FGFR2_ENST00000613048	No	Palbociclib	N460K	N	460	K	1380T>A	T	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000613048.4	FGFR2_ENST00000613048_N_460	549	FGFR2_ENST00000613048	N	460	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549K	P21802/N549K	-3.64811	-4.11211	-4.51203	-2.25892	-2.2117	-3.83119	-2.34387	-2.0932	-2.32326	-3.77184	-2.29823	-2.05102	-4.04513	-2.42111	-3.09061	-2.50446	-3.80625	-4.54717	-3.95835	-1.73318	-3.6234	-4.03561	-4.34609	-2.17698
FGFR2_ENST00000369059	No	BGJ398	L503M	L	503	M	1507T>A	T	A	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000369059.5	FGFR2_ENST00000369059_L_503	620	FGFR2_ENST00000369059	L	503	P21802	L	617	P21802_L_617	P21802	L	617	l	114	L617M	P21802/L617M	-2.1073	-2.37778	-2.56432	-0.58631	-1.99526	-3.16729	-2.95701	-3.49347	-2.54812	-4.03737	-3.19557	-3.71219	-2.13592	-3.11462	-3.57144	-3.87308	-2.20905	-2.58128	-2.17398	-2.00271	-2.08409	-2.33343	-2.49224	-0.51603
ABL1_ENST00000318560	No	Imatinib	T315I	T	315	I	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_T_315	315	ABL1_ENST00000318560	T	315	P00519	T	315	P00519_T_315	P00519	T	315	l	77	T315I	P00519/T315I	-3.83824	-3.89394	-4.90879	-4.39264	-5.08085	-3.009	-2.99728	-3.29298	-2.37856	-2.70226	-2.83383	-3.19426	-4.73256	-2.3655	-2.63879	-1.93584	-3.83098	-6.27019	-6.31943	-2.10314	-2.96885	-3.82882	-5.20793	-4.18032
ABL1_ENST00000318560	No	Imatinib	E255K	E	255	K	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_E_255	255	ABL1_ENST00000318560	E	255	P00519	E	255	P00519_E_255	P00519	E	255	k	14	E255K	P00519/E255K	-3.87752	-3.98692	-3.77258	-4.51827	-4.65119	-0.99294	-0.54953	-0.75458	-2.32244	-0.55667	-0.25813	-0.51514	-3.73023	-2.35155	-1.56173	-0.72175	-3.89441	-4.42775	-2.57996	-3.09774	-2.98345	-3.90263	-3.87545	-4.32295
ALK	Yes	Ceritinib	G1202R	G	1202	R	?	?	NA	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000389048.7	ALK_G_1202	1202	ALK	G	1202	Q9UM73	G	1202	Q9UM73_G_1202	Q9UM73	G	1202	g	83	G1202R	Q9UM73/G1202R	-4.81544	-6.73839	-7.96814	-8.23089	-8.99966	-6.51938	-6.67511	-6.18498	-8.99117	-6.52312	-6.66187	-6.17488	-7.73938	-8.17917	-9.69937	-7.04627	-7.18312	-8.85833	-9.94931	-6.31567	-4.34695	-6.57222	-7.32508	-8.42016
KIT	Yes	Imatinib	D816H	D	816	H	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000288135.5	KIT_D_816	816	KIT	D	816	P10721	D	816	P10721_D_816	P10721	D	816	e	147	D816H	P10721/D816H	-3.70478	-4.74191	-5.18786	-4.56366	-5.72064	-3.24919	-3.17906	-2.87845	-6.11584	-3.16848	-3.14213	-2.82029	-4.74194	-5.86144	-5.28885	-4.78946	-4.36262	-5.38472	-0.4766	-1.79929	-3.59347	-4.48775	-5.00371	-4.5073
KIT	Yes	Imatinib	D820Y	D	820	Y	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000288135.5	KIT_D_820	820	KIT	D	820	P10721	D	820	P10721_D_820	P10721	D	820	s	151	D820Y	P10721/D820Y	-4.8403	-5.84134	-6.35055	-6.1242	-7.00734	-3.00094	0.15198	0.23118	-7.14219	-2.61604	0.25196	0.35051	-5.88038	-5.74352	-3.56747	-0.87208	-5.46445	-6.54829	-2.1142	-2.08244	-4.74066	-5.58085	-6.15611	-5.87859
ABL1_ENST00000318560	No	Imatinib	F317L	F	317	L	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_F_317	317	ABL1_ENST00000318560	F	317	P00519	F	317	P00519_F_317	P00519	F	317	y	79	F317L	P00519/F317L	-4.46824	-4.54627	-5.33041	-7.08854	-1.29001	-1.89592	-1.93214	-1.72959	-0.94743	-1.69423	-1.77506	-1.60537	-3.09106	-2.03923	-1.23068	-1.3226	-4.47996	-4.49148	-2.7549	-2.14739	-3.56773	-4.48426	-5.71984	-7.20214
ABL1_ENST00000318560	No	Imatinib	E255K	E	255	K	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_E_255	255	ABL1_ENST00000318560	E	255	P00519	E	255	P00519_E_255	P00519	E	255	k	14	E255K	P00519/E255K	-3.87752	-3.98692	-3.77258	-4.51827	-4.65119	-0.99294	-0.54953	-0.75458	-2.32244	-0.55667	-0.25813	-0.51514	-3.73023	-2.35155	-1.56173	-0.72175	-3.89441	-4.42775	-2.57996	-3.09774	-2.98345	-3.90263	-3.87545	-4.32295
EGFR_ENST00000455089	No	Gefitinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000455089.5	EGFR_ENST00000455089_T_745	790	EGFR_ENST00000455089	T	745	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
ABL1	Yes	Imatinib	T334I	T	334	I	1001C>T	C	T	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000372348.6	ABL1_T_334	334	ABL1	T	334	P00519	T	315	P00519_T_315	P00519	T	315	l	77	T315I	P00519/T315I	-3.83824	-3.89394	-4.90879	-4.39264	-5.08085	-3.009	-2.99728	-3.29298	-2.37856	-2.70226	-2.83383	-3.19426	-4.73256	-2.3655	-2.63879	-1.93584	-3.83098	-6.27019	-6.31943	-2.10314	-2.96885	-3.82882	-5.20793	-4.18032
ABL1_ENST00000318560	No	Imatinib	T315I	T	315	I	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	Unknown	ENST00000318560.5	ABL1_ENST00000318560_T_315	315	ABL1_ENST00000318560	T	315	P00519	T	315	P00519_T_315	P00519	T	315	l	77	T315I	P00519/T315I	-3.83824	-3.89394	-4.90879	-4.39264	-5.08085	-3.009	-2.99728	-3.29298	-2.37856	-2.70226	-2.83383	-3.19426	-4.73256	-2.3655	-2.63879	-1.93584	-3.83098	-6.27019	-6.31943	-2.10314	-2.96885	-3.82882	-5.20793	-4.18032
ABL1_ENST00000318560	No	Imatinib	E255K	E	255	K	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	Unknown	ENST00000318560.5	ABL1_ENST00000318560_E_255	255	ABL1_ENST00000318560	E	255	P00519	E	255	P00519_E_255	P00519	E	255	k	14	E255K	P00519/E255K	-3.87752	-3.98692	-3.77258	-4.51827	-4.65119	-0.99294	-0.54953	-0.75458	-2.32244	-0.55667	-0.25813	-0.51514	-3.73023	-2.35155	-1.56173	-0.72175	-3.89441	-4.42775	-2.57996	-3.09774	-2.98345	-3.90263	-3.87545	-4.32295
EGFR	Yes	Osimertinib	C797S	C	797	S	?	?	NA	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000275493.6	EGFR_C_797	797	EGFR	C	797	P00533	C	797	P00533_C_797	P00533	C	797	e	84	C797S	P00533/C797S	-6.10543	-6.64002	-6.96375	-2.21228	-7.28074	-5.17489	-1.99234	-1.36406	-7.39063	-3.56928	-2.02928	-1.47672	-3.7615	-5.10149	-5.84303	-2.46042	-6.15484	-6.83722	-5.65101	-2.29663	-6.04365	-6.40311	-6.66681	-2.05142
BTK_ENST00000618050	No	Ibrutinib	C481S	C	481	S	1441T>A	T	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Homozygous	ENST00000618050.4	BTK_ENST00000618050_C_481	481	BTK_ENST00000618050	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
FGFR2_ENST00000358487	No	BGJ398	V564F	V	564	F	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	FGFR2_ENST00000358487_V_564	564	FGFR2_ENST00000358487	V	564	P21802	V	564	P21802_V_564	P21802	V	564	l	77	V564F	P21802/V564F	-2.85153	-3.20953	-3.50491	-2.10805	-4.18898	-3.81074	-2.83954	-2.984	-3.8908	-3.42842	-2.69866	-2.92404	-3.13122	-4.59599	-1.81944	-1.03805	-2.97592	-3.5125	-3.84418	-1.91019	-2.82301	-3.15051	-3.39588	-1.90599
ABL1_ENST00000318560	No	Dasatinib	T315I	T	315	I	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_T_315	315	ABL1_ENST00000318560	T	315	P00519	T	315	P00519_T_315	P00519	T	315	l	77	T315I	P00519/T315I	-3.83824	-3.89394	-4.90879	-4.39264	-5.08085	-3.009	-2.99728	-3.29298	-2.37856	-2.70226	-2.83383	-3.19426	-4.73256	-2.3655	-2.63879	-1.93584	-3.83098	-6.27019	-6.31943	-2.10314	-2.96885	-3.82882	-5.20793	-4.18032
ALK	Yes	Crizotinib	G1202R	G	1202	R	?	?	NA	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000389048.7	ALK_G_1202	1202	ALK	G	1202	Q9UM73	G	1202	Q9UM73_G_1202	Q9UM73	G	1202	g	83	G1202R	Q9UM73/G1202R	-4.81544	-6.73839	-7.96814	-8.23089	-8.99966	-6.51938	-6.67511	-6.18498	-8.99117	-6.52312	-6.66187	-6.17488	-7.73938	-8.17917	-9.69937	-7.04627	-7.18312	-8.85833	-9.94931	-6.31567	-4.34695	-6.57222	-7.32508	-8.42016
BTK_ENST00000308731	No	Ibrutinib	C481Y	C	481	Y	1442G>A	G	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Unknown	ENST00000308731.7	BTK_ENST00000308731_C_481	481	BTK_ENST00000308731	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481Y	Q06187/C481Y	-7.42147	-6.85939	-7.0678	-9.31334	-6.81445	-6.28611	-6.37594	-7.34037	-3.91449	-5.45128	-5.70888	-6.59455	-4.26101	-4.15799	-2.72652	-2.51016	-7.12058	-4.37441	-5.39488	-6.19902	-6.08369	-7.18425	-6.09403	-6.93796
FGFR1_ENST00000335922	No	Palbociclib	N536K	N	536	K	1608C>A	C	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000335922.9	FGFR1_ENST00000335922_N_536	546	FGFR1_ENST00000335922	N	536	P11362	N	546	P11362_N_546	P11362	N	546	r	62	N546K	P11362/N546K	-3.13103	-3.95788	-5.01381	-2.25003	-2.27094	-3.82251	-2.35447	-2.0932	-2.45129	-3.71966	-2.28948	-2.07549	-4.04513	-2.42111	-3.09498	-2.50446	-3.44124	-4.39563	-4.24681	-1.09163	-3.14929	-3.56415	-4.57374	-2.1373
FGFR2_ENST00000356226	No	BGJ398	L500M	L	500	M	1498T>A	T	A	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000356226.8	FGFR2_ENST00000356226_L_500	617	FGFR2_ENST00000356226	L	500	P21802	L	617	P21802_L_617	P21802	L	617	l	114	L617M	P21802/L617M	-2.1073	-2.37778	-2.56432	-0.58631	-1.99526	-3.16729	-2.95701	-3.49347	-2.54812	-4.03737	-3.19557	-3.71219	-2.13592	-3.11462	-3.57144	-3.87308	-2.20905	-2.58128	-2.17398	-2.00271	-2.08409	-2.33343	-2.49224	-0.51603
KIT	Yes	Imatinib	N822K	N	822	K	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000288135.5	KIT_N_822	822	KIT	N	822	P10721	N	822	P10721_N_822	P10721	N	822	k	153	N822K	P10721/N822K	-3.43164	-4.65104	-5.21801	-4.95388	-4.84253	-2.03841	-1.844	-1.6082	-4.85631	-1.78246	-1.69447	-1.44971	-4.70887	-4.01165	-3.0352	-0.87894	-4.196	-4.44176	-2.84777	-2.514	-3.33111	-4.31337	-5.02839	-4.78265
KIT	Yes	Imatinib	N822Y	N	822	Y	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000288135.5	KIT_N_822	822	KIT	N	822	P10721	N	822	P10721_N_822	P10721	N	822	k	153	N822Y	P10721/N822Y	-4.0991	-5.09322	-5.6225	-5.85844	-5.93412	1.27756	1.13517	1.18695	-5.9424	1.4315	1.30957	1.35549	-5.26013	-5.04078	0.02553	0.17044	-4.72791	-5.20896	-0.79151	-0.78431	-4.02075	-4.83141	-5.43269	-5.56545
ABL1_ENST00000318560	No	Dasatinib	F317L	F	317	L	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	Unknown	ENST00000318560.5	ABL1_ENST00000318560_F_317	317	ABL1_ENST00000318560	F	317	P00519	F	317	P00519_F_317	P00519	F	317	y	79	F317L	P00519/F317L	-4.46824	-4.54627	-5.33041	-7.08854	-1.29001	-1.89592	-1.93214	-1.72959	-0.94743	-1.69423	-1.77506	-1.60537	-3.09106	-2.03923	-1.23068	-1.3226	-4.47996	-4.49148	-2.7549	-2.14739	-3.56773	-4.48426	-5.71984	-7.20214
ABL1_ENST00000318560	No	Tyrosine kinase inhibitor - NS	T315I	T	315	I	944C>T	C	T	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_T_315	315	ABL1_ENST00000318560	T	315	P00519	T	315	P00519_T_315	P00519	T	315	l	77	T315I	P00519/T315I	-3.83824	-3.89394	-4.90879	-4.39264	-5.08085	-3.009	-2.99728	-3.29298	-2.37856	-2.70226	-2.83383	-3.19426	-4.73256	-2.3655	-2.63879	-1.93584	-3.83098	-6.27019	-6.31943	-2.10314	-2.96885	-3.82882	-5.20793	-4.18032
ABL1_ENST00000318560	No	Tyrosine kinase inhibitor - NS	F317L	F	317	L	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_F_317	317	ABL1_ENST00000318560	F	317	P00519	F	317	P00519_F_317	P00519	F	317	y	79	F317L	P00519/F317L	-4.46824	-4.54627	-5.33041	-7.08854	-1.29001	-1.89592	-1.93214	-1.72959	-0.94743	-1.69423	-1.77506	-1.60537	-3.09106	-2.03923	-1.23068	-1.3226	-4.47996	-4.49148	-2.7549	-2.14739	-3.56773	-4.48426	-5.71984	-7.20214
ABL1_ENST00000318560	No	Tyrosine kinase inhibitor - NS	Y253H	Y	253	H	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_Y_253	253	ABL1_ENST00000318560	Y	253	P00519	Y	253	P00519_Y_253	P00519	Y	253	f	12	Y253H	P00519/Y253H	-4.89532	-4.98695	-5.85466	-6.40595	-7.04709	-5.54449	-3.47977	-3.44568	-3.6467	-4.56531	-2.75965	-2.89919	-3.78921	-4.06068	-3.91027	-3.18392	-4.90827	-5.82537	-7.37698	-7.52041	-4.13495	-4.92132	-6.08031	-6.33863
ALK_ENST00000618119	No	Crizotinib	L819M	L	819	M	2455C>A	C	A	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000618119.4	ALK_ENST00000618119_L_819	1196	ALK_ENST00000618119	L	819	Q9UM73	L	1196	Q9UM73_L_1196	Q9UM73	L	1196	l	77	L1196M	Q9UM73/L1196M	-2.10714	-3.04155	-2.93754	-0.65705	1.58653	2.74448	2.99869	3.18813	2.09569	2.92517	3.12183	3.29347	0.72507	0.39472	1.81289	1.8037	-3.29014	-2.42223	-1.1506	0.19169	-1.87869	-2.94667	-3.37793	-3.58831
ALK_ENST00000642122	No	Alectinib	I103N	I	103	N	308T>A	T	A	lung	carcinoma	non_small_cell_carcinoma	NS	Heterozygous	ENST00000642122.1	ALK_ENST00000642122_I_103	1171	ALK_ENST00000642122	I	103	Q9UM73	I	1171	Q9UM73_I_1171	Q9UM73	I	1171	l	52	I1171N	Q9UM73/I1171N	-5.17128	-6.74603	-6.94801	-6.49109	-3.57766	-3.2095	-3.74306	-3.41998	-2.58232	-2.53444	-3.18063	-2.96084	-6.18051	-6.39335	-7.5839	-6.3031	-6.60105	-8.88445	-9.69268	-6.19401	-4.80406	-6.58397	-6.76653	-6.06903
ABL1_ENST00000318560	No	Imatinib	G250E	G	250	E	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	Unknown	ENST00000318560.5	ABL1_ENST00000318560_G_250	250	ABL1_ENST00000318560	G	250	P00519	G	250	P00519_G_250	P00519	G	250	e	9	G250E	P00519/G250E	-6.10879	-6.25099	-7.27815	-4.42786	-2.11968	1.3822	1.76775	2.03896	1.61495	4.00556	3.01981	3.23876	-1.32824	-0.68916	-0.68473	-0.08813	-6.14112	-5.31538	-2.08641	-2.08598	-4.79607	-6.15321	-7.55871	-6.7245
ABL1_ENST00000318560	No	Dasatinib	F317L	F	317	L	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_F_317	317	ABL1_ENST00000318560	F	317	P00519	F	317	P00519_F_317	P00519	F	317	y	79	F317L	P00519/F317L	-4.46824	-4.54627	-5.33041	-7.08854	-1.29001	-1.89592	-1.93214	-1.72959	-0.94743	-1.69423	-1.77506	-1.60537	-3.09106	-2.03923	-1.23068	-1.3226	-4.47996	-4.49148	-2.7549	-2.14739	-3.56773	-4.48426	-5.71984	-7.20214
MAP2K2_ENST00000394867	No	Dabrafenib	C28S	C	28	S	83G>C	G	C	skin	malignant_melanoma	NS	NS	Heterozygous	ENST00000394867.8	MAP2K2_ENST00000394867_C_28	125	MAP2K2_ENST00000394867	C	28	P36507	C	125	P36507_C_125	P36507	C	125	l	55	C125S	P36507/C125S	-5.86934	-4.4585	-3.71844	-3.81848	-4.54959	-4.55737	-5.1601	-4.43272	-3.00439	-3.30124	-3.84466	-4.65547	-3.42458	-5.0868	-4.0687	-5.10715	-5.47932	-5.80396	-4.90301	-5.45261	-5.68618	-5.77391	-4.33277	-3.83884
KIT	Yes	Imatinib	D820G	D	820	G	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000288135.5	KIT_D_820	820	KIT	D	820	P10721	D	820	P10721_D_820	P10721	D	820	s	151	D820G	P10721/D820G	-3.74962	-4.54439	-4.94901	-4.70049	-4.8037	-3.35095	-2.16661	-1.685	-4.84883	-3.24491	-2.05916	-1.59999	-4.63427	-4.41398	-3.56932	-3.26113	-4.22884	-5.13095	-2.62641	-0.57396	-3.68791	-4.32864	-4.78558	-4.50256
BTK_ENST00000308731	No	Ibrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	Unknown	ENST00000308731.7	BTK_ENST00000308731_C_481	481	BTK_ENST00000308731	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
EGFR	Yes	Osimertinib	G796D	G	796	D	?	?	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_G_796	796	EGFR	G	796	P00533	G	796	P00533_G_796	P00533	G	796	g	83	G796D	P00533/G796D	-5.23084	-5.8221	-6.20937	-7.44392	-6.52434	-7.57015	-8.93347	-9.76853	-6.6158	-7.43516	-8.94097	-10.22063	-3.0557	-4.32564	-5.07775	-5.61309	-5.29795	-6.04319	-8.1424	-8.6306	-5.17932	-5.57984	-5.85905	-7.24734
EGFR_ENST00000455089	No	Erlotinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	EGFR_ENST00000455089_T_745	790	EGFR_ENST00000455089	T	745	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
BTK_ENST00000618050	No	Ibrutinib	C481S	C	481	S	1441T>A	T	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Unknown	ENST00000618050.4	BTK_ENST00000618050_C_481	481	BTK_ENST00000618050	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
BTK_ENST00000308731	No	Ibrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Unknown	ENST00000308731.7	BTK_ENST00000308731_C_481	481	BTK_ENST00000308731	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
EGFR	Yes	Osimertinib	C797S	C	797	S	?	?	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_C_797	797	EGFR	C	797	P00533	C	797	P00533_C_797	P00533	C	797	e	84	C797S	P00533/C797S	-6.10543	-6.64002	-6.96375	-2.21228	-7.28074	-5.17489	-1.99234	-1.36406	-7.39063	-3.56928	-2.02928	-1.47672	-3.7615	-5.10149	-5.84303	-2.46042	-6.15484	-6.83722	-5.65101	-2.29663	-6.04365	-6.40311	-6.66681	-2.05142
EGFR_ENST00000454757	No	Osimertinib	C752S	C	752	S	2254T>A	T	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	EGFR_ENST00000454757_C_752	797	EGFR_ENST00000454757	C	752	P00533	C	797	P00533_C_797	P00533	C	797	e	84	C797S	P00533/C797S	-6.10543	-6.64002	-6.96375	-2.21228	-7.28074	-5.17489	-1.99234	-1.36406	-7.39063	-3.56928	-2.02928	-1.47672	-3.7615	-5.10149	-5.84303	-2.46042	-6.15484	-6.83722	-5.65101	-2.29663	-6.04365	-6.40311	-6.66681	-2.05142
EGFR_ENST00000455089	No	Osimertinib	L673V	L	673	V	2017C>G	C	G	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	EGFR_ENST00000455089_L_673	718	EGFR_ENST00000455089	L	673	P00533	L	718	P00533_L_718	P00533	L	718	l	7	L718V	P00533/L718V	-2.87973	-3.29071	-3.57936	-3.91461	-3.8134	-4.62156	-4.61481	-5.8953	-3.88231	-3.75331	-4.5836	-5.27275	-1.6044	-2.37985	-2.86936	-3.27274	-2.91342	-3.45256	-3.99282	-4.75855	-2.85288	-3.12469	-3.31329	-3.69748
FGFR2_ENST00000478859	No	Palbociclib	N321K	N	321	K	963T>A	T	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000478859.5	FGFR2_ENST00000478859_N_321	549	FGFR2_ENST00000478859	N	321	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549K	P21802/N549K	-3.64811	-4.11211	-4.51203	-2.25892	-2.2117	-3.83119	-2.34387	-2.0932	-2.32326	-3.77184	-2.29823	-2.05102	-4.04513	-2.42111	-3.09061	-2.50446	-3.80625	-4.54717	-3.95835	-1.73318	-3.6234	-4.03561	-4.34609	-2.17698
FGFR2_ENST00000346997	No	BGJ398	E563A	E	563	A	1688A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000346997.6	FGFR2_ENST00000346997_E_563	565	FGFR2_ENST00000346997	E	563	P21802	E	565	P21802_E_565	P21802	E	565	e	78	E565A	P21802/E565A	-3.51392	-3.80037	-4.1026300000000004	-5.41668	-4.58579	-6.64823	-4.76785	-5.44841	-4.8176	-6.62651	-4.77112	-5.42876	-3.83527	-5.50045	-6.33318	-6.87154	-3.59306	-4.12673	-3.86929	-5.82732	-3.50686	-3.74738	-3.982	-5.27335
FGFR2_ENST00000613048	No	BGJ398	L528M	L	528	M	1582T>A	T	A	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000613048.4	FGFR2_ENST00000613048_L_528	617	FGFR2_ENST00000613048	L	528	P21802	L	617	P21802_L_617	P21802	L	617	l	114	L617M	P21802/L617M	-2.1073	-2.37778	-2.56432	-0.58631	-1.99526	-3.16729	-2.95701	-3.49347	-2.54812	-4.03737	-3.19557	-3.71219	-2.13592	-3.11462	-3.57144	-3.87308	-2.20905	-2.58128	-2.17398	-2.00271	-2.08409	-2.33343	-2.49224	-0.51603
ABL1_ENST00000318560	No	Imatinib	T315I	T	315	I	944C>T	C	T	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_T_315	315	ABL1_ENST00000318560	T	315	P00519	T	315	P00519_T_315	P00519	T	315	l	77	T315I	P00519/T315I	-3.83824	-3.89394	-4.90879	-4.39264	-5.08085	-3.009	-2.99728	-3.29298	-2.37856	-2.70226	-2.83383	-3.19426	-4.73256	-2.3655	-2.63879	-1.93584	-3.83098	-6.27019	-6.31943	-2.10314	-2.96885	-3.82882	-5.20793	-4.18032
FGFR2_ENST00000357555	No	INCB054828	N460H	N	460	H	1378A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000357555.9	FGFR2_ENST00000357555_N_460	549	FGFR2_ENST00000357555	N	460	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549H	P21802/N549H	-3.59202	-4.05283	-4.45204	-1.91687	-3.2987	-5.64347	-3.43921	-3.53355	-3.40495	-5.46205	-3.3852	-3.51414	-4.11275	-4.00667	-4.83075	-4.39536	-3.73976	-4.49588	-3.98204	-1.97595	-3.56699	-3.97335	-4.2944	-1.77593
ALK	Yes	Alectinib	G1202R	G	1202	R	?	?	NA	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000389048.7	ALK_G_1202	1202	ALK	G	1202	Q9UM73	G	1202	Q9UM73_G_1202	Q9UM73	G	1202	g	83	G1202R	Q9UM73/G1202R	-4.81544	-6.73839	-7.96814	-8.23089	-8.99966	-6.51938	-6.67511	-6.18498	-8.99117	-6.52312	-6.66187	-6.17488	-7.73938	-8.17917	-9.69937	-7.04627	-7.18312	-8.85833	-9.94931	-6.31567	-4.34695	-6.57222	-7.32508	-8.42016
EGFR_ENST00000455089	No	Gefitinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	EGFR_ENST00000455089_T_745	790	EGFR_ENST00000455089	T	745	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
EGFR	Yes	Gefitinib	T790M	T	790	M	?	?	NA	lung	carcinoma	bronchioloalveolar_adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
EGFR	Yes	Gefitinib	T790M	T	790	M	?	?	NA	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
EGFR	Yes	XL647	T790M	T	790	M	?	?	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
EGFR_ENST00000455089	No	Gefitinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000455089.5	EGFR_ENST00000455089_T_745	790	EGFR_ENST00000455089	T	745	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
ABL1_ENST00000318560	No	Tyrosine kinase inhibitor - NS	G250E	G	250	E	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_G_250	250	ABL1_ENST00000318560	G	250	P00519	G	250	P00519_G_250	P00519	G	250	e	9	G250E	P00519/G250E	-6.10879	-6.25099	-7.27815	-4.42786	-2.11968	1.3822	1.76775	2.03896	1.61495	4.00556	3.01981	3.23876	-1.32824	-0.68916	-0.68473	-0.08813	-6.14112	-5.31538	-2.08641	-2.08598	-4.79607	-6.15321	-7.55871	-6.7245
FLT3	Yes	Quizartinib	F691L	F	691	L	2073T>G	T	G	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	Unknown	ENST00000241453.11	FLT3_F_691	691	FLT3	F	691	P36888	F	691	P36888_F_691	P36888	F	691	l	77	F691L	P36888/F691L	-3.01988	-3.64347	-4.11973	-3.20238	-1.69933	-0.88972	0.86864	1.37904	-0.02646	0.32759	1.80925	2.18077	-1.8588	-1.09883	-0.89006	-0.86443	-3.64347	-3.7787	-2.73864	-1.26579	-3.01988	-3.58175	-4.04303	-4.20638
ALK_ENST00000642122	No	Crizotinib	L128M	L	128	M	382C>A	C	A	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000642122.1	ALK_ENST00000642122_L_128	1196	ALK_ENST00000642122	L	128	Q9UM73	L	1196	Q9UM73_L_1196	Q9UM73	L	1196	l	77	L1196M	Q9UM73/L1196M	-2.10714	-3.04155	-2.93754	-0.65705	1.58653	2.74448	2.99869	3.18813	2.09569	2.92517	3.12183	3.29347	0.72507	0.39472	1.81289	1.8037	-3.29014	-2.42223	-1.1506	0.19169	-1.87869	-2.94667	-3.37793	-3.58831
FLT3	Yes	Sorafenib	D835H	D	835	H	2503G>C	G	C	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	Heterozygous	ENST00000241453.11	FLT3_D_835	835	FLT3	D	835	P36888	D	835	P36888_D_835	P36888	D	835	e	147	D835H	P36888/D835H	-3.55133	-4.72601	-5.49541	-5.16599	-6.09656	-3.05156	-3.10448	-2.87845	-2.38124	-3.29706	-3.07925	-2.8326	-4.78879	-5.86144	-5.22765	-4.78947	-4.72601	-5.98703	-0.51086	-1.79689	-3.55133	-4.68193	-5.4409	-4.9458
MET_ENST00000397752	No	Capmatinib	Y1230H	Y	1230	H	3688T>C	T	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000397752.7	MET_ENST00000397752_Y_1230	1230	MET_ENST00000397752	Y	1230	P08581	Y	1230	P08581_Y_1230	P08581	Y	1230	e	149	Y1230H	P08581/Y1230H	-4.76153	-4.89342	-5.71108	-6.70023	-4.80158	-5.19732	-5.53226	-6.10165	-3.6873	-4.4115	-4.07175	-4.82115	NA	-3.22438	-3.22438	-3.12487	-4.47446	-4.67827	-5.68985	-6.26703	-4.47804	-4.65967	-5.67953	-6.41406
BTK	Yes	Ibrutinib	C515S	C	515	S	1543T>A	T	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	Unknown	ENST00000621635.4	BTK_C_515	515	BTK	C	515	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
EGFR_ENST00000454757	No	Osimertinib	L673Q	L	673	Q	2018T>A	T	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	EGFR_ENST00000454757_L_673	718	EGFR_ENST00000454757	L	673	P00533	L	718	P00533_L_718	P00533	L	718	l	7	L718Q	P00533/L718Q	-5.05825	-5.64597	-6.05984	-7.36659	-6.36485	-7.36319	-7.88834	-9.14273	-6.4587	-6.85261	-7.91901	-8.63806	-2.97989	-4.1502	-4.92061	-5.49016	-5.11756	-5.85864	-7.27968	-8.23138	-4.99883	-5.39418	-5.67361	-7.19663
EGFR_ENST00000454757	No	Osimertinib	G674A	G	674	A	2021G>C	G	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	EGFR_ENST00000454757_G_674	719	EGFR_ENST00000454757	G	674	P00533	G	719	P00533_G_719	P00533	G	719	G	8	G719A	P00533/G719A	-4.74871	-5.28911	-5.602	-7.80799	-5.85998	-6.76259	-8.02437	-10.43804	-5.95321	-6.6504200000000004	-8.0232	-9.37463	-2.68973	-3.87769	-4.62106	-5.08808	-4.80937	-5.47056	-7.31253	-9.19353	-4.69939	-5.07307	-5.31496	-7.63835
FGFR2_ENST00000369060	No	BGJ398	E449A	E	449	A	1346A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000369060.8	FGFR2_ENST00000369060_E_449	565	FGFR2_ENST00000369060	E	449	P21802	E	565	P21802_E_565	P21802	E	565	e	78	E565A	P21802/E565A	-3.51392	-3.80037	-4.1026300000000004	-5.41668	-4.58579	-6.64823	-4.76785	-5.44841	-4.8176	-6.62651	-4.77112	-5.42876	-3.83527	-5.50045	-6.33318	-6.87154	-3.59306	-4.12673	-3.86929	-5.82732	-3.50686	-3.74738	-3.982	-5.27335
FGFR2_ENST00000360144	No	BGJ398	E477A	E	477	A	1430A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000360144.7	FGFR2_ENST00000360144_E_477	568	FGFR2_ENST00000360144	E	477	P21802	E	565	P21802_E_565	P21802	E	565	e	78	E565A	P21802/E565A	-3.51392	-3.80037	-4.1026300000000004	-5.41668	-4.58579	-6.64823	-4.76785	-5.44841	-4.8176	-6.62651	-4.77112	-5.42876	-3.83527	-5.50045	-6.33318	-6.87154	-3.59306	-4.12673	-3.86929	-5.82732	-3.50686	-3.74738	-3.982	-5.27335
FGFR2_ENST00000369061	No	INCB054828	N437H	N	437	H	1309A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000369061.8	FGFR2_ENST00000369061_N_437	549	FGFR2_ENST00000369061	N	437	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549H	P21802/N549H	-3.59202	-4.05283	-4.45204	-1.91687	-3.2987	-5.64347	-3.43921	-3.53355	-3.40495	-5.46205	-3.3852	-3.51414	-4.11275	-4.00667	-4.83075	-4.39536	-3.73976	-4.49588	-3.98204	-1.97595	-3.56699	-3.97335	-4.2944	-1.77593
EGFR	Yes	Gefitinib	T790M	T	790	M	2369C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
ABL1_ENST00000318560	No	Imatinib	T315I	T	315	I	944C>T	C	T	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	Unknown	ENST00000318560.5	ABL1_ENST00000318560_T_315	315	ABL1_ENST00000318560	T	315	P00519	T	315	P00519_T_315	P00519	T	315	l	77	T315I	P00519/T315I	-3.83824	-3.89394	-4.90879	-4.39264	-5.08085	-3.009	-2.99728	-3.29298	-2.37856	-2.70226	-2.83383	-3.19426	-4.73256	-2.3655	-2.63879	-1.93584	-3.83098	-6.27019	-6.31943	-2.10314	-2.96885	-3.82882	-5.20793	-4.18032
ABL1_ENST00000318560	No	Imatinib	F317L	F	317	L	951C>G	C	G	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_F_317	317	ABL1_ENST00000318560	F	317	P00519	F	317	P00519_F_317	P00519	F	317	y	79	F317L	P00519/F317L	-4.46824	-4.54627	-5.33041	-7.08854	-1.29001	-1.89592	-1.93214	-1.72959	-0.94743	-1.69423	-1.77506	-1.60537	-3.09106	-2.03923	-1.23068	-1.3226	-4.47996	-4.49148	-2.7549	-2.14739	-3.56773	-4.48426	-5.71984	-7.20214
EGFR	Yes	Afatinib	T790M	T	790	M	?	?	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
KIT	Yes	Imatinib	D820E	D	820	E	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000288135.5	KIT_D_820	820	KIT	D	820	P10721	D	820	P10721_D_820	P10721	D	820	s	151	D820E	P10721/D820E	-2.82958	-3.82597	-4.28351	-3.60032	-4.29314	-2.71429	-1.76351	-1.75803	-4.42793	-2.51089	-1.6811	-1.64789	-3.88105	-3.37616	-2.71967	-1.71802	-3.45527	-4.46882	-2.91847	-1.61746	-2.72452	-3.55671	-4.11496	-3.46792
EGFR_ENST00000455089	No	Osimertinib	C752G	C	752	G	2254T>G	T	G	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	EGFR_ENST00000455089_C_752	797	EGFR_ENST00000455089	C	752	P00533	C	797	P00533_C_797	P00533	C	797	e	84	C797G	P00533/C797G	-5.97076	-6.42613	-6.73566	-5.80842	-7.04007	-6.20105	-6.02635	-7.11823	-7.1529	-5.81504	-6.03735	-6.51646	-4.13498	-5.24136	-5.87238	-4.42025	-5.99639	-6.61957	-6.01513	-6.47651	-5.92585	-6.21455	-6.45619	-5.4909
BTK	Yes	Ibrutinib	C515S	C	515	S	1544G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Unknown	ENST00000621635.4	BTK_C_515	515	BTK	C	515	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
ALK	Yes	Crizotinib	L1196M	L	1196	M	?	?	NA	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000389048.7	ALK_L_1196	1196	ALK	L	1196	Q9UM73	L	1196	Q9UM73_L_1196	Q9UM73	L	1196	l	77	L1196M	Q9UM73/L1196M	-2.10714	-3.04155	-2.93754	-0.65705	1.58653	2.74448	2.99869	3.18813	2.09569	2.92517	3.12183	3.29347	0.72507	0.39472	1.81289	1.8037	-3.29014	-2.42223	-1.1506	0.19169	-1.87869	-2.94667	-3.37793	-3.58831
EGFR_ENST00000454757	No	Osimertinib	L747F	L	747	F	2239C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	EGFR_ENST00000454757_L_747	792	EGFR_ENST00000454757	L	747	P00533	L	792	P00533_L_792	P00533	L	792	y	79	L792F	P00533/L792F	-2.59609	-2.89655	-2.59418	-3.10204	-2.79463	-2.94014	-1.89723	-2.17756	-3.42147	-2.14595	-1.75152	-1.6736	-1.66999	-2.31034	-2.60281	-1.15156	-2.61965	-3.02695	-3.21165	-2.9848	-2.56703	-2.76477	-2.90067	-2.79167
EGFR	Yes	Osimertinib	C797S	C	797	S	2390G>C	G	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_C_797	797	EGFR	C	797	P00533	C	797	P00533_C_797	P00533	C	797	e	84	C797S	P00533/C797S	-6.10543	-6.64002	-6.96375	-2.21228	-7.28074	-5.17489	-1.99234	-1.36406	-7.39063	-3.56928	-2.02928	-1.47672	-3.7615	-5.10149	-5.84303	-2.46042	-6.15484	-6.83722	-5.65101	-2.29663	-6.04365	-6.40311	-6.66681	-2.05142
EGFR	Yes	Osimertinib	C797S	C	797	S	2389T>A	T	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_C_797	797	EGFR	C	797	P00533	C	797	P00533_C_797	P00533	C	797	e	84	C797S	P00533/C797S	-6.10543	-6.64002	-6.96375	-2.21228	-7.28074	-5.17489	-1.99234	-1.36406	-7.39063	-3.56928	-2.02928	-1.47672	-3.7615	-5.10149	-5.84303	-2.46042	-6.15484	-6.83722	-5.65101	-2.29663	-6.04365	-6.40311	-6.66681	-2.05142
FGFR2_ENST00000358487	No	FGFR	N549D	N	549	D	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	FGFR2_ENST00000358487_N_549	549	FGFR2_ENST00000358487	N	549	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549D	P21802/N549D	-3.03058	-3.37266	-3.69536	-2.98176	-3.423	-6.00578	-5.27942	-4.75236	-3.39507	-6.14844	-5.23934	-4.71553	-3.35914	-3.35922	-3.94484	-3.93016	-3.14341	-3.71937	-3.2767	-1.77236	-3.02168	-3.31144	-3.56606	-2.9123
KIT	Yes	Imatinib	V654A	V	654	A	1961T>C	T	C	soft_tissue	gastrointestinal_stromal_tumour	epithelioid	NS	Unknown	ENST00000288135.5	KIT_V_654	654	KIT	V	654	P10721	V	654	P10721_V_654	P10721	V	654	v	61	V654A	P10721/V654A	-3.0421	-3.91067	-4.28896	-4.96082	-5.97083	-6.55487	-4.62666	-4.76232	-6.07968	-6.51538	-4.42426	-4.7495	-3.86516	-4.78749	-4.69194	-5.04105	-3.59732	-4.43669	-5.88686	-5.92714	-2.94308	-3.67093	-4.14688	-4.77469
BTK_ENST00000308731	No	Ibrutinib	C481Y	C	481	Y	1442G>A	G	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	Unknown	ENST00000308731.7	BTK_ENST00000308731_C_481	481	BTK_ENST00000308731	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481Y	Q06187/C481Y	-7.42147	-6.85939	-7.0678	-9.31334	-6.81445	-6.28611	-6.37594	-7.34037	-3.91449	-5.45128	-5.70888	-6.59455	-4.26101	-4.15799	-2.72652	-2.51016	-7.12058	-4.37441	-5.39488	-6.19902	-6.08369	-7.18425	-6.09403	-6.93796
BTK_ENST00000618050	No	Ibrutinib	C481Y	C	481	Y	1442G>A	G	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Unknown	ENST00000618050.4	BTK_ENST00000618050_C_481	481	BTK_ENST00000618050	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481Y	Q06187/C481Y	-7.42147	-6.85939	-7.0678	-9.31334	-6.81445	-6.28611	-6.37594	-7.34037	-3.91449	-5.45128	-5.70888	-6.59455	-4.26101	-4.15799	-2.72652	-2.51016	-7.12058	-4.37441	-5.39488	-6.19902	-6.08369	-7.18425	-6.09403	-6.93796
BTK	Yes	Ibrutinib	C515R	C	515	R	1543T>C	T	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Unknown	ENST00000621635.4	BTK_C_515	515	BTK	C	515	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481R	Q06187/C481R	-7.59736	-7.01492	-7.02913	-8.95434	-6.28501	-4.78858	-4.65653	-4.74512	-3.18939	-3.94997	-3.97793	-3.98402	-4.23537	-3.64002	-2.08052	-1.88146	-7.29244	-4.44362	-3.4003	-3.45565	-6.1538	-7.36528	-5.89095	-6.49942
EGFR	Yes	Osimertinib	L718Q	L	718	Q	2153T>A	T	A	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000275493.6	EGFR_L_718	718	EGFR	L	718	P00533	L	718	P00533_L_718	P00533	L	718	l	7	L718Q	P00533/L718Q	-5.05825	-5.64597	-6.05984	-7.36659	-6.36485	-7.36319	-7.88834	-9.14273	-6.4587	-6.85261	-7.91901	-8.63806	-2.97989	-4.1502	-4.92061	-5.49016	-5.11756	-5.85864	-7.27968	-8.23138	-4.99883	-5.39418	-5.67361	-7.19663
EGFR_ENST00000455089	No	Osimertinib	C752S	C	752	S	2254T>A	T	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	EGFR_ENST00000455089_C_752	797	EGFR_ENST00000455089	C	752	P00533	C	797	P00533_C_797	P00533	C	797	e	84	C797S	P00533/C797S	-6.10543	-6.64002	-6.96375	-2.21228	-7.28074	-5.17489	-1.99234	-1.36406	-7.39063	-3.56928	-2.02928	-1.47672	-3.7615	-5.10149	-5.84303	-2.46042	-6.15484	-6.83722	-5.65101	-2.29663	-6.04365	-6.40311	-6.66681	-2.05142
EGFR_ENST00000455089	No	Osimertinib	L673Q	L	673	Q	2018T>A	T	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	EGFR_ENST00000455089_L_673	718	EGFR_ENST00000455089	L	673	P00533	L	718	P00533_L_718	P00533	L	718	l	7	L718Q	P00533/L718Q	-5.05825	-5.64597	-6.05984	-7.36659	-6.36485	-7.36319	-7.88834	-9.14273	-6.4587	-6.85261	-7.91901	-8.63806	-2.97989	-4.1502	-4.92061	-5.49016	-5.11756	-5.85864	-7.27968	-8.23138	-4.99883	-5.39418	-5.67361	-7.19663
FGFR1_ENST00000326324	No	Palbociclib	N455K	N	455	K	1365C>A	C	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000326324.10	FGFR1_ENST00000326324_N_455	546	FGFR1_ENST00000326324	N	455	P11362	N	546	P11362_N_546	P11362	N	546	r	62	N546K	P11362/N546K	-3.13103	-3.95788	-5.01381	-2.25003	-2.27094	-3.82251	-2.35447	-2.0932	-2.45129	-3.71966	-2.28948	-2.07549	-4.04513	-2.42111	-3.09498	-2.50446	-3.44124	-4.39563	-4.24681	-1.09163	-3.14929	-3.56415	-4.57374	-2.1373
EGFR_ENST00000454757	No	Erlotinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	bronchioloalveolar_adenocarcinoma	NS	Unknown	ENST00000454757.6	EGFR_ENST00000454757_T_745	790	EGFR_ENST00000454757	T	745	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
EGFR	Yes	Gefitinib	T790M	T	790	M	2369C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
EGFR	Yes	Tyrosine kinase inhibitor - NS	T790M	T	790	M	2369C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
ALK	Yes	Crizotinib	L1196M	L	1196	M	3586C>A	C	A	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000389048.7	ALK_L_1196	1196	ALK	L	1196	Q9UM73	L	1196	Q9UM73_L_1196	Q9UM73	L	1196	l	77	L1196M	Q9UM73/L1196M	-2.10714	-3.04155	-2.93754	-0.65705	1.58653	2.74448	2.99869	3.18813	2.09569	2.92517	3.12183	3.29347	0.72507	0.39472	1.81289	1.8037	-3.29014	-2.42223	-1.1506	0.19169	-1.87869	-2.94667	-3.37793	-3.58831
BTK_ENST00000618050	No	Ibrutinib	C481S	C	481	S	1442_1443delinsCT	T	NA	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	mantle_cell_lymphoma	NS	Unknown	ENST00000618050.4	BTK_ENST00000618050_C_481	481	BTK_ENST00000618050	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
BTK	Yes	Ibrutinib	C515Y	C	515	Y	1544G>A	G	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Unknown	ENST00000621635.4	BTK_C_515	515	BTK	C	515	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481Y	Q06187/C481Y	-7.42147	-6.85939	-7.0678	-9.31334	-6.81445	-6.28611	-6.37594	-7.34037	-3.91449	-5.45128	-5.70888	-6.59455	-4.26101	-4.15799	-2.72652	-2.51016	-7.12058	-4.37441	-5.39488	-6.19902	-6.08369	-7.18425	-6.09403	-6.93796
EGFR_ENST00000454757	No	Osimertinib	C752S	C	752	S	2254T>A	T	A	lung	carcinoma	non_small_cell_carcinoma	NS	Heterozygous	ENST00000454757.6	EGFR_ENST00000454757_C_752	797	EGFR_ENST00000454757	C	752	P00533	C	797	P00533_C_797	P00533	C	797	e	84	C797S	P00533/C797S	-6.10543	-6.64002	-6.96375	-2.21228	-7.28074	-5.17489	-1.99234	-1.36406	-7.39063	-3.56928	-2.02928	-1.47672	-3.7615	-5.10149	-5.84303	-2.46042	-6.15484	-6.83722	-5.65101	-2.29663	-6.04365	-6.40311	-6.66681	-2.05142
ALK	Yes	Alectinib	G1202R	G	1202	R	3604G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000389048.7	ALK_G_1202	1202	ALK	G	1202	Q9UM73	G	1202	Q9UM73_G_1202	Q9UM73	G	1202	g	83	G1202R	Q9UM73/G1202R	-4.81544	-6.73839	-7.96814	-8.23089	-8.99966	-6.51938	-6.67511	-6.18498	-8.99117	-6.52312	-6.66187	-6.17488	-7.73938	-8.17917	-9.69937	-7.04627	-7.18312	-8.85833	-9.94931	-6.31567	-4.34695	-6.57222	-7.32508	-8.42016
EGFR_ENST00000454757	No	Osimertinib	L747H	L	747	H	2240T>A	T	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	EGFR_ENST00000454757_L_747	792	EGFR_ENST00000454757	L	747	P00533	L	792	P00533_L_792	P00533	L	792	y	79	L792H	P00533/L792H	-4.8254	-5.38517	-5.70241	-4.97976	-5.97338	-5.92185	-5.13719	-5.83715	-6.16791	-4.82256	-5.05571	-5.49757	-2.9369	-4.01774	-4.70132	-3.09963	-4.88608	-5.59856	-5.9826	-6.32968	-4.77562	-5.16063	-5.41901	-4.6062
FGFR2_ENST00000358487	No	TAS-120	N549K	N	549	K	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	FGFR2_ENST00000358487_N_549	549	FGFR2_ENST00000358487	N	549	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549K	P21802/N549K	-3.64811	-4.11211	-4.51203	-2.25892	-2.2117	-3.83119	-2.34387	-2.0932	-2.32326	-3.77184	-2.29823	-2.05102	-4.04513	-2.42111	-3.09061	-2.50446	-3.80625	-4.54717	-3.95835	-1.73318	-3.6234	-4.03561	-4.34609	-2.17698
FGFR2_ENST00000351936	No	BGJ398	E565A	E	565	A	1694A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000351936.10	FGFR2_ENST00000351936_E_565	567	FGFR2_ENST00000351936	E	565	P21802	E	565	P21802_E_565	P21802	E	565	e	78	E565A	P21802/E565A	-3.51392	-3.80037	-4.1026300000000004	-5.41668	-4.58579	-6.64823	-4.76785	-5.44841	-4.8176	-6.62651	-4.77112	-5.42876	-3.83527	-5.50045	-6.33318	-6.87154	-3.59306	-4.12673	-3.86929	-5.82732	-3.50686	-3.74738	-3.982	-5.27335
FGFR2_ENST00000358487	No	BGJ398	E565A	E	565	A	1694A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	FGFR2_ENST00000358487_E_565	565	FGFR2_ENST00000358487	E	565	P21802	E	565	P21802_E_565	P21802	E	565	e	78	E565A	P21802/E565A	-3.51392	-3.80037	-4.1026300000000004	-5.41668	-4.58579	-6.64823	-4.76785	-5.44841	-4.8176	-6.62651	-4.77112	-5.42876	-3.83527	-5.50045	-6.33318	-6.87154	-3.59306	-4.12673	-3.86929	-5.82732	-3.50686	-3.74738	-3.982	-5.27335
ABL1	Yes	Imatinib	F336L	F	336	L	1008C>G	C	G	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000372348.6	ABL1_F_336	336	ABL1	F	336	P00519	F	317	P00519_F_317	P00519	F	317	y	79	F317L	P00519/F317L	-4.46824	-4.54627	-5.33041	-7.08854	-1.29001	-1.89592	-1.93214	-1.72959	-0.94743	-1.69423	-1.77506	-1.60537	-3.09106	-2.03923	-1.23068	-1.3226	-4.47996	-4.49148	-2.7549	-2.14739	-3.56773	-4.48426	-5.71984	-7.20214
EGFR	Yes	Tyrosine kinase inhibitor - NS	T790M	T	790	M	2369C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
FLT3	Yes	Quizartinib	D835V	D	835	V	2504A>T	A	T	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	Unknown	ENST00000241453.11	FLT3_D_835	835	FLT3	D	835	P36888	D	835	P36888_D_835	P36888	D	835	e	147	D835V	P36888/D835V	-4.96562	-6.21256	-7.04139	-7.03779	-7.64955	-5.40875	-3.16203	-2.56912	-7.66318	-5.73566	-3.14655	-2.54353	-6.37617	-7.44297	-6.90696	-6.78856	-6.21256	-7.55115	-4.32197	-1.06469	-4.96562	-6.15481	-6.99066	-6.7724
EGFR_ENST00000454757	No	Gefitinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000454757.6	EGFR_ENST00000454757_T_745	790	EGFR_ENST00000454757	T	745	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
BTK_ENST00000618050	No	Ibrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	Unknown	ENST00000618050.4	BTK_ENST00000618050_C_481	481	BTK_ENST00000618050	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
FGFR2	Yes	BGJ398	L618M	L	618	M	1852T>A	T	A	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000457416.6	FGFR2_L_618	620	FGFR2	L	618	P21802	L	617	P21802_L_617	P21802	L	617	l	114	L617M	P21802/L617M	-2.1073	-2.37778	-2.56432	-0.58631	-1.99526	-3.16729	-2.95701	-3.49347	-2.54812	-4.03737	-3.19557	-3.71219	-2.13592	-3.11462	-3.57144	-3.87308	-2.20905	-2.58128	-2.17398	-2.00271	-2.08409	-2.33343	-2.49224	-0.51603
FGFR2_ENST00000346997	No	BGJ398	L615M	L	615	M	1843T>A	T	A	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000346997.6	FGFR2_ENST00000346997_L_615	617	FGFR2_ENST00000346997	L	615	P21802	L	617	P21802_L_617	P21802	L	617	l	114	L617M	P21802/L617M	-2.1073	-2.37778	-2.56432	-0.58631	-1.99526	-3.16729	-2.95701	-3.49347	-2.54812	-4.03737	-3.19557	-3.71219	-2.13592	-3.11462	-3.57144	-3.87308	-2.20905	-2.58128	-2.17398	-2.00271	-2.08409	-2.33343	-2.49224	-0.51603
EGFR_ENST00000455089	No	Erlotinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000455089.5	EGFR_ENST00000455089_T_745	790	EGFR_ENST00000455089	T	745	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
KDR	Yes	Cetuximab	L840F	L	840	F	2518C>T	C	T	large_intestine	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000645273.1	KDR_L_840	840	KDR	L	840	P35968	L	840	P35968_L_840	P35968	L	840	l	7	L840F	P35968/L840F	-3.45547	-3.88577	-4.08777	-4.73728	-4.33993	-4.909	-6.59791	-7.00366	-4.57468	-5.2917	-6.06613	-6.81201	-3.03397	-3.5591	-3.87938	-3.35501	-2.32656	-3.38252	-4.39197	-5.06598	-2.27186	-3.12373	-3.73069	-4.63944
KIT	Yes	Imatinib	N822K	N	822	K	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	spindle_and_epithelioid	NS	Unknown	ENST00000288135.5	KIT_N_822	822	KIT	N	822	P10721	N	822	P10721_N_822	P10721	N	822	k	153	N822K	P10721/N822K	-3.43164	-4.65104	-5.21801	-4.95388	-4.84253	-2.03841	-1.844	-1.6082	-4.85631	-1.78246	-1.69447	-1.44971	-4.70887	-4.01165	-3.0352	-0.87894	-4.196	-4.44176	-2.84777	-2.514	-3.33111	-4.31337	-5.02839	-4.78265
ERBB2_ENST00000406381	No	Trastuzumab	L839R	L	839	R	2516T>G	T	G	breast	carcinoma	ductal_carcinoma	NS	Unknown	ENST00000406381.6	ERBB2_ENST00000406381_L_839	869	ERBB2_ENST00000406381	L	839	P04626	L	869	P04626_L_869	P04626	L	869	e	147	L869R	P04626/L869R	-4.58599	-5.51191	-6.16009	-4.4753	-6.62002	-7.22887	-7.71834	-6.71801	-6.05186	-7.10053	-8.34153	-9.28128	-2.97229	-4.13897	-4.83246	-5.40982	-4.92181	-6.14972	-7.62842	-6.37544	-4.50616	-5.40427	-6.11379	-4.44968
KIT	Yes	Imatinib	D816E	D	816	E	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000288135.5	KIT_D_816	816	KIT	D	816	P10721	D	816	P10721_D_816	P10721	D	816	e	147	D816E	P10721/D816E	-2.82958	-3.82597	-4.28351	-3.5839	-4.49372	-4.01731	-3.02961	-2.82581	-4.89268	-3.9718	-3.00779	-2.78364	-3.88105	-4.95912	-4.28354	-2.73595	-3.45527	-4.46882	-2.79109	-2.3757	-2.72452	-3.55671	-4.11496	-3.46792
KIT	Yes	Imatinib	A829P	A	829	P	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000288135.5	KIT_A_829	829	KIT	A	829	P10721	A	829	P10721_A_829	P10721	A	829	f	157	A829P	P10721/A829P	-3.1707	-3.41791	-3.85179	-3.57403	-5.2594	-3.96685	-3.3405	-2.37821	-5.40868	-3.78603	-3.24772	-2.27798	-2.83151	-3.83099	-3.71698	-2.9407	-3.62693	-3.62633	-3.57147	-3.12061	-3.11389	-3.22891	-3.7098	-3.1564
ALK_ENST00000618119	No	Alectinib	G825R	G	825	R	2473G>A	G	A	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000618119.4	ALK_ENST00000618119_G_825	1202	ALK_ENST00000618119	G	825	Q9UM73	G	1202	Q9UM73_G_1202	Q9UM73	G	1202	g	83	G1202R	Q9UM73/G1202R	-4.81544	-6.73839	-7.96814	-8.23089	-8.99966	-6.51938	-6.67511	-6.18498	-8.99117	-6.52312	-6.66187	-6.17488	-7.73938	-8.17917	-9.69937	-7.04627	-7.18312	-8.85833	-9.94931	-6.31567	-4.34695	-6.57222	-7.32508	-8.42016
EGFR	Yes	Afatinib	T790M	T	790	M	?	?	NA	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
BTK_ENST00000308731	No	Ibrutinib	C481S	C	481	S	1442_1443delinsCT	T	NA	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	mantle_cell_lymphoma	NS	Unknown	ENST00000308731.7	BTK_ENST00000308731_C_481	481	BTK_ENST00000308731	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
BTK	Yes	Ibrutinib	C515S	C	515	S	1544G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	mantle_cell_lymphoma	NS	Unknown	ENST00000621635.4	BTK_C_515	515	BTK	C	515	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
EGFR	Yes	Osimertinib	L792F	L	792	F	2374C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_L_792	792	EGFR	L	792	P00533	L	792	P00533_L_792	P00533	L	792	y	79	L792F	P00533/L792F	-2.59609	-2.89655	-2.59418	-3.10204	-2.79463	-2.94014	-1.89723	-2.17756	-3.42147	-2.14595	-1.75152	-1.6736	-1.66999	-2.31034	-2.60281	-1.15156	-2.61965	-3.02695	-3.21165	-2.9848	-2.56703	-2.76477	-2.90067	-2.79167
EGFR	Yes	Osimertinib	G796R	G	796	R	2386G>C	G	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_G_796	796	EGFR	G	796	P00533	G	796	P00533_G_796	P00533	G	796	g	83	G796R	P00533/G796R	-5.8894	-6.50654	-6.88271	-7.69727	-7.18103	-8.1574	-9.35562	-9.83555	-7.27842	-8.07728	-9.35596	-10.43741	-3.43735	-4.80524	-5.63375	-6.24461	-5.96451	-6.71416	-8.62616	-8.7685	-5.82291	-6.25349	-6.54279	-7.52392
EGFR	Yes	Erlotinib	T790M	T	790	M	2369C>T	C	T	lung	carcinoma	non_small_cell_carcinoma	NS	Heterozygous	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
EGFR_ENST00000454757	No	Osimertinib	C752S	C	752	S	2255G>C	G	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	EGFR_ENST00000454757_C_752	797	EGFR_ENST00000454757	C	752	P00533	C	797	P00533_C_797	P00533	C	797	e	84	C797S	P00533/C797S	-6.10543	-6.64002	-6.96375	-2.21228	-7.28074	-5.17489	-1.99234	-1.36406	-7.39063	-3.56928	-2.02928	-1.47672	-3.7615	-5.10149	-5.84303	-2.46042	-6.15484	-6.83722	-5.65101	-2.29663	-6.04365	-6.40311	-6.66681	-2.05142
EGFR	Yes	Osimertinib	L792R	L	792	R	2375T>G	T	G	lung	carcinoma	small_cell_carcinoma	NS	Unknown	ENST00000275493.6	EGFR_L_792	792	EGFR	L	792	P00533	L	792	P00533_L_792	P00533	L	792	y	79	L792R	P00533/L792R	-4.96286	-5.52208	-5.81876	-5.52458	-6.10266	-6.50809	-6.50853	-6.33732	-6.33728	-6.2104	-6.68425	-6.14665	-3.0097	-4.13503	-4.83246	-4.07524	-5.02047	-5.73482	-6.94495	-7.1884	-4.91371	-5.2765	-5.55817	-5.40253
EGFR	Yes	Osimertinib	G719A	G	719	A	2156G>C	G	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_G_719	719	EGFR	G	719	P00533	G	719	P00533_G_719	P00533	G	719	G	8	G719A	P00533/G719A	-4.74871	-5.28911	-5.602	-7.80799	-5.85998	-6.76259	-8.02437	-10.43804	-5.95321	-6.6504200000000004	-8.0232	-9.37463	-2.68973	-3.87769	-4.62106	-5.08808	-4.80937	-5.47056	-7.31253	-9.19353	-4.69939	-5.07307	-5.31496	-7.63835
MAP2K2_ENST00000394867	No	Dabrafenib	N29D	N	29	D	85A>G	A	G	NS	malignant_melanoma	NS	NS	Unknown	ENST00000394867.8	MAP2K2_ENST00000394867_N_29	126	MAP2K2_ENST00000394867	N	29	P36507	N	126	P36507_N_126	P36507	N	126	k	56	N126D	P36507/N126D	-2.9932	-1.75133	-0.59599	-0.16023	0.98671	0.56986	0.77648	0.34866	0.8821	0.60901	0.59771	0.49564	0.98234	1.14554	-0.54651	-0.29951	-2.7456	-2.60863	-2.13363	-0.91236	-2.89837	-2.96616	-2.79945	-1.27488
ABL1_ENST00000318560	No	Imatinib	D276G	D	276	G	827A>G	A	G	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	Unknown	ENST00000318560.5	ABL1_ENST00000318560_D_276	276	ABL1_ENST00000318560	D	276	P00519	D	276	P00519_D_276	P00519	D	276	e	35	D276G	P00519/D276G	-4.61113	-4.70641	-4.62081	-4.51285	0.09	-1.38166	-1.42012	-0.98863	0.51515	-1.12016	-1.14944	-0.70223	-0.13093	-0.72866	-0.77165	-0.73963	-4.61302	-3.3239	-1.58787	-2.30446	-3.99384	-4.62544	-4.56025	-5.17359
EGFR_ENST00000454757	No	Erlotinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000454757.6	EGFR_ENST00000454757_T_745	790	EGFR_ENST00000454757	T	745	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
ALK	Yes	Crizotinib	F1174L	F	1174	L	3522C>G	C	G	soft_tissue	inflammatory_myofibroblastic_tumour	NS	NS	Homozygous	ENST00000389048.7	ALK_F_1174	1174	ALK	F	1174	Q9UM73	F	1174	Q9UM73_F_1174	Q9UM73	F	1174	l	55	F1174L	Q9UM73/F1174L	-3.81827	-5.2478	-6.47368	-2.31841	-0.60269	0.94324	0.99964	1.10868	-0.25872	1.18764	1.16412	1.25703	-1.33672	-0.58613	-0.00266	-0.21463	-5.69483	-2.46391	-0.84444	-0.12169	-3.46176	-5.10815	-5.76626	-3.17882
ABL1_ENST00000318560	No	Tyrosine kinase inhibitor - NS	T315I	T	315	I	?	?	NA	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	Unknown	ENST00000318560.5	ABL1_ENST00000318560_T_315	315	ABL1_ENST00000318560	T	315	P00519	T	315	P00519_T_315	P00519	T	315	l	77	T315I	P00519/T315I	-3.83824	-3.89394	-4.90879	-4.39264	-5.08085	-3.009	-2.99728	-3.29298	-2.37856	-2.70226	-2.83383	-3.19426	-4.73256	-2.3655	-2.63879	-1.93584	-3.83098	-6.27019	-6.31943	-2.10314	-2.96885	-3.82882	-5.20793	-4.18032
EGFR	Yes	Erlotinib	T790M	T	790	M	?	?	NA	lung	carcinoma	acinar_adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
KIT	Yes	Imatinib	K642E	K	642	E	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Unknown	ENST00000288135.5	KIT_K_642	642	KIT	K	642	P10721	K	642	P10721_K_642	P10721	K	642	k	50	K642E	P10721/K642E	-2.86871	-3.83495	-4.33693	-5.2914	-6.0895	-0.75961	-1.10055	-1.30422	-6.2368	-0.66001	-1.03398	-1.24659	-4.05048	-5.1073	-1.31724	-0.6052	-3.4613	-4.54826	-2.02884	-1.1982	-2.78518	-3.56152	-4.15965	-5.00163
EGFR	Yes	Osimertinib	L747P	L	747	P	2239_2240delinsCC	C	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_L_747	747	EGFR	L	747	P00533	L	747	P00533_L_747	P00533	L	747	i	32	L747P	P00533/L747P	-5.15844	-5.61755	-5.97927	-7.03261	-6.26699	-7.10149	-7.60373	-5.08077	-6.36391	-6.80535	-7.6097	-4.44279	-3.67888	-4.62437	-5.24789	-5.34102	-5.19961	-5.81396	-7.50647	-7.92142	-5.1311	-5.39869	-5.6449	-6.69272
EGFR_ENST00000455089	No	Osimertinib	C752S	C	752	S	2255G>C	G	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	EGFR_ENST00000455089_C_752	797	EGFR_ENST00000455089	C	752	P00533	C	797	P00533_C_797	P00533	C	797	e	84	C797S	P00533/C797S	-6.10543	-6.64002	-6.96375	-2.21228	-7.28074	-5.17489	-1.99234	-1.36406	-7.39063	-3.56928	-2.02928	-1.47672	-3.7615	-5.10149	-5.84303	-2.46042	-6.15484	-6.83722	-5.65101	-2.29663	-6.04365	-6.40311	-6.66681	-2.05142
EGFR_ENST00000454757	No	Osimertinib	C752S	C	752	S	2255G>C	G	C	lung	carcinoma	small_cell_carcinoma	NS	Unknown	ENST00000454757.6	EGFR_ENST00000454757_C_752	797	EGFR_ENST00000454757	C	752	P00533	C	797	P00533_C_797	P00533	C	797	e	84	C797S	P00533/C797S	-6.10543	-6.64002	-6.96375	-2.21228	-7.28074	-5.17489	-1.99234	-1.36406	-7.39063	-3.56928	-2.02928	-1.47672	-3.7615	-5.10149	-5.84303	-2.46042	-6.15484	-6.83722	-5.65101	-2.29663	-6.04365	-6.40311	-6.66681	-2.05142
FGFR2_ENST00000357555	No	BGJ398	E476A	E	476	A	1427A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000357555.9	FGFR2_ENST00000357555_E_476	565	FGFR2_ENST00000357555	E	476	P21802	E	565	P21802_E_565	P21802	E	565	e	78	E565A	P21802/E565A	-3.51392	-3.80037	-4.1026300000000004	-5.41668	-4.58579	-6.64823	-4.76785	-5.44841	-4.8176	-6.62651	-4.77112	-5.42876	-3.83527	-5.50045	-6.33318	-6.87154	-3.59306	-4.12673	-3.86929	-5.82732	-3.50686	-3.74738	-3.982	-5.27335
FGFR2_ENST00000369061	No	BGJ398	L505M	L	505	M	1513T>A	T	A	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000369061.8	FGFR2_ENST00000369061_L_505	617	FGFR2_ENST00000369061	L	505	P21802	L	617	P21802_L_617	P21802	L	617	l	114	L617M	P21802/L617M	-2.1073	-2.37778	-2.56432	-0.58631	-1.99526	-3.16729	-2.95701	-3.49347	-2.54812	-4.03737	-3.19557	-3.71219	-2.13592	-3.11462	-3.57144	-3.87308	-2.20905	-2.58128	-2.17398	-2.00271	-2.08409	-2.33343	-2.49224	-0.51603
ALK_ENST00000642122	No	Crizotinib	L128M	L	128	M	382C>A	C	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000642122.1	ALK_ENST00000642122_L_128	1196	ALK_ENST00000642122	L	128	Q9UM73	L	1196	Q9UM73_L_1196	Q9UM73	L	1196	l	77	L1196M	Q9UM73/L1196M	-2.10714	-3.04155	-2.93754	-0.65705	1.58653	2.74448	2.99869	3.18813	2.09569	2.92517	3.12183	3.29347	0.72507	0.39472	1.81289	1.8037	-3.29014	-2.42223	-1.1506	0.19169	-1.87869	-2.94667	-3.37793	-3.58831
ABL1_ENST00000318560	No	Imatinib	Y253H	Y	253	H	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	Unknown	ENST00000318560.5	ABL1_ENST00000318560_Y_253	253	ABL1_ENST00000318560	Y	253	P00519	Y	253	P00519_Y_253	P00519	Y	253	f	12	Y253H	P00519/Y253H	-4.89532	-4.98695	-5.85466	-6.40595	-7.04709	-5.54449	-3.47977	-3.44568	-3.6467	-4.56531	-2.75965	-2.89919	-3.78921	-4.06068	-3.91027	-3.18392	-4.90827	-5.82537	-7.37698	-7.52041	-4.13495	-4.92132	-6.08031	-6.33863
EGFR	Yes	Gefitinib	T790M	T	790	M	2369C>T	C	T	lung	carcinoma	squamous_cell_carcinoma	NS	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
KIT	Yes	Imatinib	C809G	C	809	G	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000288135.5	KIT_C_809	809	KIT	C	809	P10721	C	809	P10721_C_809	P10721	C	809	t	140	C809G	P10721/C809G	-5.41602	-6.43427	-6.89524	-6.30445	-4.84592	-4.61218	-4.22611	-3.86201	-4.87046	-4.49714	-4.10753	-3.7546	-3.03547	-4.31105	-4.17121	-4.37649	-6.04777	-7.12275	-5.96182	-5.4037	-5.32745	-6.16419	-6.71848	-5.94644
FGFR4	Yes	Fisogatinib	V550L	V	550	L	1648G>T	G	T	liver	carcinoma	hepatocellular_carcinoma	NS	Unknown	ENST00000292408.8	FGFR4_V_550	550	FGFR4	V	550	P22455	V	550	P22455_V_550	P22455	V	550	l	77	V550L	P22455/V550L	-2.4551	-2.99716	-3.082	-1.2076	-3.37839	-3.45376	-2.33025	-1.60496	-3.24753	-3.35757	-2.23668	-1.59437	-2.66871	-3.9419	-3.38869	-1.90248	-2.8906	-3.08134	-3.31301	-1.64314	-2.45229	-2.99361	-3.02446	-1.0623
FGFR4_ENST00000393648	No	Fisogatinib	V482L	V	482	L	1444G>T	G	T	liver	carcinoma	hepatocellular_carcinoma	NS	Unknown	ENST00000393648.6	FGFR4_ENST00000393648_V_482	550	FGFR4_ENST00000393648	V	482	P22455	V	550	P22455_V_550	P22455	V	550	l	77	V550L	P22455/V550L	-2.4551	-2.99716	-3.082	-1.2076	-3.37839	-3.45376	-2.33025	-1.60496	-3.24753	-3.35757	-2.23668	-1.59437	-2.66871	-3.9419	-3.38869	-1.90248	-2.8906	-3.08134	-3.31301	-1.64314	-2.45229	-2.99361	-3.02446	-1.0623
ALK	Yes	Lorlatinib	L1196M	L	1196	M	?	?	NA	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000389048.7	ALK_L_1196	1196	ALK	L	1196	Q9UM73	L	1196	Q9UM73_L_1196	Q9UM73	L	1196	l	77	L1196M	Q9UM73/L1196M	-2.10714	-3.04155	-2.93754	-0.65705	1.58653	2.74448	2.99869	3.18813	2.09569	2.92517	3.12183	3.29347	0.72507	0.39472	1.81289	1.8037	-3.29014	-2.42223	-1.1506	0.19169	-1.87869	-2.94667	-3.37793	-3.58831
EGFR_ENST00000455089	No	Osimertinib	L747F	L	747	F	2239C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	EGFR_ENST00000455089_L_747	792	EGFR_ENST00000455089	L	747	P00533	L	792	P00533_L_792	P00533	L	792	y	79	L792F	P00533/L792F	-2.59609	-2.89655	-2.59418	-3.10204	-2.79463	-2.94014	-1.89723	-2.17756	-3.42147	-2.14595	-1.75152	-1.6736	-1.66999	-2.31034	-2.60281	-1.15156	-2.61965	-3.02695	-3.21165	-2.9848	-2.56703	-2.76477	-2.90067	-2.79167
EGFR_ENST00000455089	No	Osimertinib	L747H	L	747	H	2240T>A	T	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	EGFR_ENST00000455089_L_747	792	EGFR_ENST00000455089	L	747	P00533	L	792	P00533_L_792	P00533	L	792	y	79	L792H	P00533/L792H	-4.8254	-5.38517	-5.70241	-4.97976	-5.97338	-5.92185	-5.13719	-5.83715	-6.16791	-4.82256	-5.05571	-5.49757	-2.9369	-4.01774	-4.70132	-3.09963	-4.88608	-5.59856	-5.9826	-6.32968	-4.77562	-5.16063	-5.41901	-4.6062
FGFR2	Yes	BGJ398	E566A	E	566	A	1697A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000457416.6	FGFR2_E_566	568	FGFR2	E	566	P21802	E	565	P21802_E_565	P21802	E	565	e	78	E565A	P21802/E565A	-3.51392	-3.80037	-4.1026300000000004	-5.41668	-4.58579	-6.64823	-4.76785	-5.44841	-4.8176	-6.62651	-4.77112	-5.42876	-3.83527	-5.50045	-6.33318	-6.87154	-3.59306	-4.12673	-3.86929	-5.82732	-3.50686	-3.74738	-3.982	-5.27335
FGFR2_ENST00000369059	No	BGJ398	E451A	E	451	A	1352A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000369059.5	FGFR2_ENST00000369059_E_451	568	FGFR2_ENST00000369059	E	451	P21802	E	565	P21802_E_565	P21802	E	565	e	78	E565A	P21802/E565A	-3.51392	-3.80037	-4.1026300000000004	-5.41668	-4.58579	-6.64823	-4.76785	-5.44841	-4.8176	-6.62651	-4.77112	-5.42876	-3.83527	-5.50045	-6.33318	-6.87154	-3.59306	-4.12673	-3.86929	-5.82732	-3.50686	-3.74738	-3.982	-5.27335
MET_ENST00000397752	No	Crizotinib	D1228N	D	1228	N	3682G>A	G	A	breast	carcinoma	basal_(triple-negative)_carcinoma	NS	Unknown	ENST00000397752.7	MET_ENST00000397752_D_1228	1228	MET_ENST00000397752	D	1228	P08581	D	1228	P08581_D_1228	P08581	D	1228	e	147	D1228N	P08581/D1228N	-3.89302	-4.01672	-4.87037	-5.99475	-3.93587	-5.76835	-4.83304	-5.73344	-5.48859	-6.01457	-4.16378	-4.89599	NA	-2.44536	-2.44536	-3.29238	-3.56174	-3.76361	-4.83157	-6.00582	-3.56492	-3.74382	-4.8243	-5.69045
MAP2K1	Yes	Vemurafenib	P124L	P	124	L	371C>T	C	T	NS	malignant_melanoma	NS	NS	Unknown	ENST00000307102.9	MAP2K1_P_124	124	MAP2K1	P	124	Q02750	P	124	Q02750_P_124	Q02750	P	124	p	58	P124L	Q02750/P124L	-4.32536	-4.96281	-4.83065	-4.70525	-6.41237	-6.74282	-6.69555	-5.45584	-4.46015	-5.05171	-5.09626	-5.63378	-3.42825	-4.60081	-3.50115	-5.33579	-5.06128	-4.69757	-4.29548	-4.61463	-4.70173	-4.19717	-4.77772	-4.30673
PDGFRA	Yes	Imatinib	D842V	D	842	V	2525A>T	A	T	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000257290.9	PDGFRA_D_842	842	PDGFRA	D	842	P16234	D	842	P16234_D_842	P16234	D	842	e	147	D842V	P16234/D842V	-4.31564	-5.1395	-5.72083	-6.23429	-7.50222	-5.58834	-3.17398	-2.56912	-7.12687	-5.66214	-2.91303	-2.5456	-6.35691	-7.44297	-7.97849	-6.78856	-5.04194	-6.07278	-4.61315	-1.093	-4.28226	-5.10224	-5.65105	-5.81161
ABL1_ENST00000318560	No	Dasatinib	Y253H	Y	253	H	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_Y_253	253	ABL1_ENST00000318560	Y	253	P00519	Y	253	P00519_Y_253	P00519	Y	253	f	12	Y253H	P00519/Y253H	-4.89532	-4.98695	-5.85466	-6.40595	-7.04709	-5.54449	-3.47977	-3.44568	-3.6467	-4.56531	-2.75965	-2.89919	-3.78921	-4.06068	-3.91027	-3.18392	-4.90827	-5.82537	-7.37698	-7.52041	-4.13495	-4.92132	-6.08031	-6.33863
MET	Yes	Crizotinib	D1246N	D	1246	N	?	?	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000318493.10	MET_D_1246	1246	MET	D	1246	P08581	D	1228	P08581_D_1228	P08581	D	1228	e	147	D1228N	P08581/D1228N	-3.89302	-4.01672	-4.87037	-5.99475	-3.93587	-5.76835	-4.83304	-5.73344	-5.48859	-6.01457	-4.16378	-4.89599	NA	-2.44536	-2.44536	-3.29238	-3.56174	-3.76361	-4.83157	-6.00582	-3.56492	-3.74382	-4.8243	-5.69045
FGFR4_ENST00000393637	No	Fisogatinib	V510L	V	510	L	1528G>T	G	T	liver	carcinoma	hepatocellular_carcinoma	NS	Unknown	ENST00000393637.5	FGFR4_ENST00000393637_V_510	550	FGFR4_ENST00000393637	V	510	P22455	V	550	P22455_V_550	P22455	V	550	l	77	V550L	P22455/V550L	-2.4551	-2.99716	-3.082	-1.2076	-3.37839	-3.45376	-2.33025	-1.60496	-3.24753	-3.35757	-2.23668	-1.59437	-2.66871	-3.9419	-3.38869	-1.90248	-2.8906	-3.08134	-3.31301	-1.64314	-2.45229	-2.99361	-3.02446	-1.0623
FGFR4_ENST00000393648	No	Fisogatinib	V482M	V	482	M	1444G>A	G	A	liver	carcinoma	hepatocellular_carcinoma	NS	Unknown	ENST00000393648.6	FGFR4_ENST00000393648_V_482	550	FGFR4_ENST00000393648	V	482	P22455	V	550	P22455_V_550	P22455	V	550	l	77	V550M	P22455/V550M	-2.44418	-3.17199	-3.23108	-0.48639	-3.57459	-2.99973	-0.40315	0.13372	-3.14058	-2.29023	-0.33867	0.14108	-2.88083	-4.19547	-3.47476	-2.47998	-3.00659	-3.33739	-3.38134	-0.65289	-2.43951	-3.14519	-3.2612	-0.67212
BTK_ENST00000308731	No	Acalabrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	Unknown	ENST00000308731.7	BTK_ENST00000308731_C_481	481	BTK_ENST00000308731	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
ABL1_ENST00000318560	No	Imatinib	T315I	T	315	I	944C>T	C	T	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_T_315	315	ABL1_ENST00000318560	T	315	P00519	T	315	P00519_T_315	P00519	T	315	l	77	T315I	P00519/T315I	-3.83824	-3.89394	-4.90879	-4.39264	-5.08085	-3.009	-2.99728	-3.29298	-2.37856	-2.70226	-2.83383	-3.19426	-4.73256	-2.3655	-2.63879	-1.93584	-3.83098	-6.27019	-6.31943	-2.10314	-2.96885	-3.82882	-5.20793	-4.18032
ABL1_ENST00000318560	No	Imatinib	T315I	T	315	I	?	?	NA	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_T_315	315	ABL1_ENST00000318560	T	315	P00519	T	315	P00519_T_315	P00519	T	315	l	77	T315I	P00519/T315I	-3.83824	-3.89394	-4.90879	-4.39264	-5.08085	-3.009	-2.99728	-3.29298	-2.37856	-2.70226	-2.83383	-3.19426	-4.73256	-2.3655	-2.63879	-1.93584	-3.83098	-6.27019	-6.31943	-2.10314	-2.96885	-3.82882	-5.20793	-4.18032
ABL1_ENST00000318560	No	Imatinib	G250E	G	250	E	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_G_250	250	ABL1_ENST00000318560	G	250	P00519	G	250	P00519_G_250	P00519	G	250	e	9	G250E	P00519/G250E	-6.10879	-6.25099	-7.27815	-4.42786	-2.11968	1.3822	1.76775	2.03896	1.61495	4.00556	3.01981	3.23876	-1.32824	-0.68916	-0.68473	-0.08813	-6.14112	-5.31538	-2.08641	-2.08598	-4.79607	-6.15321	-7.55871	-6.7245
EGFR_ENST00000454757	No	Erlotinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	EGFR_ENST00000454757_T_745	790	EGFR_ENST00000454757	T	745	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
KIT	Yes	Imatinib	D820G	D	820	G	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Unknown	ENST00000288135.5	KIT_D_820	820	KIT	D	820	P10721	D	820	P10721_D_820	P10721	D	820	s	151	D820G	P10721/D820G	-3.74962	-4.54439	-4.94901	-4.70049	-4.8037	-3.35095	-2.16661	-1.685	-4.84883	-3.24491	-2.05916	-1.59999	-4.63427	-4.41398	-3.56932	-3.26113	-4.22884	-5.13095	-2.62641	-0.57396	-3.68791	-4.32864	-4.78558	-4.50256
BTK	Yes	Ibrutinib	C515S	C	515	S	1544_1545delinsCT	T	NA	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	mantle_cell_lymphoma	NS	Unknown	ENST00000621635.4	BTK_C_515	515	BTK	C	515	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
EGFR_ENST00000454757	No	Osimertinib	G751R	G	751	R	2251G>C	G	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	EGFR_ENST00000454757_G_751	796	EGFR_ENST00000454757	G	751	P00533	G	796	P00533_G_796	P00533	G	796	g	83	G796R	P00533/G796R	-5.8894	-6.50654	-6.88271	-7.69727	-7.18103	-8.1574	-9.35562	-9.83555	-7.27842	-8.07728	-9.35596	-10.43741	-3.43735	-4.80524	-5.63375	-6.24461	-5.96451	-6.71416	-8.62616	-8.7685	-5.82291	-6.25349	-6.54279	-7.52392
MET_ENST00000397752	No	Crizotinib	D1228N	D	1228	N	3682G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000397752.7	MET_ENST00000397752_D_1228	1228	MET_ENST00000397752	D	1228	P08581	D	1228	P08581_D_1228	P08581	D	1228	e	147	D1228N	P08581/D1228N	-3.89302	-4.01672	-4.87037	-5.99475	-3.93587	-5.76835	-4.83304	-5.73344	-5.48859	-6.01457	-4.16378	-4.89599	NA	-2.44536	-2.44536	-3.29238	-3.56174	-3.76361	-4.83157	-6.00582	-3.56492	-3.74382	-4.8243	-5.69045
BTK_ENST00000618050	No	Acalabrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	Unknown	ENST00000618050.4	BTK_ENST00000618050_C_481	481	BTK_ENST00000618050	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
KIT	Yes	Imatinib	T670I	T	670	I	2009C>T	C	T	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Heterozygous	ENST00000288135.5	KIT_T_670	670	KIT	T	670	P10721	T	670	P10721_T_670	P10721	T	670	l	77	T670I	P10721/T670I	-3.21372	-3.61	-4.07085	-3.06475	-1.69942	-0.73517	-0.29682	-0.27338	-1.91451	-0.43354	-0.20002	-0.12691	-4.41323	-0.99524	-0.62606	0.45647	-3.86569	-4.28669	-1.91173	-0.20553	-3.15078	-3.33921	-3.90805	-4.70736
FGFR2_ENST00000369060	No	INCB054828	N433H	N	433	H	1297A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000369060.8	FGFR2_ENST00000369060_N_433	549	FGFR2_ENST00000369060	N	433	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549H	P21802/N549H	-3.59202	-4.05283	-4.45204	-1.91687	-3.2987	-5.64347	-3.43921	-3.53355	-3.40495	-5.46205	-3.3852	-3.51414	-4.11275	-4.00667	-4.83075	-4.39536	-3.73976	-4.49588	-3.98204	-1.97595	-3.56699	-3.97335	-4.2944	-1.77593
EGFR_ENST00000455089	No	Tyrosine kinase inhibitor - NS	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000455089.5	EGFR_ENST00000455089_T_745	790	EGFR_ENST00000455089	T	745	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
ALK_ENST00000642122	No	Crizotinib	G134R	G	134	R	400G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000642122.1	ALK_ENST00000642122_G_134	1202	ALK_ENST00000642122	G	134	Q9UM73	G	1202	Q9UM73_G_1202	Q9UM73	G	1202	g	83	G1202R	Q9UM73/G1202R	-4.81544	-6.73839	-7.96814	-8.23089	-8.99966	-6.51938	-6.67511	-6.18498	-8.99117	-6.52312	-6.66187	-6.17488	-7.73938	-8.17917	-9.69937	-7.04627	-7.18312	-8.85833	-9.94931	-6.31567	-4.34695	-6.57222	-7.32508	-8.42016
ALK	Yes	Crizotinib	C1156Y	C	1156	Y	3467G>A	G	A	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000389048.7	ALK_C_1156	1156	ALK	C	1156	Q9UM73	C	1156	Q9UM73_C_1156	Q9UM73	C	1156	k	36	C1156Y	Q9UM73/C1156Y	-6.16	-8.02876	-5.18122	-3.34554	-4.30317	-4.78336	-3.16122	-2.7816	-3.24014	-3.73867	-2.97655	-2.57337	-3.60733	-3.66879	-4.32301	-3.58122	-8.43152	-7.57398	-7.10224	-4.80166	-5.76175	-7.84685	-4.66663	-3.25208
KIT	Yes	Imatinib	D820Y	D	820	Y	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Unknown	ENST00000288135.5	KIT_D_820	820	KIT	D	820	P10721	D	820	P10721_D_820	P10721	D	820	s	151	D820Y	P10721/D820Y	-4.8403	-5.84134	-6.35055	-6.1242	-7.00734	-3.00094	0.15198	0.23118	-7.14219	-2.61604	0.25196	0.35051	-5.88038	-5.74352	-3.56747	-0.87208	-5.46445	-6.54829	-2.1142	-2.08244	-4.74066	-5.58085	-6.15611	-5.87859
BTK_ENST00000618050	No	Ibrutinib	C481S	C	481	S	1441T>A	T	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	Unknown	ENST00000618050.4	BTK_ENST00000618050_C_481	481	BTK_ENST00000618050	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
EGFR	Yes	Osimertinib	L718Q	L	718	Q	2153T>A	T	A	lung	carcinoma	adenocarcinoma	NS	Homozygous	ENST00000275493.6	EGFR_L_718	718	EGFR	L	718	P00533	L	718	P00533_L_718	P00533	L	718	l	7	L718Q	P00533/L718Q	-5.05825	-5.64597	-6.05984	-7.36659	-6.36485	-7.36319	-7.88834	-9.14273	-6.4587	-6.85261	-7.91901	-8.63806	-2.97989	-4.1502	-4.92061	-5.49016	-5.11756	-5.85864	-7.27968	-8.23138	-4.99883	-5.39418	-5.67361	-7.19663
EGFR_ENST00000454757	No	Osimertinib	L747H	L	747	H	2240T>A	T	A	lung	carcinoma	non_small_cell_carcinoma	NS	Heterozygous	ENST00000454757.6	EGFR_ENST00000454757_L_747	792	EGFR_ENST00000454757	L	747	P00533	L	792	P00533_L_792	P00533	L	792	y	79	L792H	P00533/L792H	-4.8254	-5.38517	-5.70241	-4.97976	-5.97338	-5.92185	-5.13719	-5.83715	-6.16791	-4.82256	-5.05571	-5.49757	-2.9369	-4.01774	-4.70132	-3.09963	-4.88608	-5.59856	-5.9826	-6.32968	-4.77562	-5.16063	-5.41901	-4.6062
EGFR	Yes	Osimertinib	L792H	L	792	H	2375T>A	T	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_L_792	792	EGFR	L	792	P00533	L	792	P00533_L_792	P00533	L	792	y	79	L792H	P00533/L792H	-4.8254	-5.38517	-5.70241	-4.97976	-5.97338	-5.92185	-5.13719	-5.83715	-6.16791	-4.82256	-5.05571	-5.49757	-2.9369	-4.01774	-4.70132	-3.09963	-4.88608	-5.59856	-5.9826	-6.32968	-4.77562	-5.16063	-5.41901	-4.6062
FGFR1_ENST00000397091	No	Palbociclib	N544K	N	544	K	1632C>A	C	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000397091.9	FGFR1_ENST00000397091_N_544	546	FGFR1_ENST00000397091	N	544	P11362	N	546	P11362_N_546	P11362	N	546	r	62	N546K	P11362/N546K	-3.13103	-3.95788	-5.01381	-2.25003	-2.27094	-3.82251	-2.35447	-2.0932	-2.45129	-3.71966	-2.28948	-2.07549	-4.04513	-2.42111	-3.09498	-2.50446	-3.44124	-4.39563	-4.24681	-1.09163	-3.14929	-3.56415	-4.57374	-2.1373
EGFR_ENST00000454757	No	Gefitinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	bronchioloalveolar_adenocarcinoma	NS	Unknown	ENST00000454757.6	EGFR_ENST00000454757_T_745	790	EGFR_ENST00000454757	T	745	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
ALK	Yes	Crizotinib	L1196M	L	1196	M	3586C>A	C	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000389048.7	ALK_L_1196	1196	ALK	L	1196	Q9UM73	L	1196	Q9UM73_L_1196	Q9UM73	L	1196	l	77	L1196M	Q9UM73/L1196M	-2.10714	-3.04155	-2.93754	-0.65705	1.58653	2.74448	2.99869	3.18813	2.09569	2.92517	3.12183	3.29347	0.72507	0.39472	1.81289	1.8037	-3.29014	-2.42223	-1.1506	0.19169	-1.87869	-2.94667	-3.37793	-3.58831
FLT3	Yes	Quizartinib	D835Y	D	835	Y	2503G>T	G	T	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	Unknown	ENST00000241453.11	FLT3_D_835	835	FLT3	D	835	P36888	D	835	P36888_D_835	P36888	D	835	e	147	D835Y	P36888/D835Y	-4.81333	-5.99384	-6.76524	-6.67394	-7.35723	-2.72249	-3.55366	-3.42703	-6.96725	-3.15452	-3.53455	-3.3969	-5.94919	-6.88241	-6.56247	-6.24567	-5.99384	-7.20319	-4.30916	-3.71481	-4.81333	-5.94335	-6.71481	-6.44769
ALK	Yes	Crizotinib	F1174V	F	1174	V	3520T>G	T	G	lung	carcinoma	mixed_adenosquamous_carcinoma	NS	Heterozygous	ENST00000389048.7	ALK_F_1174	1174	ALK	F	1174	Q9UM73	F	1174	Q9UM73_F_1174	Q9UM73	F	1174	l	55	F1174V	Q9UM73/F1174V	-4.54475	-6.10166	-7.42974	-5.00243	-3.26443	-2.40253	-2.05906	-1.75415	-2.97726	-2.15128	-1.89088	-1.60229	-2.61845	-2.78999	-4.00753	-1.88374	-6.56082	-6.12358	-4.63506	-5.17354	-4.15177	-5.95075	-6.669	-4.75915
EGFR	Yes	Afatinib	T790M	T	790	M	2369C>T	C	T	lung	carcinoma	bronchioloalveolar_adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
KIT	Yes	Imatinib	N822Y	N	822	Y	2464A>T	A	T	soft_tissue	gastrointestinal_stromal_tumour	spindle_and_epithelioid	NS	Unknown	ENST00000288135.5	KIT_N_822	822	KIT	N	822	P10721	N	822	P10721_N_822	P10721	N	822	k	153	N822Y	P10721/N822Y	-4.0991	-5.09322	-5.6225	-5.85844	-5.93412	1.27756	1.13517	1.18695	-5.9424	1.4315	1.30957	1.35549	-5.26013	-5.04078	0.02553	0.17044	-4.72791	-5.20896	-0.79151	-0.78431	-4.02075	-4.83141	-5.43269	-5.56545
BRAF	Yes	Vemurafenib	L505H	L	505	H	1514T>A	T	A	skin	malignant_melanoma	NS	NS	Unknown	ENST00000646891.1	BRAF_L_505	505	BRAF	L	505	P15056	L	505	P15056_L_505	P15056	L	505	l	52	L505H	P15056/L505H	-4.49898	-5.11796	-3.87829	-3.72459	-6.4033	-5.87471	-5.27101	-4.62655	-6.58159	-6.01428	-5.24153	-4.60449	-5.62844	-6.63841	-7.43405	-5.678	-4.7105	-5.81922	-6.77955	-4.86641	-4.20459	-4.17317	-5.19648	-2.84207
MET_ENST00000397752	No	Crizotinib	Y1230C	Y	1230	C	3689A>G	A	G	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000397752.7	MET_ENST00000397752_Y_1230	1230	MET_ENST00000397752	Y	1230	P08581	Y	1230	P08581_Y_1230	P08581	Y	1230	e	149	Y1230C	P08581/Y1230C	-5.98198	-6.09983	-7.00208	-7.78299	-6.01402	-7.11051	-7.26012	-5.71538	-5.46578	-6.07977	-5.30387	-4.682	NA	-4.41087	-4.41087	-3.7573	-5.66313	-5.86123	-6.97855	-7.02948	-5.66559	-5.83954	-6.97261	-7.3954
BTK	Yes	Ibrutinib	C515S	C	515	S	1544G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	Unknown	ENST00000621635.4	BTK_C_515	515	BTK	C	515	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
BTK	Yes	Ibrutinib	C515S	C	515	S	1543T>A	T	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Homozygous	ENST00000621635.4	BTK_C_515	515	BTK	C	515	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
BTK_ENST00000308731	No	Ibrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	mantle_cell_lymphoma	NS	Unknown	ENST00000308731.7	BTK_ENST00000308731_C_481	481	BTK_ENST00000308731	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
ALK	Yes	Lorlatinib	G1202R	G	1202	R	3604G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000389048.7	ALK_G_1202	1202	ALK	G	1202	Q9UM73	G	1202	Q9UM73_G_1202	Q9UM73	G	1202	g	83	G1202R	Q9UM73/G1202R	-4.81544	-6.73839	-7.96814	-8.23089	-8.99966	-6.51938	-6.67511	-6.18498	-8.99117	-6.52312	-6.66187	-6.17488	-7.73938	-8.17917	-9.69937	-7.04627	-7.18312	-8.85833	-9.94931	-6.31567	-4.34695	-6.57222	-7.32508	-8.42016
BTK_ENST00000618050	No	Ibrutinib	C481S	C	481	S	1441T>A	T	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	Unknown	ENST00000618050.4	BTK_ENST00000618050_C_481	481	BTK_ENST00000618050	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
EGFR_ENST00000454757	No	Osimertinib	L673V	L	673	V	2017C>G	C	G	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	EGFR_ENST00000454757_L_673	718	EGFR_ENST00000454757	L	673	P00533	L	718	P00533_L_718	P00533	L	718	l	7	L718V	P00533/L718V	-2.87973	-3.29071	-3.57936	-3.91461	-3.8134	-4.62156	-4.61481	-5.8953	-3.88231	-3.75331	-4.5836	-5.27275	-1.6044	-2.37985	-2.86936	-3.27274	-2.91342	-3.45256	-3.99282	-4.75855	-2.85288	-3.12469	-3.31329	-3.69748
FGFR2_ENST00000369061	No	BGJ398	E453A	E	453	A	1358A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000369061.8	FGFR2_ENST00000369061_E_453	565	FGFR2_ENST00000369061	E	453	P21802	E	565	P21802_E_565	P21802	E	565	e	78	E565A	P21802/E565A	-3.51392	-3.80037	-4.1026300000000004	-5.41668	-4.58579	-6.64823	-4.76785	-5.44841	-4.8176	-6.62651	-4.77112	-5.42876	-3.83527	-5.50045	-6.33318	-6.87154	-3.59306	-4.12673	-3.86929	-5.82732	-3.50686	-3.74738	-3.982	-5.27335
FGFR2_ENST00000613048	No	BGJ398	E476A	E	476	A	1427A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000613048.4	FGFR2_ENST00000613048_E_476	565	FGFR2_ENST00000613048	E	476	P21802	E	565	P21802_E_565	P21802	E	565	e	78	E565A	P21802/E565A	-3.51392	-3.80037	-4.1026300000000004	-5.41668	-4.58579	-6.64823	-4.76785	-5.44841	-4.8176	-6.62651	-4.77112	-5.42876	-3.83527	-5.50045	-6.33318	-6.87154	-3.59306	-4.12673	-3.86929	-5.82732	-3.50686	-3.74738	-3.982	-5.27335
ABL1_ENST00000318560	No	Imatinib	F311I	F	311	I	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_F_311	311	ABL1_ENST00000318560	F	311	P00519	F	311	P00519_F_311	P00519	F	311	l	73	F311I	P00519/F311I	-4.74562	-4.83823	-5.89307	-5.77723	0.16107	0.27727	0.0412	-0.12629	1.316	1.43556	0.66188	0.37482	-0.10514	0.08101	0.83664	0.11118	-4.75104	-3.6225	-2.40098	-2.24701	-3.81248	-4.75469	-6.18946	-5.87615
ABL1_ENST00000318560	No	Imatinib	Y253H	Y	253	H	?	?	NA	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_Y_253	253	ABL1_ENST00000318560	Y	253	P00519	Y	253	P00519_Y_253	P00519	Y	253	f	12	Y253H	P00519/Y253H	-4.89532	-4.98695	-5.85466	-6.40595	-7.04709	-5.54449	-3.47977	-3.44568	-3.6467	-4.56531	-2.75965	-2.89919	-3.78921	-4.06068	-3.91027	-3.18392	-4.90827	-5.82537	-7.37698	-7.52041	-4.13495	-4.92132	-6.08031	-6.33863
PDGFRA	Yes	Sunitinib	D842V	D	842	V	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000257290.9	PDGFRA_D_842	842	PDGFRA	D	842	P16234	D	842	P16234_D_842	P16234	D	842	e	147	D842V	P16234/D842V	-4.31564	-5.1395	-5.72083	-6.23429	-7.50222	-5.58834	-3.17398	-2.56912	-7.12687	-5.66214	-2.91303	-2.5456	-6.35691	-7.44297	-7.97849	-6.78856	-5.04194	-6.07278	-4.61315	-1.093	-4.28226	-5.10224	-5.65105	-5.81161
FLT3	Yes	Sorafenib	D835X	D	835	X	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	Heterozygous	ENST00000241453.11	FLT3_D_835	835	FLT3	D	835	P36888	D	835	P36888_D_835	P36888	D	835	e	147	D835X	P36888/D835X	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
BTK_ENST00000308731	No	Ibrutinib	C481S	C	481	S	1441T>A	T	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	Unknown	ENST00000308731.7	BTK_ENST00000308731_C_481	481	BTK_ENST00000308731	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
BTK_ENST00000308731	No	Ibrutinib	C481S	C	481	S	1441T>A	T	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Homozygous	ENST00000308731.7	BTK_ENST00000308731_C_481	481	BTK_ENST00000308731	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
EGFR_ENST00000454757	No	Osimertinib	L747F	L	747	F	2239C>T	C	T	lung	carcinoma	non_small_cell_carcinoma	NS	Heterozygous	ENST00000454757.6	EGFR_ENST00000454757_L_747	792	EGFR_ENST00000454757	L	747	P00533	L	792	P00533_L_792	P00533	L	792	y	79	L792F	P00533/L792F	-2.59609	-2.89655	-2.59418	-3.10204	-2.79463	-2.94014	-1.89723	-2.17756	-3.42147	-2.14595	-1.75152	-1.6736	-1.66999	-2.31034	-2.60281	-1.15156	-2.61965	-3.02695	-3.21165	-2.9848	-2.56703	-2.76477	-2.90067	-2.79167
EGFR_ENST00000455089	No	Osimertinib	G674A	G	674	A	2021G>C	G	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	EGFR_ENST00000455089_G_674	719	EGFR_ENST00000455089	G	674	P00533	G	719	P00533_G_719	P00533	G	719	G	8	G719A	P00533/G719A	-4.74871	-5.28911	-5.602	-7.80799	-5.85998	-6.76259	-8.02437	-10.43804	-5.95321	-6.6504200000000004	-8.0232	-9.37463	-2.68973	-3.87769	-4.62106	-5.08808	-4.80937	-5.47056	-7.31253	-9.19353	-4.69939	-5.07307	-5.31496	-7.63835
ABL1	Yes	Imatinib	T334I	T	334	I	1001C>T	C	T	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000372348.6	ABL1_T_334	334	ABL1	T	334	P00519	T	315	P00519_T_315	P00519	T	315	l	77	T315I	P00519/T315I	-3.83824	-3.89394	-4.90879	-4.39264	-5.08085	-3.009	-2.99728	-3.29298	-2.37856	-2.70226	-2.83383	-3.19426	-4.73256	-2.3655	-2.63879	-1.93584	-3.83098	-6.27019	-6.31943	-2.10314	-2.96885	-3.82882	-5.20793	-4.18032
EGFR	Yes	Erlotinib	T790M	T	790	M	?	?	NA	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
ABL1	Yes	Imatinib	T334I	T	334	I	1001C>T	C	T	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	Unknown	ENST00000372348.6	ABL1_T_334	334	ABL1	T	334	P00519	T	315	P00519_T_315	P00519	T	315	l	77	T315I	P00519/T315I	-3.83824	-3.89394	-4.90879	-4.39264	-5.08085	-3.009	-2.99728	-3.29298	-2.37856	-2.70226	-2.83383	-3.19426	-4.73256	-2.3655	-2.63879	-1.93584	-3.83098	-6.27019	-6.31943	-2.10314	-2.96885	-3.82882	-5.20793	-4.18032
ABL1_ENST00000318560	No	Dasatinib	T315I	T	315	I	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_T_315	315	ABL1_ENST00000318560	T	315	P00519	T	315	P00519_T_315	P00519	T	315	l	77	T315I	P00519/T315I	-3.83824	-3.89394	-4.90879	-4.39264	-5.08085	-3.009	-2.99728	-3.29298	-2.37856	-2.70226	-2.83383	-3.19426	-4.73256	-2.3655	-2.63879	-1.93584	-3.83098	-6.27019	-6.31943	-2.10314	-2.96885	-3.82882	-5.20793	-4.18032
ALK	Yes	Crizotinib	S1206F	S	1206	F	?	?	NA	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000389048.7	ALK_S_1206	1206	ALK	S	1206	Q9UM73	S	1206	Q9UM73_S_1206	Q9UM73	S	1206	d	87	S1206F	Q9UM73/S1206F	-3.79194	-4.57804	-4.57685	-4.92397	-3.7957	-2.9223	-3.15843	-3.39688	-3.52506	-2.72174	-3.04452	-3.29448	-3.19089	-3.32683	-3.11044	-2.72464	-4.98923	-4.44431	-4.73465	-5.03714	-3.49135	-4.47306	-4.47194	-5.23808
FGFR2_ENST00000358487	No	TAS-120	V564F	V	564	F	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	FGFR2_ENST00000358487_V_564	564	FGFR2_ENST00000358487	V	564	P21802	V	564	P21802_V_564	P21802	V	564	l	77	V564F	P21802/V564F	-2.85153	-3.20953	-3.50491	-2.10805	-4.18898	-3.81074	-2.83954	-2.984	-3.8908	-3.42842	-2.69866	-2.92404	-3.13122	-4.59599	-1.81944	-1.03805	-2.97592	-3.5125	-3.84418	-1.91019	-2.82301	-3.15051	-3.39588	-1.90599
MAP2K1	Yes	Vemurafenib	G128V	G	128	V	383G>T	G	T	NS	malignant_melanoma	NS	NS	Unknown	ENST00000307102.9	MAP2K1_G_128	128	MAP2K1	G	128	Q02750	G	128	Q02750_G_128	Q02750	G	128	r	62	G128V	Q02750/G128V	-3.95885	-2.1401	-0.83574	-1.17767	-1.40064	-4.01652	-4.87869	-2.13792	-0.84889	-1.80728	-2.19656	-2.18773	-1.97487	-2.97713	-1.81617	-2.15723	-4.52374	-3.17911	-1.65056	-1.90299	-4.15985	-4.97502	-1.99748	-1.57693
MAP2K1	Yes	Vemurafenib	C121S	C	121	S	362G>C	G	C	NS	malignant_melanoma	NS	NS	Unknown	ENST00000307102.9	MAP2K1_C_121	121	MAP2K1	C	121	Q02750	C	121	Q02750_C_121	Q02750	C	121	l	55	C121S	Q02750/C121S	-5.89874	-4.44514	-3.69602	-3.81848	-4.84388	-4.72477	-5.12448	-4.43271	-3.21884	-3.34909	-3.84685	-4.6551	-3.42458	-5.0868	-4.74742	-5.10715	-5.43259	-5.54393	-4.83991	-5.5636	-4.91539	-5.80385	-3.87085	-3.68584
ABL1_ENST00000318560	No	Dasatinib	F317L	F	317	L	?	?	NA	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	Unknown	ENST00000318560.5	ABL1_ENST00000318560_F_317	317	ABL1_ENST00000318560	F	317	P00519	F	317	P00519_F_317	P00519	F	317	y	79	F317L	P00519/F317L	-4.46824	-4.54627	-5.33041	-7.08854	-1.29001	-1.89592	-1.93214	-1.72959	-0.94743	-1.69423	-1.77506	-1.60537	-3.09106	-2.03923	-1.23068	-1.3226	-4.47996	-4.49148	-2.7549	-2.14739	-3.56773	-4.48426	-5.71984	-7.20214
ALK_ENST00000642122	No	Alectinib	G134R	G	134	R	400G>A	G	A	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000642122.1	ALK_ENST00000642122_G_134	1202	ALK_ENST00000642122	G	134	Q9UM73	G	1202	Q9UM73_G_1202	Q9UM73	G	1202	g	83	G1202R	Q9UM73/G1202R	-4.81544	-6.73839	-7.96814	-8.23089	-8.99966	-6.51938	-6.67511	-6.18498	-8.99117	-6.52312	-6.66187	-6.17488	-7.73938	-8.17917	-9.69937	-7.04627	-7.18312	-8.85833	-9.94931	-6.31567	-4.34695	-6.57222	-7.32508	-8.42016
EGFR_ENST00000454757	No	HM61713	C752S	C	752	S	2255G>C	G	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	EGFR_ENST00000454757_C_752	797	EGFR_ENST00000454757	C	752	P00533	C	797	P00533_C_797	P00533	C	797	e	84	C797S	P00533/C797S	-6.10543	-6.64002	-6.96375	-2.21228	-7.28074	-5.17489	-1.99234	-1.36406	-7.39063	-3.56928	-2.02928	-1.47672	-3.7615	-5.10149	-5.84303	-2.46042	-6.15484	-6.83722	-5.65101	-2.29663	-6.04365	-6.40311	-6.66681	-2.05142
BTK_ENST00000308731	No	Ibrutinib	C481R	C	481	R	1441T>C	T	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	Unknown	ENST00000308731.7	BTK_ENST00000308731_C_481	481	BTK_ENST00000308731	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481R	Q06187/C481R	-7.59736	-7.01492	-7.02913	-8.95434	-6.28501	-4.78858	-4.65653	-4.74512	-3.18939	-3.94997	-3.97793	-3.98402	-4.23537	-3.64002	-2.08052	-1.88146	-7.29244	-4.44362	-3.4003	-3.45565	-6.1538	-7.36528	-5.89095	-6.49942
ALK_ENST00000642122	No	Lorlatinib	G134R	G	134	R	400G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000642122.1	ALK_ENST00000642122_G_134	1202	ALK_ENST00000642122	G	134	Q9UM73	G	1202	Q9UM73_G_1202	Q9UM73	G	1202	g	83	G1202R	Q9UM73/G1202R	-4.81544	-6.73839	-7.96814	-8.23089	-8.99966	-6.51938	-6.67511	-6.18498	-8.99117	-6.52312	-6.66187	-6.17488	-7.73938	-8.17917	-9.69937	-7.04627	-7.18312	-8.85833	-9.94931	-6.31567	-4.34695	-6.57222	-7.32508	-8.42016
EGFR_ENST00000454757	No	Osimertinib	L673Q	L	673	Q	2018T>A	T	A	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000454757.6	EGFR_ENST00000454757_L_673	718	EGFR_ENST00000454757	L	673	P00533	L	718	P00533_L_718	P00533	L	718	l	7	L718Q	P00533/L718Q	-5.05825	-5.64597	-6.05984	-7.36659	-6.36485	-7.36319	-7.88834	-9.14273	-6.4587	-6.85261	-7.91901	-8.63806	-2.97989	-4.1502	-4.92061	-5.49016	-5.11756	-5.85864	-7.27968	-8.23138	-4.99883	-5.39418	-5.67361	-7.19663
MAP2K1	Yes	Vemurafenib	C121S	C	121	S	361T>A	T	A	skin	malignant_melanoma	NS	NS	Unknown	ENST00000307102.9	MAP2K1_C_121	121	MAP2K1	C	121	Q02750	C	121	Q02750_C_121	Q02750	C	121	l	55	C121S	Q02750/C121S	-5.89874	-4.44514	-3.69602	-3.81848	-4.84388	-4.72477	-5.12448	-4.43271	-3.21884	-3.34909	-3.84685	-4.6551	-3.42458	-5.0868	-4.74742	-5.10715	-5.43259	-5.54393	-4.83991	-5.5636	-4.91539	-5.80385	-3.87085	-3.68584
FGFR1_ENST00000397108	No	Palbociclib	N544K	N	544	K	1632C>A	C	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000397108.8	FGFR1_ENST00000397108_N_544	546	FGFR1_ENST00000397108	N	544	P11362	N	546	P11362_N_546	P11362	N	546	r	62	N546K	P11362/N546K	-3.13103	-3.95788	-5.01381	-2.25003	-2.27094	-3.82251	-2.35447	-2.0932	-2.45129	-3.71966	-2.28948	-2.07549	-4.04513	-2.42111	-3.09498	-2.50446	-3.44124	-4.39563	-4.24681	-1.09163	-3.14929	-3.56415	-4.57374	-2.1373
FGFR2_ENST00000356226	No	Palbociclib	N432K	N	432	K	1296T>A	T	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000356226.8	FGFR2_ENST00000356226_N_432	549	FGFR2_ENST00000356226	N	432	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549K	P21802/N549K	-3.64811	-4.11211	-4.51203	-2.25892	-2.2117	-3.83119	-2.34387	-2.0932	-2.32326	-3.77184	-2.29823	-2.05102	-4.04513	-2.42111	-3.09061	-2.50446	-3.80625	-4.54717	-3.95835	-1.73318	-3.6234	-4.03561	-4.34609	-2.17698
FGFR2_ENST00000478859	No	BGJ398	E337A	E	337	A	1010A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000478859.5	FGFR2_ENST00000478859_E_337	565	FGFR2_ENST00000478859	E	337	P21802	E	565	P21802_E_565	P21802	E	565	e	78	E565A	P21802/E565A	-3.51392	-3.80037	-4.1026300000000004	-5.41668	-4.58579	-6.64823	-4.76785	-5.44841	-4.8176	-6.62651	-4.77112	-5.42876	-3.83527	-5.50045	-6.33318	-6.87154	-3.59306	-4.12673	-3.86929	-5.82732	-3.50686	-3.74738	-3.982	-5.27335
EGFR_ENST00000454757	No	Erlotinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000454757.6	EGFR_ENST00000454757_T_745	790	EGFR_ENST00000454757	T	745	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
KIT	Yes	Imatinib	V654A	V	654	A	1961T>C	T	C	soft_tissue	gastrointestinal_stromal_tumour	spindle_and_epithelioid	NS	Heterozygous	ENST00000288135.5	KIT_V_654	654	KIT	V	654	P10721	V	654	P10721_V_654	P10721	V	654	v	61	V654A	P10721/V654A	-3.0421	-3.91067	-4.28896	-4.96082	-5.97083	-6.55487	-4.62666	-4.76232	-6.07968	-6.51538	-4.42426	-4.7495	-3.86516	-4.78749	-4.69194	-5.04105	-3.59732	-4.43669	-5.88686	-5.92714	-2.94308	-3.67093	-4.14688	-4.77469
EGFR_ENST00000455089	No	Tyrosine kinase inhibitor - NS	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	EGFR_ENST00000455089_T_745	790	EGFR_ENST00000455089	T	745	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
ABL1_ENST00000318560	No	Nilotinib	T315I	T	315	I	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_T_315	315	ABL1_ENST00000318560	T	315	P00519	T	315	P00519_T_315	P00519	T	315	l	77	T315I	P00519/T315I	-3.83824	-3.89394	-4.90879	-4.39264	-5.08085	-3.009	-2.99728	-3.29298	-2.37856	-2.70226	-2.83383	-3.19426	-4.73256	-2.3655	-2.63879	-1.93584	-3.83098	-6.27019	-6.31943	-2.10314	-2.96885	-3.82882	-5.20793	-4.18032
ABL1_ENST00000318560	No	Dasatinib	E255K	E	255	K	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_E_255	255	ABL1_ENST00000318560	E	255	P00519	E	255	P00519_E_255	P00519	E	255	k	14	E255K	P00519/E255K	-3.87752	-3.98692	-3.77258	-4.51827	-4.65119	-0.99294	-0.54953	-0.75458	-2.32244	-0.55667	-0.25813	-0.51514	-3.73023	-2.35155	-1.56173	-0.72175	-3.89441	-4.42775	-2.57996	-3.09774	-2.98345	-3.90263	-3.87545	-4.32295
BRAF_ENST00000644969	No	Vemurafenib	L545H	L	545	H	1634T>A	T	A	skin	malignant_melanoma	NS	NS	Unknown	ENST00000644969.1	BRAF_ENST00000644969_L_545	545	BRAF_ENST00000644969	L	545	P15056	L	505	P15056_L_505	P15056	L	505	l	52	L505H	P15056/L505H	-4.49898	-5.11796	-3.87829	-3.72459	-6.4033	-5.87471	-5.27101	-4.62655	-6.58159	-6.01428	-5.24153	-4.60449	-5.62844	-6.63841	-7.43405	-5.678	-4.7105	-5.81922	-6.77955	-4.86641	-4.20459	-4.17317	-5.19648	-2.84207
BTK_ENST00000618050	No	Ibrutinib	C481R	C	481	R	1441T>C	T	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	Unknown	ENST00000618050.4	BTK_ENST00000618050_C_481	481	BTK_ENST00000618050	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481R	Q06187/C481R	-7.59736	-7.01492	-7.02913	-8.95434	-6.28501	-4.78858	-4.65653	-4.74512	-3.18939	-3.94997	-3.97793	-3.98402	-4.23537	-3.64002	-2.08052	-1.88146	-7.29244	-4.44362	-3.4003	-3.45565	-6.1538	-7.36528	-5.89095	-6.49942
ALK_ENST00000642122	No	Alectinib	G134R	G	134	R	400G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000642122.1	ALK_ENST00000642122_G_134	1202	ALK_ENST00000642122	G	134	Q9UM73	G	1202	Q9UM73_G_1202	Q9UM73	G	1202	g	83	G1202R	Q9UM73/G1202R	-4.81544	-6.73839	-7.96814	-8.23089	-8.99966	-6.51938	-6.67511	-6.18498	-8.99117	-6.52312	-6.66187	-6.17488	-7.73938	-8.17917	-9.69937	-7.04627	-7.18312	-8.85833	-9.94931	-6.31567	-4.34695	-6.57222	-7.32508	-8.42016
FGFR2_ENST00000358487	No	Pemigatinib	N549K	N	549	K	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	FGFR2_ENST00000358487_N_549	549	FGFR2_ENST00000358487	N	549	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549K	P21802/N549K	-3.64811	-4.11211	-4.51203	-2.25892	-2.2117	-3.83119	-2.34387	-2.0932	-2.32326	-3.77184	-2.29823	-2.05102	-4.04513	-2.42111	-3.09061	-2.50446	-3.80625	-4.54717	-3.95835	-1.73318	-3.6234	-4.03561	-4.34609	-2.17698
ABL1_ENST00000318560	No	Imatinib	T315I	T	315	I	944C>T	C	T	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	Heterozygous	ENST00000318560.5	ABL1_ENST00000318560_T_315	315	ABL1_ENST00000318560	T	315	P00519	T	315	P00519_T_315	P00519	T	315	l	77	T315I	P00519/T315I	-3.83824	-3.89394	-4.90879	-4.39264	-5.08085	-3.009	-2.99728	-3.29298	-2.37856	-2.70226	-2.83383	-3.19426	-4.73256	-2.3655	-2.63879	-1.93584	-3.83098	-6.27019	-6.31943	-2.10314	-2.96885	-3.82882	-5.20793	-4.18032
ABL1_ENST00000318560	No	Imatinib	F317L	F	317	L	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_F_317	317	ABL1_ENST00000318560	F	317	P00519	F	317	P00519_F_317	P00519	F	317	y	79	F317L	P00519/F317L	-4.46824	-4.54627	-5.33041	-7.08854	-1.29001	-1.89592	-1.93214	-1.72959	-0.94743	-1.69423	-1.77506	-1.60537	-3.09106	-2.03923	-1.23068	-1.3226	-4.47996	-4.49148	-2.7549	-2.14739	-3.56773	-4.48426	-5.71984	-7.20214
ABL1_ENST00000318560	No	Imatinib	Y253H	Y	253	H	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_Y_253	253	ABL1_ENST00000318560	Y	253	P00519	Y	253	P00519_Y_253	P00519	Y	253	f	12	Y253H	P00519/Y253H	-4.89532	-4.98695	-5.85466	-6.40595	-7.04709	-5.54449	-3.47977	-3.44568	-3.6467	-4.56531	-2.75965	-2.89919	-3.78921	-4.06068	-3.91027	-3.18392	-4.90827	-5.82537	-7.37698	-7.52041	-4.13495	-4.92132	-6.08031	-6.33863
EGFR	Yes	Erlotinib	T790M	T	790	M	2369C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
ALK_ENST00000642122	No	Crizotinib	F106V	F	106	V	316T>G	T	G	lung	carcinoma	mixed_adenosquamous_carcinoma	NS	Heterozygous	ENST00000642122.1	ALK_ENST00000642122_F_106	1174	ALK_ENST00000642122	F	106	Q9UM73	F	1174	Q9UM73_F_1174	Q9UM73	F	1174	l	55	F1174V	Q9UM73/F1174V	-4.54475	-6.10166	-7.42974	-5.00243	-3.26443	-2.40253	-2.05906	-1.75415	-2.97726	-2.15128	-1.89088	-1.60229	-2.61845	-2.78999	-4.00753	-1.88374	-6.56082	-6.12358	-4.63506	-5.17354	-4.15177	-5.95075	-6.669	-4.75915
MET_ENST00000397752	No	Savolitinib	D1228V	D	1228	V	3683A>T	A	T	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000397752.7	MET_ENST00000397752_D_1228	1228	MET_ENST00000397752	D	1228	P08581	D	1228	P08581_D_1228	P08581	D	1228	e	147	D1228V	P08581/D1228V	-6.05982	-6.20082	-7.16938	-5.13495	-6.10837	-8.19915	-7.65892	-6.18013	-8.04047	-8.61861	-6.69852	-7.85318	NA	-4.26001	-4.26001	-5.55237	-5.68383	-5.91053	-7.12997	-5.03916	-5.68706	-5.88416	-7.12721	-4.77826
MET	Yes	Crizotinib	Y1248S	Y	1248	S	?	?	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000318493.10	MET_Y_1248	1248	MET	Y	1248	P08581	Y	1230	P08581_Y_1230	P08581	Y	1230	e	149	Y1230S	P08581/Y1230S	-6.29637	-6.44602	-7.50304	-7.49861	-6.33686	-7.737	-7.88654	-6.3360900000000004	-5.9993	-6.64845	-5.99907	-5.38708	NA	-4.29948	-4.29948	-4.05324	-5.92013	-6.16484	-7.47144	-7.19977	-5.92297	-6.14025	-7.45876	-7.09887
EGFR_ENST00000455089	No	Osimertinib	L747H	L	747	H	2240T>A	T	A	lung	carcinoma	non_small_cell_carcinoma	NS	Heterozygous	ENST00000455089.5	EGFR_ENST00000455089_L_747	792	EGFR_ENST00000455089	L	747	P00533	L	792	P00533_L_792	P00533	L	792	y	79	L792H	P00533/L792H	-4.8254	-5.38517	-5.70241	-4.97976	-5.97338	-5.92185	-5.13719	-5.83715	-6.16791	-4.82256	-5.05571	-5.49757	-2.9369	-4.01774	-4.70132	-3.09963	-4.88608	-5.59856	-5.9826	-6.32968	-4.77562	-5.16063	-5.41901	-4.6062
EGFR_ENST00000454757	No	Osimertinib	L747R	L	747	R	2240T>G	T	G	lung	carcinoma	small_cell_carcinoma	NS	Unknown	ENST00000454757.6	EGFR_ENST00000454757_L_747	792	EGFR_ENST00000454757	L	747	P00533	L	792	P00533_L_792	P00533	L	792	y	79	L792R	P00533/L792R	-4.96286	-5.52208	-5.81876	-5.52458	-6.10266	-6.50809	-6.50853	-6.33732	-6.33728	-6.2104	-6.68425	-6.14665	-3.0097	-4.13503	-4.83246	-4.07524	-5.02047	-5.73482	-6.94495	-7.1884	-4.91371	-5.2765	-5.55817	-5.40253
EGFR	Yes	Osimertinib	C797G	C	797	G	2389T>G	T	G	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_C_797	797	EGFR	C	797	P00533	C	797	P00533_C_797	P00533	C	797	e	84	C797G	P00533/C797G	-5.97076	-6.42613	-6.73566	-5.80842	-7.04007	-6.20105	-6.02635	-7.11823	-7.1529	-5.81504	-6.03735	-6.51646	-4.13498	-5.24136	-5.87238	-4.42025	-5.99639	-6.61957	-6.01513	-6.47651	-5.92585	-6.21455	-6.45619	-5.4909
EGFR_ENST00000454757	No	Osimertinib	L747V	L	747	V	2239C>G	C	G	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	EGFR_ENST00000454757_L_747	792	EGFR_ENST00000454757	L	747	P00533	L	792	P00533_L_792	P00533	L	792	y	79	L792V	P00533/L792V	-2.87973	-3.29071	-3.04304	-3.68482	-3.24709	-3.81058	-4.1472	-4.17932	-3.88231	-3.81785	-4.39253	-3.84676	-1.6044	-2.37985	-2.86936	-2.526	-2.91342	-3.45256	-4.41504	-4.71537	-2.85288	-3.12469	-3.31329	-4.06925
ERBB2_ENST00000445658	No	Trastuzumab	L593R	L	593	R	1778T>G	T	G	breast	carcinoma	ductal_carcinoma	NS	Unknown	ENST00000445658.6	ERBB2_ENST00000445658_L_593	869	ERBB2_ENST00000445658	L	593	P04626	L	869	P04626_L_869	P04626	L	869	e	147	L869R	P04626/L869R	-4.58599	-5.51191	-6.16009	-4.4753	-6.62002	-7.22887	-7.71834	-6.71801	-6.05186	-7.10053	-8.34153	-9.28128	-2.97229	-4.13897	-4.83246	-5.40982	-4.92181	-6.14972	-7.62842	-6.37544	-4.50616	-5.40427	-6.11379	-4.44968
KIT	Yes	Imatinib	N822K	N	822	K	2466T>A	T	A	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Heterozygous	ENST00000288135.5	KIT_N_822	822	KIT	N	822	P10721	N	822	P10721_N_822	P10721	N	822	k	153	N822K	P10721/N822K	-3.43164	-4.65104	-5.21801	-4.95388	-4.84253	-2.03841	-1.844	-1.6082	-4.85631	-1.78246	-1.69447	-1.44971	-4.70887	-4.01165	-3.0352	-0.87894	-4.196	-4.44176	-2.84777	-2.514	-3.33111	-4.31337	-5.02839	-4.78265
EGFR_ENST00000454757	No	Osimertinib	C752G	C	752	G	2254T>G	T	G	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	EGFR_ENST00000454757_C_752	797	EGFR_ENST00000454757	C	752	P00533	C	797	P00533_C_797	P00533	C	797	e	84	C797G	P00533/C797G	-5.97076	-6.42613	-6.73566	-5.80842	-7.04007	-6.20105	-6.02635	-7.11823	-7.1529	-5.81504	-6.03735	-6.51646	-4.13498	-5.24136	-5.87238	-4.42025	-5.99639	-6.61957	-6.01513	-6.47651	-5.92585	-6.21455	-6.45619	-5.4909
FGFR2_ENST00000369060	No	Palbociclib	N433K	N	433	K	1299T>A	T	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000369060.8	FGFR2_ENST00000369060_N_433	549	FGFR2_ENST00000369060	N	433	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549K	P21802/N549K	-3.64811	-4.11211	-4.51203	-2.25892	-2.2117	-3.83119	-2.34387	-2.0932	-2.32326	-3.77184	-2.29823	-2.05102	-4.04513	-2.42111	-3.09061	-2.50446	-3.80625	-4.54717	-3.95835	-1.73318	-3.6234	-4.03561	-4.34609	-2.17698
FGFR2_ENST00000358487	No	Debio1347	N549T	N	549	T	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	FGFR2_ENST00000358487_N_549	549	FGFR2_ENST00000358487	N	549	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549T	P21802/N549T	-3.85497	-4.25313	-4.59464	-3.13938	-3.81525	-6.10319	-4.3384	-4.38784	-3.90865	-6.12954	-4.0766	-4.33868	-4.19708	-4.51108	-5.32631	-4.99863	-3.98999	-4.62001	-3.80671	-2.66537	-3.84539	-4.18782	-4.44465	-3.06495
MAP2K2_ENST00000394867	No	Vemurafenib	C28S	C	28	S	82T>A	T	A	NS	malignant_melanoma	NS	NS	Unknown	ENST00000394867.8	MAP2K2_ENST00000394867_C_28	125	MAP2K2_ENST00000394867	C	28	P36507	C	125	P36507_C_125	P36507	C	125	l	55	C125S	P36507/C125S	-5.86934	-4.4585	-3.71844	-3.81848	-4.54959	-4.55737	-5.1601	-4.43272	-3.00439	-3.30124	-3.84466	-4.65547	-3.42458	-5.0868	-4.0687	-5.10715	-5.47932	-5.80396	-4.90301	-5.45261	-5.68618	-5.77391	-4.33277	-3.83884
ERBB2_ENST00000584450	No	Trastuzumab	L869R	L	869	R	2606T>G	T	G	breast	carcinoma	ductal_carcinoma	NS	Unknown	ENST00000584450.5	ERBB2_ENST00000584450_L_869	869	ERBB2_ENST00000584450	L	869	P04626	L	869	P04626_L_869	P04626	L	869	e	147	L869R	P04626/L869R	-4.58599	-5.51191	-6.16009	-4.4753	-6.62002	-7.22887	-7.71834	-6.71801	-6.05186	-7.10053	-8.34153	-9.28128	-2.97229	-4.13897	-4.83246	-5.40982	-4.92181	-6.14972	-7.62842	-6.37544	-4.50616	-5.40427	-6.11379	-4.44968
FGFR2_ENST00000356226	No	INCB054828	N432H	N	432	H	1294A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000356226.8	FGFR2_ENST00000356226_N_432	549	FGFR2_ENST00000356226	N	432	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549H	P21802/N549H	-3.59202	-4.05283	-4.45204	-1.91687	-3.2987	-5.64347	-3.43921	-3.53355	-3.40495	-5.46205	-3.3852	-3.51414	-4.11275	-4.00667	-4.83075	-4.39536	-3.73976	-4.49588	-3.98204	-1.97595	-3.56699	-3.97335	-4.2944	-1.77593
ABL1_ENST00000318560	No	Imatinib	G250E	G	250	E	?	?	NA	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_G_250	250	ABL1_ENST00000318560	G	250	P00519	G	250	P00519_G_250	P00519	G	250	e	9	G250E	P00519/G250E	-6.10879	-6.25099	-7.27815	-4.42786	-2.11968	1.3822	1.76775	2.03896	1.61495	4.00556	3.01981	3.23876	-1.32824	-0.68916	-0.68473	-0.08813	-6.14112	-5.31538	-2.08641	-2.08598	-4.79607	-6.15321	-7.55871	-6.7245
FLT3	Yes	Sorafenib	D835H	D	835	H	2503G>C	G	C	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	acute_myeloid_leukaemia_associated_with_MDS	NS	Heterozygous	ENST00000241453.11	FLT3_D_835	835	FLT3	D	835	P36888	D	835	P36888_D_835	P36888	D	835	e	147	D835H	P36888/D835H	-3.55133	-4.72601	-5.49541	-5.16599	-6.09656	-3.05156	-3.10448	-2.87845	-2.38124	-3.29706	-3.07925	-2.8326	-4.78879	-5.86144	-5.22765	-4.78947	-4.72601	-5.98703	-0.51086	-1.79689	-3.55133	-4.68193	-5.4409	-4.9458
EGFR	Yes	Osimertinib	G796S	G	796	S	2386G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_G_796	796	EGFR	G	796	P00533	G	796	P00533_G_796	P00533	G	796	g	83	G796S	P00533/G796S	-4.9247	-5.49166	-5.85547	-5.62995	-6.1146	-7.11257	-8.58284	-7.65056	-6.1739	-6.98521	-8.57015	-10.16888	-2.77362	-3.99679	-4.74452	-5.28501	-4.99239	-5.67681	-7.66537	-6.58351	-4.8691700000000004	-5.26273	-5.5165	-5.48273
MET	Yes	Crizotinib	Y1248H	Y	1248	H	3742T>C	T	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000318493.10	MET_Y_1248	1248	MET	Y	1248	P08581	Y	1230	P08581_Y_1230	P08581	Y	1230	e	149	Y1230H	P08581/Y1230H	-4.76153	-4.89342	-5.71108	-6.70023	-4.80158	-5.19732	-5.53226	-6.10165	-3.6873	-4.4115	-4.07175	-4.82115	NA	-3.22438	-3.22438	-3.12487	-4.47446	-4.67827	-5.68985	-6.26703	-4.47804	-4.65967	-5.67953	-6.41406
MET_ENST00000397752	No	Crizotinib	Y1230H	Y	1230	H	3688T>C	T	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000397752.7	MET_ENST00000397752_Y_1230	1230	MET_ENST00000397752	Y	1230	P08581	Y	1230	P08581_Y_1230	P08581	Y	1230	e	149	Y1230H	P08581/Y1230H	-4.76153	-4.89342	-5.71108	-6.70023	-4.80158	-5.19732	-5.53226	-6.10165	-3.6873	-4.4115	-4.07175	-4.82115	NA	-3.22438	-3.22438	-3.12487	-4.47446	-4.67827	-5.68985	-6.26703	-4.47804	-4.65967	-5.67953	-6.41406
FGFR4	Yes	Fisogatinib	V550M	V	550	M	1648G>A	G	A	liver	carcinoma	hepatocellular_carcinoma	NS	Unknown	ENST00000292408.8	FGFR4_V_550	550	FGFR4	V	550	P22455	V	550	P22455_V_550	P22455	V	550	l	77	V550M	P22455/V550M	-2.44418	-3.17199	-3.23108	-0.48639	-3.57459	-2.99973	-0.40315	0.13372	-3.14058	-2.29023	-0.33867	0.14108	-2.88083	-4.19547	-3.47476	-2.47998	-3.00659	-3.33739	-3.38134	-0.65289	-2.43951	-3.14519	-3.2612	-0.67212
EGFR_ENST00000454757	No	Tyrosine kinase inhibitor - NS	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000454757.6	EGFR_ENST00000454757_T_745	790	EGFR_ENST00000454757	T	745	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
BTK	Yes	Ibrutinib	C515S	C	515	S	1543T>A	T	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Unknown	ENST00000621635.4	BTK_C_515	515	BTK	C	515	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
EGFR_ENST00000454757	No	Osimertinib	G751S	G	751	S	2251G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	EGFR_ENST00000454757_G_751	796	EGFR_ENST00000454757	G	751	P00533	G	796	P00533_G_796	P00533	G	796	g	83	G796S	P00533/G796S	-4.9247	-5.49166	-5.85547	-5.62995	-6.1146	-7.11257	-8.58284	-7.65056	-6.1739	-6.98521	-8.57015	-10.16888	-2.77362	-3.99679	-4.74452	-5.28501	-4.99239	-5.67681	-7.66537	-6.58351	-4.8691700000000004	-5.26273	-5.5165	-5.48273
KIT	Yes	Imatinib	T670I	T	670	I	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Unknown	ENST00000288135.5	KIT_T_670	670	KIT	T	670	P10721	T	670	P10721_T_670	P10721	T	670	l	77	T670I	P10721/T670I	-3.21372	-3.61	-4.07085	-3.06475	-1.69942	-0.73517	-0.29682	-0.27338	-1.91451	-0.43354	-0.20002	-0.12691	-4.41323	-0.99524	-0.62606	0.45647	-3.86569	-4.28669	-1.91173	-0.20553	-3.15078	-3.33921	-3.90805	-4.70736
FGFR2_ENST00000346997	No	INCB054828	N547H	N	547	H	1639A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000346997.6	FGFR2_ENST00000346997_N_547	549	FGFR2_ENST00000346997	N	547	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549H	P21802/N549H	-3.59202	-4.05283	-4.45204	-1.91687	-3.2987	-5.64347	-3.43921	-3.53355	-3.40495	-5.46205	-3.3852	-3.51414	-4.11275	-4.00667	-4.83075	-4.39536	-3.73976	-4.49588	-3.98204	-1.97595	-3.56699	-3.97335	-4.2944	-1.77593
EGFR	Yes	Gefitinib	T790M	T	790	M	?	?	NA	lung	carcinoma	mixed_adenosquamous_carcinoma	NS	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
ALK_ENST00000618119	No	Alectinib	I794N	I	794	N	2381T>A	T	A	lung	carcinoma	non_small_cell_carcinoma	NS	Heterozygous	ENST00000618119.4	ALK_ENST00000618119_I_794	1171	ALK_ENST00000618119	I	794	Q9UM73	I	1171	Q9UM73_I_1171	Q9UM73	I	1171	l	52	I1171N	Q9UM73/I1171N	-5.17128	-6.74603	-6.94801	-6.49109	-3.57766	-3.2095	-3.74306	-3.41998	-2.58232	-2.53444	-3.18063	-2.96084	-6.18051	-6.39335	-7.5839	-6.3031	-6.60105	-8.88445	-9.69268	-6.19401	-4.80406	-6.58397	-6.76653	-6.06903
KIT	Yes	Imatinib	K642E	K	642	E	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000288135.5	KIT_K_642	642	KIT	K	642	P10721	K	642	P10721_K_642	P10721	K	642	k	50	K642E	P10721/K642E	-2.86871	-3.83495	-4.33693	-5.2914	-6.0895	-0.75961	-1.10055	-1.30422	-6.2368	-0.66001	-1.03398	-1.24659	-4.05048	-5.1073	-1.31724	-0.6052	-3.4613	-4.54826	-2.02884	-1.1982	-2.78518	-3.56152	-4.15965	-5.00163
BTK	Yes	Ibrutinib	C515S	C	515	S	1543T>A	T	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	Unknown	ENST00000621635.4	BTK_C_515	515	BTK	C	515	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
BTK_ENST00000618050	No	Ibrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	mantle_cell_lymphoma	NS	Unknown	ENST00000618050.4	BTK_ENST00000618050_C_481	481	BTK_ENST00000618050	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
FGFR4_ENST00000393637	No	Fisogatinib	V510M	V	510	M	1528G>A	G	A	liver	carcinoma	hepatocellular_carcinoma	NS	Unknown	ENST00000393637.5	FGFR4_ENST00000393637_V_510	550	FGFR4_ENST00000393637	V	510	P22455	V	550	P22455_V_550	P22455	V	550	l	77	V550M	P22455/V550M	-2.44418	-3.17199	-3.23108	-0.48639	-3.57459	-2.99973	-0.40315	0.13372	-3.14058	-2.29023	-0.33867	0.14108	-2.88083	-4.19547	-3.47476	-2.47998	-3.00659	-3.33739	-3.38134	-0.65289	-2.43951	-3.14519	-3.2612	-0.67212
EGFR_ENST00000454757	No	Osimertinib	L747P	L	747	P	2240T>C	T	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	EGFR_ENST00000454757_L_747	792	EGFR_ENST00000454757	L	747	P00533	L	792	P00533_L_792	P00533	L	792	y	79	L792P	P00533/L792P	-5.15844	-5.61755	-5.93526	-6.18939	-6.21444	-6.71833	-6.7635	-6.87896	-6.36391	-6.36826	-6.9507	-6.56556	-3.67888	-4.62437	-5.24789	-4.57306	-5.19961	-5.81396	-7.17777	-7.5768	-5.1311	-5.39869	-5.6449	-6.19451
KIT	Yes	Imatinib	N822K	N	822	K	2466T>A	T	A	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Homozygous	ENST00000288135.5	KIT_N_822	822	KIT	N	822	P10721	N	822	P10721_N_822	P10721	N	822	k	153	N822K	P10721/N822K	-3.43164	-4.65104	-5.21801	-4.95388	-4.84253	-2.03841	-1.844	-1.6082	-4.85631	-1.78246	-1.69447	-1.44971	-4.70887	-4.01165	-3.0352	-0.87894	-4.196	-4.44176	-2.84777	-2.514	-3.33111	-4.31337	-5.02839	-4.78265
ALK_ENST00000618119	No	Crizotinib	F797V	F	797	V	2389T>G	T	G	lung	carcinoma	mixed_adenosquamous_carcinoma	NS	Heterozygous	ENST00000618119.4	ALK_ENST00000618119_F_797	1174	ALK_ENST00000618119	F	797	Q9UM73	F	1174	Q9UM73_F_1174	Q9UM73	F	1174	l	55	F1174V	Q9UM73/F1174V	-4.54475	-6.10166	-7.42974	-5.00243	-3.26443	-2.40253	-2.05906	-1.75415	-2.97726	-2.15128	-1.89088	-1.60229	-2.61845	-2.78999	-4.00753	-1.88374	-6.56082	-6.12358	-4.63506	-5.17354	-4.15177	-5.95075	-6.669	-4.75915
MAP2K2	Yes	Dabrafenib	C125S	C	125	S	374G>C	G	C	skin	malignant_melanoma	NS	NS	Unknown	ENST00000262948.9	MAP2K2_C_125	125	MAP2K2	C	125	P36507	C	125	P36507_C_125	P36507	C	125	l	55	C125S	P36507/C125S	-5.86934	-4.4585	-3.71844	-3.81848	-4.54959	-4.55737	-5.1601	-4.43272	-3.00439	-3.30124	-3.84466	-4.65547	-3.42458	-5.0868	-4.0687	-5.10715	-5.47932	-5.80396	-4.90301	-5.45261	-5.68618	-5.77391	-4.33277	-3.83884
FLT3	Yes	Sorafenib	D835Y	D	835	Y	2503G>T	G	T	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	Heterozygous	ENST00000241453.11	FLT3_D_835	835	FLT3	D	835	P36888	D	835	P36888_D_835	P36888	D	835	e	147	D835Y	P36888/D835Y	-4.81333	-5.99384	-6.76524	-6.67394	-7.35723	-2.72249	-3.55366	-3.42703	-6.96725	-3.15452	-3.53455	-3.3969	-5.94919	-6.88241	-6.56247	-6.24567	-5.99384	-7.20319	-4.30916	-3.71481	-4.81333	-5.94335	-6.71481	-6.44769
BTK_ENST00000618050	No	Ibrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Homozygous	ENST00000618050.4	BTK_ENST00000618050_C_481	481	BTK_ENST00000618050	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
FGFR4_ENST00000502906	No	Fisogatinib	V550L	V	550	L	1648G>C	G	C	liver	carcinoma	hepatocellular_carcinoma	NS	Unknown	ENST00000502906.5	FGFR4_ENST00000502906_V_550	550	FGFR4_ENST00000502906	V	550	P22455	V	550	P22455_V_550	P22455	V	550	l	77	V550L	P22455/V550L	-2.4551	-2.99716	-3.082	-1.2076	-3.37839	-3.45376	-2.33025	-1.60496	-3.24753	-3.35757	-2.23668	-1.59437	-2.66871	-3.9419	-3.38869	-1.90248	-2.8906	-3.08134	-3.31301	-1.64314	-2.45229	-2.99361	-3.02446	-1.0623
EGFR_ENST00000455089	No	Erlotinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	non_small_cell_carcinoma	NS	Heterozygous	ENST00000455089.5	EGFR_ENST00000455089_T_745	790	EGFR_ENST00000455089	T	745	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
FGFR2_ENST00000369056	No	BGJ398	L618M	L	618	M	1852T>A	T	A	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000369056.5	FGFR2_ENST00000369056_L_618	620	FGFR2_ENST00000369056	L	618	P21802	L	617	P21802_L_617	P21802	L	617	l	114	L617M	P21802/L617M	-2.1073	-2.37778	-2.56432	-0.58631	-1.99526	-3.16729	-2.95701	-3.49347	-2.54812	-4.03737	-3.19557	-3.71219	-2.13592	-3.11462	-3.57144	-3.87308	-2.20905	-2.58128	-2.17398	-2.00271	-2.08409	-2.33343	-2.49224	-0.51603
MAP2K2	Yes	Dabrafenib	N126D	N	126	D	376A>G	A	G	NS	malignant_melanoma	NS	NS	Unknown	ENST00000262948.9	MAP2K2_N_126	126	MAP2K2	N	126	P36507	N	126	P36507_N_126	P36507	N	126	k	56	N126D	P36507/N126D	-2.9932	-1.75133	-0.59599	-0.16023	0.98671	0.56986	0.77648	0.34866	0.8821	0.60901	0.59771	0.49564	0.98234	1.14554	-0.54651	-0.29951	-2.7456	-2.60863	-2.13363	-0.91236	-2.89837	-2.96616	-2.79945	-1.27488
ERBB2	Yes	Trastuzumab	L869R	L	869	R	2606T>G	T	G	breast	carcinoma	ductal_carcinoma	NS	Unknown	ENST00000269571.9	ERBB2_L_869	869	ERBB2	L	869	P04626	L	869	P04626_L_869	P04626	L	869	e	147	L869R	P04626/L869R	-4.58599	-5.51191	-6.16009	-4.4753	-6.62002	-7.22887	-7.71834	-6.71801	-6.05186	-7.10053	-8.34153	-9.28128	-2.97229	-4.13897	-4.83246	-5.40982	-4.92181	-6.14972	-7.62842	-6.37544	-4.50616	-5.40427	-6.11379	-4.44968
FGFR2	Yes	INCB054828	N550H	N	550	H	1648A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000457416.6	FGFR2_N_550	552	FGFR2	N	550	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549H	P21802/N549H	-3.59202	-4.05283	-4.45204	-1.91687	-3.2987	-5.64347	-3.43921	-3.53355	-3.40495	-5.46205	-3.3852	-3.51414	-4.11275	-4.00667	-4.83075	-4.39536	-3.73976	-4.49588	-3.98204	-1.97595	-3.56699	-3.97335	-4.2944	-1.77593
ABL1_ENST00000318560	No	Tyrosine kinase inhibitor - NS	D276G	D	276	G	827A>G	A	G	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_D_276	276	ABL1_ENST00000318560	D	276	P00519	D	276	P00519_D_276	P00519	D	276	e	35	D276G	P00519/D276G	-4.61113	-4.70641	-4.62081	-4.51285	0.09	-1.38166	-1.42012	-0.98863	0.51515	-1.12016	-1.14944	-0.70223	-0.13093	-0.72866	-0.77165	-0.73963	-4.61302	-3.3239	-1.58787	-2.30446	-3.99384	-4.62544	-4.56025	-5.17359
KIT	Yes	Nilotinib	N655T	N	655	T	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Unknown	ENST00000288135.5	KIT_N_655	655	KIT	N	655	P10721	N	655	P10721_N_655	P10721	N	655	r	62	N655T	P10721/N655T	-3.63103	-4.73797	-5.2289	-4.71749	-6.44111	-5.61288	-4.41524	-4.38784	-8.16996	-5.59669	-4.38676	-4.34326	-4.83568	-5.94686	-6.43516	-4.99863	-4.33776	-5.43945	-5.76359	-3.18381	-3.54498	-4.44826	-5.06825	-5.88346
BTK	Yes	Ibrutinib	C515R	C	515	R	1543T>C	T	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	Unknown	ENST00000621635.4	BTK_C_515	515	BTK	C	515	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481R	Q06187/C481R	-7.59736	-7.01492	-7.02913	-8.95434	-6.28501	-4.78858	-4.65653	-4.74512	-3.18939	-3.94997	-3.97793	-3.98402	-4.23537	-3.64002	-2.08052	-1.88146	-7.29244	-4.44362	-3.4003	-3.45565	-6.1538	-7.36528	-5.89095	-6.49942
EGFR_ENST00000455089	No	Osimertinib	L673Q	L	673	Q	2018T>A	T	A	lung	carcinoma	adenocarcinoma	NS	Homozygous	ENST00000455089.5	EGFR_ENST00000455089_L_673	718	EGFR_ENST00000455089	L	673	P00533	L	718	P00533_L_718	P00533	L	718	l	7	L718Q	P00533/L718Q	-5.05825	-5.64597	-6.05984	-7.36659	-6.36485	-7.36319	-7.88834	-9.14273	-6.4587	-6.85261	-7.91901	-8.63806	-2.97989	-4.1502	-4.92061	-5.49016	-5.11756	-5.85864	-7.27968	-8.23138	-4.99883	-5.39418	-5.67361	-7.19663
MET_ENST00000397752	No	Capmatinib	D1228N	D	1228	N	3682G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000397752.7	MET_ENST00000397752_D_1228	1228	MET_ENST00000397752	D	1228	P08581	D	1228	P08581_D_1228	P08581	D	1228	e	147	D1228N	P08581/D1228N	-3.89302	-4.01672	-4.87037	-5.99475	-3.93587	-5.76835	-4.83304	-5.73344	-5.48859	-6.01457	-4.16378	-4.89599	NA	-2.44536	-2.44536	-3.29238	-3.56174	-3.76361	-4.83157	-6.00582	-3.56492	-3.74382	-4.8243	-5.69045
FGFR1_ENST00000397113	No	Palbociclib	N544K	N	544	K	1632C>A	C	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000397113.6	FGFR1_ENST00000397113_N_544	546	FGFR1_ENST00000397113	N	544	P11362	N	546	P11362_N_546	P11362	N	546	r	62	N546K	P11362/N546K	-3.13103	-3.95788	-5.01381	-2.25003	-2.27094	-3.82251	-2.35447	-2.0932	-2.45129	-3.71966	-2.28948	-2.07549	-4.04513	-2.42111	-3.09498	-2.50446	-3.44124	-4.39563	-4.24681	-1.09163	-3.14929	-3.56415	-4.57374	-2.1373
FGFR2_ENST00000358487	No	Pemigatinib	K641R	K	641	R	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	FGFR2_ENST00000358487_K_641	641	FGFR2_ENST00000358487	K	641	P21802	K	641	P21802_K_641	P21802	K	641	K	138	K641R	P21802/K641R	-1.97616	-2.17433	-2.40038	-4.92066	-4.25178	-4.52295	-4.76559	-4.41246	-4.24182	-4.52791	-4.63682	-4.29722	-2.27397	-3.54142	-4.26173	-4.74522	-2.00146	-2.42722	-3.20991	-3.43315	-1.97025	-2.12498	-2.30968	-4.76574
ERBB2_ENST00000584601	No	Trastuzumab	L839R	L	839	R	2516T>G	T	G	breast	carcinoma	ductal_carcinoma	NS	Unknown	ENST00000584601.5	ERBB2_ENST00000584601_L_839	869	ERBB2_ENST00000584601	L	839	P04626	L	869	P04626_L_869	P04626	L	869	e	147	L869R	P04626/L869R	-4.58599	-5.51191	-6.16009	-4.4753	-6.62002	-7.22887	-7.71834	-6.71801	-6.05186	-7.10053	-8.34153	-9.28128	-2.97229	-4.13897	-4.83246	-5.40982	-4.92181	-6.14972	-7.62842	-6.37544	-4.50616	-5.40427	-6.11379	-4.44968
ABL1_ENST00000318560	No	Dasatinib	F317L	F	317	L	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_F_317	317	ABL1_ENST00000318560	F	317	P00519	F	317	P00519_F_317	P00519	F	317	y	79	F317L	P00519/F317L	-4.46824	-4.54627	-5.33041	-7.08854	-1.29001	-1.89592	-1.93214	-1.72959	-0.94743	-1.69423	-1.77506	-1.60537	-3.09106	-2.03923	-1.23068	-1.3226	-4.47996	-4.49148	-2.7549	-2.14739	-3.56773	-4.48426	-5.71984	-7.20214
EGFR	Yes	Erlotinib	T790M	T	790	M	?	?	NA	lung	carcinoma	adenocarcinoma	transformed_to_small_cell_carcinoma	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
BTK	Yes	Ibrutinib	C515Y	C	515	Y	1544G>A	G	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	Unknown	ENST00000621635.4	BTK_C_515	515	BTK	C	515	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481Y	Q06187/C481Y	-7.42147	-6.85939	-7.0678	-9.31334	-6.81445	-6.28611	-6.37594	-7.34037	-3.91449	-5.45128	-5.70888	-6.59455	-4.26101	-4.15799	-2.72652	-2.51016	-7.12058	-4.37441	-5.39488	-6.19902	-6.08369	-7.18425	-6.09403	-6.93796
EGFR_ENST00000455089	No	Osimertinib	L702P	L	702	P	2104_2105delinsCC	C	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	EGFR_ENST00000455089_L_702	747	EGFR_ENST00000455089	L	702	P00533	L	747	P00533_L_747	P00533	L	747	i	32	L747P	P00533/L747P	-5.15844	-5.61755	-5.97927	-7.03261	-6.26699	-7.10149	-7.60373	-5.08077	-6.36391	-6.80535	-7.6097	-4.44279	-3.67888	-4.62437	-5.24789	-5.34102	-5.19961	-5.81396	-7.50647	-7.92142	-5.1311	-5.39869	-5.6449	-6.69272
BTK_ENST00000308731	No	Ibrutinib	C481S	C	481	S	1441T>A	T	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Unknown	ENST00000308731.7	BTK_ENST00000308731_C_481	481	BTK_ENST00000308731	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
BTK	Yes	Ibrutinib	C515S	C	515	S	1544G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	Unknown	ENST00000621635.4	BTK_C_515	515	BTK	C	515	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
EGFR	Yes	Osimertinib	L792F	L	792	F	2374C>T	C	T	lung	carcinoma	non_small_cell_carcinoma	NS	Heterozygous	ENST00000275493.6	EGFR_L_792	792	EGFR	L	792	P00533	L	792	P00533_L_792	P00533	L	792	y	79	L792F	P00533/L792F	-2.59609	-2.89655	-2.59418	-3.10204	-2.79463	-2.94014	-1.89723	-2.17756	-3.42147	-2.14595	-1.75152	-1.6736	-1.66999	-2.31034	-2.60281	-1.15156	-2.61965	-3.02695	-3.21165	-2.9848	-2.56703	-2.76477	-2.90067	-2.79167
ALK_ENST00000618119	No	Alectinib	G825R	G	825	R	2473G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000618119.4	ALK_ENST00000618119_G_825	1202	ALK_ENST00000618119	G	825	Q9UM73	G	1202	Q9UM73_G_1202	Q9UM73	G	1202	g	83	G1202R	Q9UM73/G1202R	-4.81544	-6.73839	-7.96814	-8.23089	-8.99966	-6.51938	-6.67511	-6.18498	-8.99117	-6.52312	-6.66187	-6.17488	-7.73938	-8.17917	-9.69937	-7.04627	-7.18312	-8.85833	-9.94931	-6.31567	-4.34695	-6.57222	-7.32508	-8.42016
EGFR_ENST00000455089	No	Gefitinib	D716Y	D	716	Y	2146G>T	G	T	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000455089.5	EGFR_ENST00000455089_D_716	761	EGFR_ENST00000455089	D	716	P00533	D	761	P00533_D_761	P00533	D	761	r	47	D761Y	P00533/D761Y	-5.3867	-5.9495	-6.32091	-4.64807	-6.57853	-6.09538	-6.18149	-5.99906	-6.62793	-5.96446	-5.50531	-5.64162	-3.73298	-4.80966	-5.38183	-5.94314	-5.43186	-6.13773	-5.48231	-4.58334	-5.33549	-5.71756	-5.96957	-4.36782
ABL1_ENST00000318560	No	Imatinib	E255K	E	255	K	?	?	NA	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_E_255	255	ABL1_ENST00000318560	E	255	P00519	E	255	P00519_E_255	P00519	E	255	k	14	E255K	P00519/E255K	-3.87752	-3.98692	-3.77258	-4.51827	-4.65119	-0.99294	-0.54953	-0.75458	-2.32244	-0.55667	-0.25813	-0.51514	-3.73023	-2.35155	-1.56173	-0.72175	-3.89441	-4.42775	-2.57996	-3.09774	-2.98345	-3.90263	-3.87545	-4.32295
ABL1_ENST00000318560	No	Nilotinib	G250E	G	250	E	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_G_250	250	ABL1_ENST00000318560	G	250	P00519	G	250	P00519_G_250	P00519	G	250	e	9	G250E	P00519/G250E	-6.10879	-6.25099	-7.27815	-4.42786	-2.11968	1.3822	1.76775	2.03896	1.61495	4.00556	3.01981	3.23876	-1.32824	-0.68916	-0.68473	-0.08813	-6.14112	-5.31538	-2.08641	-2.08598	-4.79607	-6.15321	-7.55871	-6.7245
ALK_ENST00000642122	No	Crizotinib	C88Y	C	88	Y	263G>A	G	A	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000642122.1	ALK_ENST00000642122_C_88	1156	ALK_ENST00000642122	C	88	Q9UM73	C	1156	Q9UM73_C_1156	Q9UM73	C	1156	k	36	C1156Y	Q9UM73/C1156Y	-6.16	-8.02876	-5.18122	-3.34554	-4.30317	-4.78336	-3.16122	-2.7816	-3.24014	-3.73867	-2.97655	-2.57337	-3.60733	-3.66879	-4.32301	-3.58122	-8.43152	-7.57398	-7.10224	-4.80166	-5.76175	-7.84685	-4.66663	-3.25208
ALK_ENST00000618119	No	Crizotinib	G825R	G	825	R	2473G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000618119.4	ALK_ENST00000618119_G_825	1202	ALK_ENST00000618119	G	825	Q9UM73	G	1202	Q9UM73_G_1202	Q9UM73	G	1202	g	83	G1202R	Q9UM73/G1202R	-4.81544	-6.73839	-7.96814	-8.23089	-8.99966	-6.51938	-6.67511	-6.18498	-8.99117	-6.52312	-6.66187	-6.17488	-7.73938	-8.17917	-9.69937	-7.04627	-7.18312	-8.85833	-9.94931	-6.31567	-4.34695	-6.57222	-7.32508	-8.42016
KIT	Yes	Imatinib	N822Y	N	822	Y	2464A>T	A	T	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Unknown	ENST00000288135.5	KIT_N_822	822	KIT	N	822	P10721	N	822	P10721_N_822	P10721	N	822	k	153	N822Y	P10721/N822Y	-4.0991	-5.09322	-5.6225	-5.85844	-5.93412	1.27756	1.13517	1.18695	-5.9424	1.4315	1.30957	1.35549	-5.26013	-5.04078	0.02553	0.17044	-4.72791	-5.20896	-0.79151	-0.78431	-4.02075	-4.83141	-5.43269	-5.56545
BRAF_ENST00000496384	No	Vemurafenib	L505H	L	505	H	1514T>A	T	A	skin	malignant_melanoma	NS	NS	Unknown	ENST00000496384.7	BRAF_ENST00000496384_L_505	505	BRAF_ENST00000496384	L	505	P15056	L	505	P15056_L_505	P15056	L	505	l	52	L505H	P15056/L505H	-4.49898	-5.11796	-3.87829	-3.72459	-6.4033	-5.87471	-5.27101	-4.62655	-6.58159	-6.01428	-5.24153	-4.60449	-5.62844	-6.63841	-7.43405	-5.678	-4.7105	-5.81922	-6.77955	-4.86641	-4.20459	-4.17317	-5.19648	-2.84207
BTK	Yes	Acalabrutinib	C515S	C	515	S	1544G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	Unknown	ENST00000621635.4	BTK_C_515	515	BTK	C	515	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
EGFR_ENST00000455089	No	Osimertinib	C752S	C	752	S	2254T>A	T	A	lung	carcinoma	non_small_cell_carcinoma	NS	Heterozygous	ENST00000455089.5	EGFR_ENST00000455089_C_752	797	EGFR_ENST00000455089	C	752	P00533	C	797	P00533_C_797	P00533	C	797	e	84	C797S	P00533/C797S	-6.10543	-6.64002	-6.96375	-2.21228	-7.28074	-5.17489	-1.99234	-1.36406	-7.39063	-3.56928	-2.02928	-1.47672	-3.7615	-5.10149	-5.84303	-2.46042	-6.15484	-6.83722	-5.65101	-2.29663	-6.04365	-6.40311	-6.66681	-2.05142
FGFR2_ENST00000358487	No	Palbociclib	N549K	N	549	K	1647T>A	T	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000358487.9	FGFR2_ENST00000358487_N_549	549	FGFR2_ENST00000358487	N	549	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549K	P21802/N549K	-3.64811	-4.11211	-4.51203	-2.25892	-2.2117	-3.83119	-2.34387	-2.0932	-2.32326	-3.77184	-2.29823	-2.05102	-4.04513	-2.42111	-3.09061	-2.50446	-3.80625	-4.54717	-3.95835	-1.73318	-3.6234	-4.03561	-4.34609	-2.17698
FGFR2_ENST00000358487	No	Debio1347	L617V	L	617	V	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	FGFR2_ENST00000358487_L_617	617	FGFR2_ENST00000358487	L	617	P21802	L	617	P21802_L_617	P21802	L	617	l	114	L617V	P21802/L617V	-2.49762	-2.75915	-2.98537	-4.0619	-3.8637	-5.63552	-5.12245	-5.58345	-3.80499	-5.60023	-5.06176	-5.54424	-2.64079	-4.0085	-4.62204	-5.04042	-2.58403	-3.00731	-3.12501	-4.55764	-2.48827	-2.70931	-2.88989	-3.93592
KIT	Yes	Imatinib	V654A	V	654	A	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Unknown	ENST00000288135.5	KIT_V_654	654	KIT	V	654	P10721	V	654	P10721_V_654	P10721	V	654	v	61	V654A	P10721/V654A	-3.0421	-3.91067	-4.28896	-4.96082	-5.97083	-6.55487	-4.62666	-4.76232	-6.07968	-6.51538	-4.42426	-4.7495	-3.86516	-4.78749	-4.69194	-5.04105	-3.59732	-4.43669	-5.88686	-5.92714	-2.94308	-3.67093	-4.14688	-4.77469
ALK	Yes	Brigatinib	G1202R	G	1202	R	?	?	NA	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000389048.7	ALK_G_1202	1202	ALK	G	1202	Q9UM73	G	1202	Q9UM73_G_1202	Q9UM73	G	1202	g	83	G1202R	Q9UM73/G1202R	-4.81544	-6.73839	-7.96814	-8.23089	-8.99966	-6.51938	-6.67511	-6.18498	-8.99117	-6.52312	-6.66187	-6.17488	-7.73938	-8.17917	-9.69937	-7.04627	-7.18312	-8.85833	-9.94931	-6.31567	-4.34695	-6.57222	-7.32508	-8.42016
KIT	Yes	Imatinib	N822K	N	822	K	2466T>G	T	G	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000288135.5	KIT_N_822	822	KIT	N	822	P10721	N	822	P10721_N_822	P10721	N	822	k	153	N822K	P10721/N822K	-3.43164	-4.65104	-5.21801	-4.95388	-4.84253	-2.03841	-1.844	-1.6082	-4.85631	-1.78246	-1.69447	-1.44971	-4.70887	-4.01165	-3.0352	-0.87894	-4.196	-4.44176	-2.84777	-2.514	-3.33111	-4.31337	-5.02839	-4.78265
ALK_ENST00000618119	No	Crizotinib	C779Y	C	779	Y	2336G>A	G	A	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000618119.4	ALK_ENST00000618119_C_779	1156	ALK_ENST00000618119	C	779	Q9UM73	C	1156	Q9UM73_C_1156	Q9UM73	C	1156	k	36	C1156Y	Q9UM73/C1156Y	-6.16	-8.02876	-5.18122	-3.34554	-4.30317	-4.78336	-3.16122	-2.7816	-3.24014	-3.73867	-2.97655	-2.57337	-3.60733	-3.66879	-4.32301	-3.58122	-8.43152	-7.57398	-7.10224	-4.80166	-5.76175	-7.84685	-4.66663	-3.25208
MAP2K1	Yes	Dabrafenib	G128D	G	128	D	383G>A	G	A	skin	malignant_melanoma	NS	NS	Heterozygous	ENST00000307102.9	MAP2K1_G_128	128	MAP2K1	G	128	Q02750	G	128	Q02750_G_128	Q02750	G	128	r	62	G128D	Q02750/G128D	-3.31802	-1.92508	-1.99396	-1.62492	-0.74785	-2.84383	-2.63185	-0.85241	0.81375	-0.38068	-0.68567	-0.61203	-0.86372	-2.02788	-0.88521	-0.52879	-3.85211	-2.49646	-0.83654	-1.20953	-3.47365	-4.31545	-1.97959	-1.16489
MET_ENST00000397752	No	Crizotinib	D1228N	D	1228	N	3682G>A	G	A	lung	carcinoma	squamous_cell_carcinoma	NS	Unknown	ENST00000397752.7	MET_ENST00000397752_D_1228	1228	MET_ENST00000397752	D	1228	P08581	D	1228	P08581_D_1228	P08581	D	1228	e	147	D1228N	P08581/D1228N	-3.89302	-4.01672	-4.87037	-5.99475	-3.93587	-5.76835	-4.83304	-5.73344	-5.48859	-6.01457	-4.16378	-4.89599	NA	-2.44536	-2.44536	-3.29238	-3.56174	-3.76361	-4.83157	-6.00582	-3.56492	-3.74382	-4.8243	-5.69045
EGFR_ENST00000454757	No	Osimertinib	L702P	L	702	P	2104_2105delinsCC	C	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	EGFR_ENST00000454757_L_702	747	EGFR_ENST00000454757	L	702	P00533	L	747	P00533_L_747	P00533	L	747	i	32	L747P	P00533/L747P	-5.15844	-5.61755	-5.97927	-7.03261	-6.26699	-7.10149	-7.60373	-5.08077	-6.36391	-6.80535	-7.6097	-4.44279	-3.67888	-4.62437	-5.24789	-5.34102	-5.19961	-5.81396	-7.50647	-7.92142	-5.1311	-5.39869	-5.6449	-6.69272
ALK	Yes	Brigatinib	L1196M	L	1196	M	?	?	NA	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000389048.7	ALK_L_1196	1196	ALK	L	1196	Q9UM73	L	1196	Q9UM73_L_1196	Q9UM73	L	1196	l	77	L1196M	Q9UM73/L1196M	-2.10714	-3.04155	-2.93754	-0.65705	1.58653	2.74448	2.99869	3.18813	2.09569	2.92517	3.12183	3.29347	0.72507	0.39472	1.81289	1.8037	-3.29014	-2.42223	-1.1506	0.19169	-1.87869	-2.94667	-3.37793	-3.58831
EGFR_ENST00000455089	No	Osimertinib	C752S	C	752	S	2255G>C	G	C	lung	carcinoma	small_cell_carcinoma	NS	Unknown	ENST00000455089.5	EGFR_ENST00000455089_C_752	797	EGFR_ENST00000455089	C	752	P00533	C	797	P00533_C_797	P00533	C	797	e	84	C797S	P00533/C797S	-6.10543	-6.64002	-6.96375	-2.21228	-7.28074	-5.17489	-1.99234	-1.36406	-7.39063	-3.56928	-2.02928	-1.47672	-3.7615	-5.10149	-5.84303	-2.46042	-6.15484	-6.83722	-5.65101	-2.29663	-6.04365	-6.40311	-6.66681	-2.05142
MAP2K1	Yes	Dabrafenib	P124S	P	124	S	370C>T	C	T	NS	malignant_melanoma	NS	NS	Unknown	ENST00000307102.9	MAP2K1_P_124	124	MAP2K1	P	124	Q02750	P	124	Q02750_P_124	Q02750	P	124	p	58	P124S	Q02750/P124S	-3.14949	-2.81418	-2.97932	-3.27703	-4.38549	-4.79695	-4.70129	-4.1485	-3.09742	-3.57666	-3.59481	-4.32367	-1.62205	-2.72827	-3.46526	-3.8663	-4.19725	-3.31658	-3.07027	-4.136	-3.76989	-2.93129	-3.24071	-3.65482
ABL1	Yes	Imatinib	D295G	D	295	G	884A>G	A	G	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	Unknown	ENST00000372348.6	ABL1_D_295	295	ABL1	D	295	P00519	D	276	P00519_D_276	P00519	D	276	e	35	D276G	P00519/D276G	-4.61113	-4.70641	-4.62081	-4.51285	0.09	-1.38166	-1.42012	-0.98863	0.51515	-1.12016	-1.14944	-0.70223	-0.13093	-0.72866	-0.77165	-0.73963	-4.61302	-3.3239	-1.58787	-2.30446	-3.99384	-4.62544	-4.56025	-5.17359
EGFR_ENST00000455089	No	Erlotinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000455089.5	EGFR_ENST00000455089_T_745	790	EGFR_ENST00000455089	T	745	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
FGFR4_ENST00000393637	No	Fisogatinib	V510L	V	510	L	1528G>C	G	C	liver	carcinoma	hepatocellular_carcinoma	NS	Unknown	ENST00000393637.5	FGFR4_ENST00000393637_V_510	550	FGFR4_ENST00000393637	V	510	P22455	V	550	P22455_V_550	P22455	V	550	l	77	V550L	P22455/V550L	-2.4551	-2.99716	-3.082	-1.2076	-3.37839	-3.45376	-2.33025	-1.60496	-3.24753	-3.35757	-2.23668	-1.59437	-2.66871	-3.9419	-3.38869	-1.90248	-2.8906	-3.08134	-3.31301	-1.64314	-2.45229	-2.99361	-3.02446	-1.0623
PDGFRA	Yes	Crenolanib	D842V	D	842	V	2525A>T	A	T	soft_tissue	gastrointestinal_stromal_tumour	epithelioid	NS	Heterozygous	ENST00000257290.9	PDGFRA_D_842	842	PDGFRA	D	842	P16234	D	842	P16234_D_842	P16234	D	842	e	147	D842V	P16234/D842V	-4.31564	-5.1395	-5.72083	-6.23429	-7.50222	-5.58834	-3.17398	-2.56912	-7.12687	-5.66214	-2.91303	-2.5456	-6.35691	-7.44297	-7.97849	-6.78856	-5.04194	-6.07278	-4.61315	-1.093	-4.28226	-5.10224	-5.65105	-5.81161
FGFR2_ENST00000346997	No	Palbociclib	N547K	N	547	K	1641T>A	T	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000346997.6	FGFR2_ENST00000346997_N_547	549	FGFR2_ENST00000346997	N	547	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549K	P21802/N549K	-3.64811	-4.11211	-4.51203	-2.25892	-2.2117	-3.83119	-2.34387	-2.0932	-2.32326	-3.77184	-2.29823	-2.05102	-4.04513	-2.42111	-3.09061	-2.50446	-3.80625	-4.54717	-3.95835	-1.73318	-3.6234	-4.03561	-4.34609	-2.17698
FGFR2_ENST00000358487	No	Pemigatinib	E565A	E	565	A	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	FGFR2_ENST00000358487_E_565	565	FGFR2_ENST00000358487	E	565	P21802	E	565	P21802_E_565	P21802	E	565	e	78	E565A	P21802/E565A	-3.51392	-3.80037	-4.1026300000000004	-5.41668	-4.58579	-6.64823	-4.76785	-5.44841	-4.8176	-6.62651	-4.77112	-5.42876	-3.83527	-5.50045	-6.33318	-6.87154	-3.59306	-4.12673	-3.86929	-5.82732	-3.50686	-3.74738	-3.982	-5.27335
MAP2K2	Yes	Vemurafenib	C125S	C	125	S	373T>A	T	A	NS	malignant_melanoma	NS	NS	Unknown	ENST00000262948.9	MAP2K2_C_125	125	MAP2K2	C	125	P36507	C	125	P36507_C_125	P36507	C	125	l	55	C125S	P36507/C125S	-5.86934	-4.4585	-3.71844	-3.81848	-4.54959	-4.55737	-5.1601	-4.43272	-3.00439	-3.30124	-3.84466	-4.65547	-3.42458	-5.0868	-4.0687	-5.10715	-5.47932	-5.80396	-4.90301	-5.45261	-5.68618	-5.77391	-4.33277	-3.83884
KIT	Yes	Imatinib	V654A	V	654	A	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	epithelioid	NS	Unknown	ENST00000288135.5	KIT_V_654	654	KIT	V	654	P10721	V	654	P10721_V_654	P10721	V	654	v	61	V654A	P10721/V654A	-3.0421	-3.91067	-4.28896	-4.96082	-5.97083	-6.55487	-4.62666	-4.76232	-6.07968	-6.51538	-4.42426	-4.7495	-3.86516	-4.78749	-4.69194	-5.04105	-3.59732	-4.43669	-5.88686	-5.92714	-2.94308	-3.67093	-4.14688	-4.77469
EGFR	Yes	Gefitinib	T790M	T	790	M	2369C>T	C	T	lung	carcinoma	bronchioloalveolar_adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
ABL1_ENST00000318560	No	Imatinib	T315I	T	315	I	944C>T	C	T	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	Heterozygous	ENST00000318560.5	ABL1_ENST00000318560_T_315	315	ABL1_ENST00000318560	T	315	P00519	T	315	P00519_T_315	P00519	T	315	l	77	T315I	P00519/T315I	-3.83824	-3.89394	-4.90879	-4.39264	-5.08085	-3.009	-2.99728	-3.29298	-2.37856	-2.70226	-2.83383	-3.19426	-4.73256	-2.3655	-2.63879	-1.93584	-3.83098	-6.27019	-6.31943	-2.10314	-2.96885	-3.82882	-5.20793	-4.18032
ALK_ENST00000642122	No	Crizotinib	G134R	G	134	R	400G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000642122.1	ALK_ENST00000642122_G_134	1202	ALK_ENST00000642122	G	134	Q9UM73	G	1202	Q9UM73_G_1202	Q9UM73	G	1202	g	83	G1202R	Q9UM73/G1202R	-4.81544	-6.73839	-7.96814	-8.23089	-8.99966	-6.51938	-6.67511	-6.18498	-8.99117	-6.52312	-6.66187	-6.17488	-7.73938	-8.17917	-9.69937	-7.04627	-7.18312	-8.85833	-9.94931	-6.31567	-4.34695	-6.57222	-7.32508	-8.42016
BRAF_ENST00000288602	No	Vemurafenib	L545H	L	545	H	1634T>A	T	A	skin	malignant_melanoma	NS	NS	Unknown	ENST00000288602.11	BRAF_ENST00000288602_L_545	545	BRAF_ENST00000288602	L	545	P15056	L	505	P15056_L_505	P15056	L	505	l	52	L505H	P15056/L505H	-4.49898	-5.11796	-3.87829	-3.72459	-6.4033	-5.87471	-5.27101	-4.62655	-6.58159	-6.01428	-5.24153	-4.60449	-5.62844	-6.63841	-7.43405	-5.678	-4.7105	-5.81922	-6.77955	-4.86641	-4.20459	-4.17317	-5.19648	-2.84207
EGFR_ENST00000455089	No	Osimertinib	G751S	G	751	S	2251G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	EGFR_ENST00000455089_G_751	796	EGFR_ENST00000455089	G	751	P00533	G	796	P00533_G_796	P00533	G	796	g	83	G796S	P00533/G796S	-4.9247	-5.49166	-5.85547	-5.62995	-6.1146	-7.11257	-8.58284	-7.65056	-6.1739	-6.98521	-8.57015	-10.16888	-2.77362	-3.99679	-4.74452	-5.28501	-4.99239	-5.67681	-7.66537	-6.58351	-4.8691700000000004	-5.26273	-5.5165	-5.48273
FGFR2_ENST00000358487	No	BGJ398	N549H	N	549	H	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	FGFR2_ENST00000358487_N_549	549	FGFR2_ENST00000358487	N	549	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549H	P21802/N549H	-3.59202	-4.05283	-4.45204	-1.91687	-3.2987	-5.64347	-3.43921	-3.53355	-3.40495	-5.46205	-3.3852	-3.51414	-4.11275	-4.00667	-4.83075	-4.39536	-3.73976	-4.49588	-3.98204	-1.97595	-3.56699	-3.97335	-4.2944	-1.77593
FGFR4_ENST00000502906	No	Fisogatinib	V550L	V	550	L	1648G>T	G	T	liver	carcinoma	hepatocellular_carcinoma	NS	Unknown	ENST00000502906.5	FGFR4_ENST00000502906_V_550	550	FGFR4_ENST00000502906	V	550	P22455	V	550	P22455_V_550	P22455	V	550	l	77	V550L	P22455/V550L	-2.4551	-2.99716	-3.082	-1.2076	-3.37839	-3.45376	-2.33025	-1.60496	-3.24753	-3.35757	-2.23668	-1.59437	-2.66871	-3.9419	-3.38869	-1.90248	-2.8906	-3.08134	-3.31301	-1.64314	-2.45229	-2.99361	-3.02446	-1.0623
BTK_ENST00000308731	No	Ibrutinib	C481S	C	481	S	1441T>A	T	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	Unknown	ENST00000308731.7	BTK_ENST00000308731_C_481	481	BTK_ENST00000308731	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
FGFR1	Yes	Palbociclib	N577K	N	577	K	1731C>A	C	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000425967.7	FGFR1_N_577	579	FGFR1	N	577	P11362	N	546	P11362_N_546	P11362	N	546	r	62	N546K	P11362/N546K	-3.13103	-3.95788	-5.01381	-2.25003	-2.27094	-3.82251	-2.35447	-2.0932	-2.45129	-3.71966	-2.28948	-2.07549	-4.04513	-2.42111	-3.09498	-2.50446	-3.44124	-4.39563	-4.24681	-1.09163	-3.14929	-3.56415	-4.57374	-2.1373
FGFR1_ENST00000397103	No	Palbociclib	N457K	N	457	K	1371C>A	C	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000397103.5	FGFR1_ENST00000397103_N_457	550	FGFR1_ENST00000397103	N	457	P11362	N	546	P11362_N_546	P11362	N	546	r	62	N546K	P11362/N546K	-3.13103	-3.95788	-5.01381	-2.25003	-2.27094	-3.82251	-2.35447	-2.0932	-2.45129	-3.71966	-2.28948	-2.07549	-4.04513	-2.42111	-3.09498	-2.50446	-3.44124	-4.39563	-4.24681	-1.09163	-3.14929	-3.56415	-4.57374	-2.1373
FGFR2_ENST00000360144	No	Palbociclib	N461K	N	461	K	1383T>A	T	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000360144.7	FGFR2_ENST00000360144_N_461	552	FGFR2_ENST00000360144	N	461	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549K	P21802/N549K	-3.64811	-4.11211	-4.51203	-2.25892	-2.2117	-3.83119	-2.34387	-2.0932	-2.32326	-3.77184	-2.29823	-2.05102	-4.04513	-2.42111	-3.09061	-2.50446	-3.80625	-4.54717	-3.95835	-1.73318	-3.6234	-4.03561	-4.34609	-2.17698
FGFR2_ENST00000356226	No	BGJ398	E448A	E	448	A	1343A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000356226.8	FGFR2_ENST00000356226_E_448	565	FGFR2_ENST00000356226	E	448	P21802	E	565	P21802_E_565	P21802	E	565	e	78	E565A	P21802/E565A	-3.51392	-3.80037	-4.1026300000000004	-5.41668	-4.58579	-6.64823	-4.76785	-5.44841	-4.8176	-6.62651	-4.77112	-5.42876	-3.83527	-5.50045	-6.33318	-6.87154	-3.59306	-4.12673	-3.86929	-5.82732	-3.50686	-3.74738	-3.982	-5.27335
KIT	Yes	Sunitinib	N822K	N	822	K	2466T>G	T	G	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Heterozygous	ENST00000288135.5	KIT_N_822	822	KIT	N	822	P10721	N	822	P10721_N_822	P10721	N	822	k	153	N822K	P10721/N822K	-3.43164	-4.65104	-5.21801	-4.95388	-4.84253	-2.03841	-1.844	-1.6082	-4.85631	-1.78246	-1.69447	-1.44971	-4.70887	-4.01165	-3.0352	-0.87894	-4.196	-4.44176	-2.84777	-2.514	-3.33111	-4.31337	-5.02839	-4.78265
EGFR_ENST00000454757	No	Tyrosine kinase inhibitor - NS	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	EGFR_ENST00000454757_T_745	790	EGFR_ENST00000454757	T	745	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
EGFR	Yes	Erlotinib	T790M	T	790	M	?	?	NA	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
EGFR	Yes	Gefitinib	T790M	T	790	M	?	?	NA	lung	carcinoma	adenocarcinoma	transformed_to_small_cell_carcinoma	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
BTK_ENST00000308731	No	Ibrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Homozygous	ENST00000308731.7	BTK_ENST00000308731_C_481	481	BTK_ENST00000308731	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
MET	Yes	Crizotinib	D1246N	D	1246	N	3736G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000318493.10	MET_D_1246	1246	MET	D	1246	P08581	D	1228	P08581_D_1228	P08581	D	1228	e	147	D1228N	P08581/D1228N	-3.89302	-4.01672	-4.87037	-5.99475	-3.93587	-5.76835	-4.83304	-5.73344	-5.48859	-6.01457	-4.16378	-4.89599	NA	-2.44536	-2.44536	-3.29238	-3.56174	-3.76361	-4.83157	-6.00582	-3.56492	-3.74382	-4.8243	-5.69045
EGFR_ENST00000455089	No	Osimertinib	L747V	L	747	V	2239C>G	C	G	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	EGFR_ENST00000455089_L_747	792	EGFR_ENST00000455089	L	747	P00533	L	792	P00533_L_792	P00533	L	792	y	79	L792V	P00533/L792V	-2.87973	-3.29071	-3.04304	-3.68482	-3.24709	-3.81058	-4.1472	-4.17932	-3.88231	-3.81785	-4.39253	-3.84676	-1.6044	-2.37985	-2.86936	-2.526	-2.91342	-3.45256	-4.41504	-4.71537	-2.85288	-3.12469	-3.31329	-4.06925
PDGFRA	Yes	Imatinib	D842V	D	842	V	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	epithelioid	NS	Heterozygous	ENST00000257290.9	PDGFRA_D_842	842	PDGFRA	D	842	P16234	D	842	P16234_D_842	P16234	D	842	e	147	D842V	P16234/D842V	-4.31564	-5.1395	-5.72083	-6.23429	-7.50222	-5.58834	-3.17398	-2.56912	-7.12687	-5.66214	-2.91303	-2.5456	-6.35691	-7.44297	-7.97849	-6.78856	-5.04194	-6.07278	-4.61315	-1.093	-4.28226	-5.10224	-5.65105	-5.81161
EGFR_ENST00000454757	No	Gefitinib	D716Y	D	716	Y	2146G>T	G	T	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000454757.6	EGFR_ENST00000454757_D_716	761	EGFR_ENST00000454757	D	716	P00533	D	761	P00533_D_761	P00533	D	761	r	47	D761Y	P00533/D761Y	-5.3867	-5.9495	-6.32091	-4.64807	-6.57853	-6.09538	-6.18149	-5.99906	-6.62793	-5.96446	-5.50531	-5.64162	-3.73298	-4.80966	-5.38183	-5.94314	-5.43186	-6.13773	-5.48231	-4.58334	-5.33549	-5.71756	-5.96957	-4.36782
KIT	Yes	Imatinib	V654A	V	654	A	1961T>C	T	C	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Heterozygous	ENST00000288135.5	KIT_V_654	654	KIT	V	654	P10721	V	654	P10721_V_654	P10721	V	654	v	61	V654A	P10721/V654A	-3.0421	-3.91067	-4.28896	-4.96082	-5.97083	-6.55487	-4.62666	-4.76232	-6.07968	-6.51538	-4.42426	-4.7495	-3.86516	-4.78749	-4.69194	-5.04105	-3.59732	-4.43669	-5.88686	-5.92714	-2.94308	-3.67093	-4.14688	-4.77469
ABL1_ENST00000318560	No	Nilotinib	E255K	E	255	K	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_E_255	255	ABL1_ENST00000318560	E	255	P00519	E	255	P00519_E_255	P00519	E	255	k	14	E255K	P00519/E255K	-3.87752	-3.98692	-3.77258	-4.51827	-4.65119	-0.99294	-0.54953	-0.75458	-2.32244	-0.55667	-0.25813	-0.51514	-3.73023	-2.35155	-1.56173	-0.72175	-3.89441	-4.42775	-2.57996	-3.09774	-2.98345	-3.90263	-3.87545	-4.32295
EGFR	Yes	Erlotinib	T790M	T	790	M	2369C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
BTK	Yes	Ibrutinib	C515S	C	515	S	1544G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Homozygous	ENST00000621635.4	BTK_C_515	515	BTK	C	515	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
FGFR2_ENST00000369056	No	INCB054828	N550H	N	550	H	1648A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000369056.5	FGFR2_ENST00000369056_N_550	552	FGFR2_ENST00000369056	N	550	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549H	P21802/N549H	-3.59202	-4.05283	-4.45204	-1.91687	-3.2987	-5.64347	-3.43921	-3.53355	-3.40495	-5.46205	-3.3852	-3.51414	-4.11275	-4.00667	-4.83075	-4.39536	-3.73976	-4.49588	-3.98204	-1.97595	-3.56699	-3.97335	-4.2944	-1.77593
EGFR	Yes	Tyrosine kinase inhibitor - NS	T790M	T	790	M	2369C>T	C	T	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
ALK	Yes	Crizotinib	G1202R	G	1202	R	3604G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000389048.7	ALK_G_1202	1202	ALK	G	1202	Q9UM73	G	1202	Q9UM73_G_1202	Q9UM73	G	1202	g	83	G1202R	Q9UM73/G1202R	-4.81544	-6.73839	-7.96814	-8.23089	-8.99966	-6.51938	-6.67511	-6.18498	-8.99117	-6.52312	-6.66187	-6.17488	-7.73938	-8.17917	-9.69937	-7.04627	-7.18312	-8.85833	-9.94931	-6.31567	-4.34695	-6.57222	-7.32508	-8.42016
BTK	Yes	Acalabrutinib	C515S	C	515	S	1544G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Unknown	ENST00000621635.4	BTK_C_515	515	BTK	C	515	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
BTK_ENST00000618050	No	Ibrutinib	C481R	C	481	R	1441T>C	T	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Unknown	ENST00000618050.4	BTK_ENST00000618050_C_481	481	BTK_ENST00000618050	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481R	Q06187/C481R	-7.59736	-7.01492	-7.02913	-8.95434	-6.28501	-4.78858	-4.65653	-4.74512	-3.18939	-3.94997	-3.97793	-3.98402	-4.23537	-3.64002	-2.08052	-1.88146	-7.29244	-4.44362	-3.4003	-3.45565	-6.1538	-7.36528	-5.89095	-6.49942
EGFR_ENST00000455089	No	Osimertinib	L673Q	L	673	Q	2018T>A	T	A	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000455089.5	EGFR_ENST00000455089_L_673	718	EGFR_ENST00000455089	L	673	P00533	L	718	P00533_L_718	P00533	L	718	l	7	L718Q	P00533/L718Q	-5.05825	-5.64597	-6.05984	-7.36659	-6.36485	-7.36319	-7.88834	-9.14273	-6.4587	-6.85261	-7.91901	-8.63806	-2.97989	-4.1502	-4.92061	-5.49016	-5.11756	-5.85864	-7.27968	-8.23138	-4.99883	-5.39418	-5.67361	-7.19663
FGFR2_ENST00000351936	No	BGJ398	L617M	L	617	M	1849T>A	T	A	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000351936.10	FGFR2_ENST00000351936_L_617	619	FGFR2_ENST00000351936	L	617	P21802	L	617	P21802_L_617	P21802	L	617	l	114	L617M	P21802/L617M	-2.1073	-2.37778	-2.56432	-0.58631	-1.99526	-3.16729	-2.95701	-3.49347	-2.54812	-4.03737	-3.19557	-3.71219	-2.13592	-3.11462	-3.57144	-3.87308	-2.20905	-2.58128	-2.17398	-2.00271	-2.08409	-2.33343	-2.49224	-0.51603
FGFR2_ENST00000360144	No	BGJ398	L529M	L	529	M	1585T>A	T	A	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000360144.7	FGFR2_ENST00000360144_L_529	620	FGFR2_ENST00000360144	L	529	P21802	L	617	P21802_L_617	P21802	L	617	l	114	L617M	P21802/L617M	-2.1073	-2.37778	-2.56432	-0.58631	-1.99526	-3.16729	-2.95701	-3.49347	-2.54812	-4.03737	-3.19557	-3.71219	-2.13592	-3.11462	-3.57144	-3.87308	-2.20905	-2.58128	-2.17398	-2.00271	-2.08409	-2.33343	-2.49224	-0.51603
EGFR_ENST00000454757	No	Tyrosine kinase inhibitor - NS	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000454757.6	EGFR_ENST00000454757_T_745	790	EGFR_ENST00000454757	T	745	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
EGFR_ENST00000454757	No	Osimertinib	L673Q	L	673	Q	2018T>A	T	A	lung	carcinoma	adenocarcinoma	NS	Homozygous	ENST00000454757.6	EGFR_ENST00000454757_L_673	718	EGFR_ENST00000454757	L	673	P00533	L	718	P00533_L_718	P00533	L	718	l	7	L718Q	P00533/L718Q	-5.05825	-5.64597	-6.05984	-7.36659	-6.36485	-7.36319	-7.88834	-9.14273	-6.4587	-6.85261	-7.91901	-8.63806	-2.97989	-4.1502	-4.92061	-5.49016	-5.11756	-5.85864	-7.27968	-8.23138	-4.99883	-5.39418	-5.67361	-7.19663
MET	Yes	Capmatinib	Y1248H	Y	1248	H	3742T>C	T	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000318493.10	MET_Y_1248	1248	MET	Y	1248	P08581	Y	1230	P08581_Y_1230	P08581	Y	1230	e	149	Y1230H	P08581/Y1230H	-4.76153	-4.89342	-5.71108	-6.70023	-4.80158	-5.19732	-5.53226	-6.10165	-3.6873	-4.4115	-4.07175	-4.82115	NA	-3.22438	-3.22438	-3.12487	-4.47446	-4.67827	-5.68985	-6.26703	-4.47804	-4.65967	-5.67953	-6.41406
FGFR2_ENST00000369056	No	BGJ398	E566A	E	566	A	1697A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000369056.5	FGFR2_ENST00000369056_E_566	568	FGFR2_ENST00000369056	E	566	P21802	E	565	P21802_E_565	P21802	E	565	e	78	E565A	P21802/E565A	-3.51392	-3.80037	-4.1026300000000004	-5.41668	-4.58579	-6.64823	-4.76785	-5.44841	-4.8176	-6.62651	-4.77112	-5.42876	-3.83527	-5.50045	-6.33318	-6.87154	-3.59306	-4.12673	-3.86929	-5.82732	-3.50686	-3.74738	-3.982	-5.27335
KDR_ENST00000263923	No	Cetuximab	L840F	L	840	F	2518C>T	C	T	large_intestine	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000263923.5	KDR_ENST00000263923_L_840	840	KDR_ENST00000263923	L	840	P35968	L	840	P35968_L_840	P35968	L	840	l	7	L840F	P35968/L840F	-3.45547	-3.88577	-4.08777	-4.73728	-4.33993	-4.909	-6.59791	-7.00366	-4.57468	-5.2917	-6.06613	-6.81201	-3.03397	-3.5591	-3.87938	-3.35501	-2.32656	-3.38252	-4.39197	-5.06598	-2.27186	-3.12373	-3.73069	-4.63944
KIT	Yes	Imatinib	N822Y	N	822	Y	2464A>T	A	T	soft_tissue	gastrointestinal_stromal_tumour	epithelioid	NS	Unknown	ENST00000288135.5	KIT_N_822	822	KIT	N	822	P10721	N	822	P10721_N_822	P10721	N	822	k	153	N822Y	P10721/N822Y	-4.0991	-5.09322	-5.6225	-5.85844	-5.93412	1.27756	1.13517	1.18695	-5.9424	1.4315	1.30957	1.35549	-5.26013	-5.04078	0.02553	0.17044	-4.72791	-5.20896	-0.79151	-0.78431	-4.02075	-4.83141	-5.43269	-5.56545
EGFR	Yes	Gefitinib	T790M	T	790	M	?	?	NA	lung	carcinoma	adenocarcinoma	transformed_to_squamous_cell_carcinoma	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
MAP2K1	Yes	Vemurafenib	E203K	E	203	K	?	?	NA	skin	malignant_melanoma	NS	NS	Unknown	ENST00000307102.9	MAP2K1_E_203	203	MAP2K1	E	203	Q02750	E	203	Q02750_E_203	Q02750	E	203	e	136	E203K	Q02750/E203K	-3.04797	-2.42433	-3.05421	-2.2423	-3.23263	-3.47359	-3.22914	-1.36968	-0.98375	-1.07226	-1.12278	-1.21372	-0.84676	-2.62417	-1.37457	-1.63566	-2.76921	-2.35315	-1.46565	-1.86845	-2.4507	-3.05415	-3.1226	-1.69716
KIT	Yes	Imatinib	V654A	V	654	A	1961T>C	T	C	soft_tissue	gastrointestinal_stromal_tumour	transdifferentiated	rhabdomyoblastic_and_anaplastic	Heterozygous	ENST00000288135.5	KIT_V_654	654	KIT	V	654	P10721	V	654	P10721_V_654	P10721	V	654	v	61	V654A	P10721/V654A	-3.0421	-3.91067	-4.28896	-4.96082	-5.97083	-6.55487	-4.62666	-4.76232	-6.07968	-6.51538	-4.42426	-4.7495	-3.86516	-4.78749	-4.69194	-5.04105	-3.59732	-4.43669	-5.88686	-5.92714	-2.94308	-3.67093	-4.14688	-4.77469
MET	Yes	Crizotinib	Y1248H	Y	1248	H	?	?	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000318493.10	MET_Y_1248	1248	MET	Y	1248	P08581	Y	1230	P08581_Y_1230	P08581	Y	1230	e	149	Y1230H	P08581/Y1230H	-4.76153	-4.89342	-5.71108	-6.70023	-4.80158	-5.19732	-5.53226	-6.10165	-3.6873	-4.4115	-4.07175	-4.82115	NA	-3.22438	-3.22438	-3.12487	-4.47446	-4.67827	-5.68985	-6.26703	-4.47804	-4.65967	-5.67953	-6.41406
ALK_ENST00000618119	No	Crizotinib	L819M	L	819	M	2455C>A	C	A	lung	carcinoma	adenocarcinoma	NS	Homozygous	ENST00000618119.4	ALK_ENST00000618119_L_819	1196	ALK_ENST00000618119	L	819	Q9UM73	L	1196	Q9UM73_L_1196	Q9UM73	L	1196	l	77	L1196M	Q9UM73/L1196M	-2.10714	-3.04155	-2.93754	-0.65705	1.58653	2.74448	2.99869	3.18813	2.09569	2.92517	3.12183	3.29347	0.72507	0.39472	1.81289	1.8037	-3.29014	-2.42223	-1.1506	0.19169	-1.87869	-2.94667	-3.37793	-3.58831
EGFR_ENST00000454757	No	Gefitinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	squamous_cell_carcinoma	NS	Unknown	ENST00000454757.6	EGFR_ENST00000454757_T_745	790	EGFR_ENST00000454757	T	745	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
MAP2K2_ENST00000394867	No	Dabrafenib	C28S	C	28	S	83G>C	G	C	skin	malignant_melanoma	NS	NS	Unknown	ENST00000394867.8	MAP2K2_ENST00000394867_C_28	125	MAP2K2_ENST00000394867	C	28	P36507	C	125	P36507_C_125	P36507	C	125	l	55	C125S	P36507/C125S	-5.86934	-4.4585	-3.71844	-3.81848	-4.54959	-4.55737	-5.1601	-4.43272	-3.00439	-3.30124	-3.84466	-4.65547	-3.42458	-5.0868	-4.0687	-5.10715	-5.47932	-5.80396	-4.90301	-5.45261	-5.68618	-5.77391	-4.33277	-3.83884
MAP2K2_ENST00000394867	No	Dabrafenib	E110K	E	110	K	328G>A	G	A	skin	malignant_melanoma	NS	NS	Heterozygous	ENST00000394867.8	MAP2K2_ENST00000394867_E_110	207	MAP2K2_ENST00000394867	E	110	P36507	E	207	P36507_E_207	P36507	E	207	e	136	E207K	P36507/E207K	-3.04785	-2.45216	-2.83294	-2.2423	-2.70537	-2.22673	-2.99764	-1.36968	-0.82964	-1.02523	-1.03418	-1.21453	-0.84676	-2.62417	-0.95055	-1.63566	-2.75546	-2.49041	-1.52576	-1.6751	-2.869	-2.97328	-3.53505	-1.67787
FLT3	Yes	Sorafenib	F691L	F	691	L	2073T>G	T	G	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	Heterozygous	ENST00000241453.11	FLT3_F_691	691	FLT3	F	691	P36888	F	691	P36888_F_691	P36888	F	691	l	77	F691L	P36888/F691L	-3.01988	-3.64347	-4.11973	-3.20238	-1.69933	-0.88972	0.86864	1.37904	-0.02646	0.32759	1.80925	2.18077	-1.8588	-1.09883	-0.89006	-0.86443	-3.64347	-3.7787	-2.73864	-1.26579	-3.01988	-3.58175	-4.04303	-4.20638
EGFR_ENST00000455089	No	Tyrosine kinase inhibitor - NS	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000455089.5	EGFR_ENST00000455089_T_745	790	EGFR_ENST00000455089	T	745	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
EGFR_ENST00000455089	No	Osimertinib	L747R	L	747	R	2240T>G	T	G	lung	carcinoma	small_cell_carcinoma	NS	Unknown	ENST00000455089.5	EGFR_ENST00000455089_L_747	792	EGFR_ENST00000455089	L	747	P00533	L	792	P00533_L_792	P00533	L	792	y	79	L792R	P00533/L792R	-4.96286	-5.52208	-5.81876	-5.52458	-6.10266	-6.50809	-6.50853	-6.33732	-6.33728	-6.2104	-6.68425	-6.14665	-3.0097	-4.13503	-4.83246	-4.07524	-5.02047	-5.73482	-6.94495	-7.1884	-4.91371	-5.2765	-5.55817	-5.40253
EGFR_ENST00000455089	No	Osimertinib	G751R	G	751	R	2251G>C	G	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	EGFR_ENST00000455089_G_751	796	EGFR_ENST00000455089	G	751	P00533	G	796	P00533_G_796	P00533	G	796	g	83	G796R	P00533/G796R	-5.8894	-6.50654	-6.88271	-7.69727	-7.18103	-8.1574	-9.35562	-9.83555	-7.27842	-8.07728	-9.35596	-10.43741	-3.43735	-4.80524	-5.63375	-6.24461	-5.96451	-6.71416	-8.62616	-8.7685	-5.82291	-6.25349	-6.54279	-7.52392
EGFR	Yes	Gefitinib	D761Y	D	761	Y	2281G>T	G	T	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000275493.6	EGFR_D_761	761	EGFR	D	761	P00533	D	761	P00533_D_761	P00533	D	761	r	47	D761Y	P00533/D761Y	-5.3867	-5.9495	-6.32091	-4.64807	-6.57853	-6.09538	-6.18149	-5.99906	-6.62793	-5.96446	-5.50531	-5.64162	-3.73298	-4.80966	-5.38183	-5.94314	-5.43186	-6.13773	-5.48231	-4.58334	-5.33549	-5.71756	-5.96957	-4.36782
EGFR	Yes	Gefitinib	T790M	T	790	M	?	?	NA	lung	carcinoma	acinar_adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
EGFR	Yes	Osimertinib	L718V	L	718	V	2152C>G	C	G	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_L_718	718	EGFR	L	718	P00533	L	718	P00533_L_718	P00533	L	718	l	7	L718V	P00533/L718V	-2.87973	-3.29071	-3.57936	-3.91461	-3.8134	-4.62156	-4.61481	-5.8953	-3.88231	-3.75331	-4.5836	-5.27275	-1.6044	-2.37985	-2.86936	-3.27274	-2.91342	-3.45256	-3.99282	-4.75855	-2.85288	-3.12469	-3.31329	-3.69748
FGFR2_ENST00000358487	No	Pemigatinib	L617V	L	617	V	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	FGFR2_ENST00000358487_L_617	617	FGFR2_ENST00000358487	L	617	P21802	L	617	P21802_L_617	P21802	L	617	l	114	L617V	P21802/L617V	-2.49762	-2.75915	-2.98537	-4.0619	-3.8637	-5.63552	-5.12245	-5.58345	-3.80499	-5.60023	-5.06176	-5.54424	-2.64079	-4.0085	-4.62204	-5.04042	-2.58403	-3.00731	-3.12501	-4.55764	-2.48827	-2.70931	-2.88989	-3.93592
ABL1_ENST00000318560	No	Tyrosine kinase inhibitor - NS	F317L	F	317	L	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_F_317	317	ABL1_ENST00000318560	F	317	P00519	F	317	P00519_F_317	P00519	F	317	y	79	F317L	P00519/F317L	-4.46824	-4.54627	-5.33041	-7.08854	-1.29001	-1.89592	-1.93214	-1.72959	-0.94743	-1.69423	-1.77506	-1.60537	-3.09106	-2.03923	-1.23068	-1.3226	-4.47996	-4.49148	-2.7549	-2.14739	-3.56773	-4.48426	-5.71984	-7.20214
MET	Yes	Savolitinib	D1246V	D	1246	V	3737A>T	A	T	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000318493.10	MET_D_1246	1246	MET	D	1246	P08581	D	1228	P08581_D_1228	P08581	D	1228	e	147	D1228V	P08581/D1228V	-6.05982	-6.20082	-7.16938	-5.13495	-6.10837	-8.19915	-7.65892	-6.18013	-8.04047	-8.61861	-6.69852	-7.85318	NA	-4.26001	-4.26001	-5.55237	-5.68383	-5.91053	-7.12997	-5.03916	-5.68706	-5.88416	-7.12721	-4.77826
BTK	Yes	Ibrutinib	C515S	C	515	S	1544G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Heterozygous	ENST00000621635.4	BTK_C_515	515	BTK	C	515	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
FLT3	Yes	Sorafenib	D835Y	D	835	Y	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	Unknown	ENST00000241453.11	FLT3_D_835	835	FLT3	D	835	P36888	D	835	P36888_D_835	P36888	D	835	e	147	D835Y	P36888/D835Y	-4.81333	-5.99384	-6.76524	-6.67394	-7.35723	-2.72249	-3.55366	-3.42703	-6.96725	-3.15452	-3.53455	-3.3969	-5.94919	-6.88241	-6.56247	-6.24567	-5.99384	-7.20319	-4.30916	-3.71481	-4.81333	-5.94335	-6.71481	-6.44769
ALK_ENST00000618119	No	Crizotinib	G825R	G	825	R	2473G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000618119.4	ALK_ENST00000618119_G_825	1202	ALK_ENST00000618119	G	825	Q9UM73	G	1202	Q9UM73_G_1202	Q9UM73	G	1202	g	83	G1202R	Q9UM73/G1202R	-4.81544	-6.73839	-7.96814	-8.23089	-8.99966	-6.51938	-6.67511	-6.18498	-8.99117	-6.52312	-6.66187	-6.17488	-7.73938	-8.17917	-9.69937	-7.04627	-7.18312	-8.85833	-9.94931	-6.31567	-4.34695	-6.57222	-7.32508	-8.42016
ALK_ENST00000618119	No	Crizotinib	L819M	L	819	M	2455C>A	C	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000618119.4	ALK_ENST00000618119_L_819	1196	ALK_ENST00000618119	L	819	Q9UM73	L	1196	Q9UM73_L_1196	Q9UM73	L	1196	l	77	L1196M	Q9UM73/L1196M	-2.10714	-3.04155	-2.93754	-0.65705	1.58653	2.74448	2.99869	3.18813	2.09569	2.92517	3.12183	3.29347	0.72507	0.39472	1.81289	1.8037	-3.29014	-2.42223	-1.1506	0.19169	-1.87869	-2.94667	-3.37793	-3.58831
BTK_ENST00000308731	No	Acalabrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Unknown	ENST00000308731.7	BTK_ENST00000308731_C_481	481	BTK_ENST00000308731	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
BTK_ENST00000308731	No	Ibrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	Unknown	ENST00000308731.7	BTK_ENST00000308731_C_481	481	BTK_ENST00000308731	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
FGFR2_ENST00000478859	No	BGJ398	L389M	L	389	M	1165T>A	T	A	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000478859.5	FGFR2_ENST00000478859_L_389	617	FGFR2_ENST00000478859	L	389	P21802	L	617	P21802_L_617	P21802	L	617	l	114	L617M	P21802/L617M	-2.1073	-2.37778	-2.56432	-0.58631	-1.99526	-3.16729	-2.95701	-3.49347	-2.54812	-4.03737	-3.19557	-3.71219	-2.13592	-3.11462	-3.57144	-3.87308	-2.20905	-2.58128	-2.17398	-2.00271	-2.08409	-2.33343	-2.49224	-0.51603
PDGFRA	Yes	Imatinib	D842V	D	842	V	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	epithelioid	NS	Unknown	ENST00000257290.9	PDGFRA_D_842	842	PDGFRA	D	842	P16234	D	842	P16234_D_842	P16234	D	842	e	147	D842V	P16234/D842V	-4.31564	-5.1395	-5.72083	-6.23429	-7.50222	-5.58834	-3.17398	-2.56912	-7.12687	-5.66214	-2.91303	-2.5456	-6.35691	-7.44297	-7.97849	-6.78856	-5.04194	-6.07278	-4.61315	-1.093	-4.28226	-5.10224	-5.65105	-5.81161
ABL1_ENST00000318560	No	Nilotinib	Y253H	Y	253	H	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_Y_253	253	ABL1_ENST00000318560	Y	253	P00519	Y	253	P00519_Y_253	P00519	Y	253	f	12	Y253H	P00519/Y253H	-4.89532	-4.98695	-5.85466	-6.40595	-7.04709	-5.54449	-3.47977	-3.44568	-3.6467	-4.56531	-2.75965	-2.89919	-3.78921	-4.06068	-3.91027	-3.18392	-4.90827	-5.82537	-7.37698	-7.52041	-4.13495	-4.92132	-6.08031	-6.33863
ALK	Yes	Alectinib	I1171N	I	1171	N	3512T>A	T	A	lung	carcinoma	non_small_cell_carcinoma	NS	Heterozygous	ENST00000389048.7	ALK_I_1171	1171	ALK	I	1171	Q9UM73	I	1171	Q9UM73_I_1171	Q9UM73	I	1171	l	52	I1171N	Q9UM73/I1171N	-5.17128	-6.74603	-6.94801	-6.49109	-3.57766	-3.2095	-3.74306	-3.41998	-2.58232	-2.53444	-3.18063	-2.96084	-6.18051	-6.39335	-7.5839	-6.3031	-6.60105	-8.88445	-9.69268	-6.19401	-4.80406	-6.58397	-6.76653	-6.06903
FLT3	Yes	Sunitinib	D835Y	D	835	Y	2503G>T	G	T	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	Heterozygous	ENST00000241453.11	FLT3_D_835	835	FLT3	D	835	P36888	D	835	P36888_D_835	P36888	D	835	e	147	D835Y	P36888/D835Y	-4.81333	-5.99384	-6.76524	-6.67394	-7.35723	-2.72249	-3.55366	-3.42703	-6.96725	-3.15452	-3.53455	-3.3969	-5.94919	-6.88241	-6.56247	-6.24567	-5.99384	-7.20319	-4.30916	-3.71481	-4.81333	-5.94335	-6.71481	-6.44769
FGFR2_ENST00000358487	No	BGJ398	E565A	E	565	A	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	FGFR2_ENST00000358487_E_565	565	FGFR2_ENST00000358487	E	565	P21802	E	565	P21802_E_565	P21802	E	565	e	78	E565A	P21802/E565A	-3.51392	-3.80037	-4.1026300000000004	-5.41668	-4.58579	-6.64823	-4.76785	-5.44841	-4.8176	-6.62651	-4.77112	-5.42876	-3.83527	-5.50045	-6.33318	-6.87154	-3.59306	-4.12673	-3.86929	-5.82732	-3.50686	-3.74738	-3.982	-5.27335
BTK_ENST00000308731	No	Ibrutinib	C481R	C	481	R	1441T>C	T	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Unknown	ENST00000308731.7	BTK_ENST00000308731_C_481	481	BTK_ENST00000308731	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481R	Q06187/C481R	-7.59736	-7.01492	-7.02913	-8.95434	-6.28501	-4.78858	-4.65653	-4.74512	-3.18939	-3.94997	-3.97793	-3.98402	-4.23537	-3.64002	-2.08052	-1.88146	-7.29244	-4.44362	-3.4003	-3.45565	-6.1538	-7.36528	-5.89095	-6.49942
FGFR2_ENST00000613048	No	INCB054828	N460H	N	460	H	1378A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000613048.4	FGFR2_ENST00000613048_N_460	549	FGFR2_ENST00000613048	N	460	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549H	P21802/N549H	-3.59202	-4.05283	-4.45204	-1.91687	-3.2987	-5.64347	-3.43921	-3.53355	-3.40495	-5.46205	-3.3852	-3.51414	-4.11275	-4.00667	-4.83075	-4.39536	-3.73976	-4.49588	-3.98204	-1.97595	-3.56699	-3.97335	-4.2944	-1.77593
ABL1_ENST00000318560	No	Imatinib	F311I	F	311	I	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_F_311	311	ABL1_ENST00000318560	F	311	P00519	F	311	P00519_F_311	P00519	F	311	l	73	F311I	P00519/F311I	-4.74562	-4.83823	-5.89307	-5.77723	0.16107	0.27727	0.0412	-0.12629	1.316	1.43556	0.66188	0.37482	-0.10514	0.08101	0.83664	0.11118	-4.75104	-3.6225	-2.40098	-2.24701	-3.81248	-4.75469	-6.18946	-5.87615
KIT	Yes	Imatinib	D820G	D	820	G	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	spindle_and_epithelioid	NS	Unknown	ENST00000288135.5	KIT_D_820	820	KIT	D	820	P10721	D	820	P10721_D_820	P10721	D	820	s	151	D820G	P10721/D820G	-3.74962	-4.54439	-4.94901	-4.70049	-4.8037	-3.35095	-2.16661	-1.685	-4.84883	-3.24491	-2.05916	-1.59999	-4.63427	-4.41398	-3.56932	-3.26113	-4.22884	-5.13095	-2.62641	-0.57396	-3.68791	-4.32864	-4.78558	-4.50256
ALK	Yes	Crizotinib	C1156Y	C	1156	Y	3467G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000389048.7	ALK_C_1156	1156	ALK	C	1156	Q9UM73	C	1156	Q9UM73_C_1156	Q9UM73	C	1156	k	36	C1156Y	Q9UM73/C1156Y	-6.16	-8.02876	-5.18122	-3.34554	-4.30317	-4.78336	-3.16122	-2.7816	-3.24014	-3.73867	-2.97655	-2.57337	-3.60733	-3.66879	-4.32301	-3.58122	-8.43152	-7.57398	-7.10224	-4.80166	-5.76175	-7.84685	-4.66663	-3.25208
FLT3	Yes	Quizartinib	F691L	F	691	L	2073T>G	T	G	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	Heterozygous	ENST00000241453.11	FLT3_F_691	691	FLT3	F	691	P36888	F	691	P36888_F_691	P36888	F	691	l	77	F691L	P36888/F691L	-3.01988	-3.64347	-4.11973	-3.20238	-1.69933	-0.88972	0.86864	1.37904	-0.02646	0.32759	1.80925	2.18077	-1.8588	-1.09883	-0.89006	-0.86443	-3.64347	-3.7787	-2.73864	-1.26579	-3.01988	-3.58175	-4.04303	-4.20638
EGFR_ENST00000455089	No	Osimertinib	L747F	L	747	F	2239C>T	C	T	lung	carcinoma	non_small_cell_carcinoma	NS	Heterozygous	ENST00000455089.5	EGFR_ENST00000455089_L_747	792	EGFR_ENST00000455089	L	747	P00533	L	792	P00533_L_792	P00533	L	792	y	79	L792F	P00533/L792F	-2.59609	-2.89655	-2.59418	-3.10204	-2.79463	-2.94014	-1.89723	-2.17756	-3.42147	-2.14595	-1.75152	-1.6736	-1.66999	-2.31034	-2.60281	-1.15156	-2.61965	-3.02695	-3.21165	-2.9848	-2.56703	-2.76477	-2.90067	-2.79167
EGFR_ENST00000454757	No	Osimertinib	L747R	L	747	R	2240T>G	T	G	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	EGFR_ENST00000454757_L_747	792	EGFR_ENST00000454757	L	747	P00533	L	792	P00533_L_792	P00533	L	792	y	79	L792R	P00533/L792R	-4.96286	-5.52208	-5.81876	-5.52458	-6.10266	-6.50809	-6.50853	-6.33732	-6.33728	-6.2104	-6.68425	-6.14665	-3.0097	-4.13503	-4.83246	-4.07524	-5.02047	-5.73482	-6.94495	-7.1884	-4.91371	-5.2765	-5.55817	-5.40253
FGFR2_ENST00000369060	No	BGJ398	L501M	L	501	M	1501T>A	T	A	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000369060.8	FGFR2_ENST00000369060_L_501	617	FGFR2_ENST00000369060	L	501	P21802	L	617	P21802_L_617	P21802	L	617	l	114	L617M	P21802/L617M	-2.1073	-2.37778	-2.56432	-0.58631	-1.99526	-3.16729	-2.95701	-3.49347	-2.54812	-4.03737	-3.19557	-3.71219	-2.13592	-3.11462	-3.57144	-3.87308	-2.20905	-2.58128	-2.17398	-2.00271	-2.08409	-2.33343	-2.49224	-0.51603
EGFR	Yes	Erlotinib	T790M	T	790	M	2369C>T	C	T	lung	carcinoma	bronchioloalveolar_adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
ERBB2_ENST00000541774	No	Trastuzumab	L854R	L	854	R	2561T>G	T	G	breast	carcinoma	ductal_carcinoma	NS	Unknown	ENST00000541774.5	ERBB2_ENST00000541774_L_854	869	ERBB2_ENST00000541774	L	854	P04626	L	869	P04626_L_869	P04626	L	869	e	147	L869R	P04626/L869R	-4.58599	-5.51191	-6.16009	-4.4753	-6.62002	-7.22887	-7.71834	-6.71801	-6.05186	-7.10053	-8.34153	-9.28128	-2.97229	-4.13897	-4.83246	-5.40982	-4.92181	-6.14972	-7.62842	-6.37544	-4.50616	-5.40427	-6.11379	-4.44968
FGFR2_ENST00000358487	No	INCB054828	N549H	N	549	H	1645A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	FGFR2_ENST00000358487_N_549	549	FGFR2_ENST00000358487	N	549	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549H	P21802/N549H	-3.59202	-4.05283	-4.45204	-1.91687	-3.2987	-5.64347	-3.43921	-3.53355	-3.40495	-5.46205	-3.3852	-3.51414	-4.11275	-4.00667	-4.83075	-4.39536	-3.73976	-4.49588	-3.98204	-1.97595	-3.56699	-3.97335	-4.2944	-1.77593
ALK_ENST00000642122	No	Crizotinib	F106L	F	106	L	318C>G	C	G	soft_tissue	inflammatory_myofibroblastic_tumour	NS	NS	Homozygous	ENST00000642122.1	ALK_ENST00000642122_F_106	1174	ALK_ENST00000642122	F	106	Q9UM73	F	1174	Q9UM73_F_1174	Q9UM73	F	1174	l	55	F1174L	Q9UM73/F1174L	-3.81827	-5.2478	-6.47368	-2.31841	-0.60269	0.94324	0.99964	1.10868	-0.25872	1.18764	1.16412	1.25703	-1.33672	-0.58613	-0.00266	-0.21463	-5.69483	-2.46391	-0.84444	-0.12169	-3.46176	-5.10815	-5.76626	-3.17882
ALK_ENST00000642122	No	Crizotinib	C88Y	C	88	Y	263G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000642122.1	ALK_ENST00000642122_C_88	1156	ALK_ENST00000642122	C	88	Q9UM73	C	1156	Q9UM73_C_1156	Q9UM73	C	1156	k	36	C1156Y	Q9UM73/C1156Y	-6.16	-8.02876	-5.18122	-3.34554	-4.30317	-4.78336	-3.16122	-2.7816	-3.24014	-3.73867	-2.97655	-2.57337	-3.60733	-3.66879	-4.32301	-3.58122	-8.43152	-7.57398	-7.10224	-4.80166	-5.76175	-7.84685	-4.66663	-3.25208
KIT	Yes	Imatinib	V654A	V	654	A	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	dedifferentiated	anaplastic_and_spindle_and_epithelioid	Unknown	ENST00000288135.5	KIT_V_654	654	KIT	V	654	P10721	V	654	P10721_V_654	P10721	V	654	v	61	V654A	P10721/V654A	-3.0421	-3.91067	-4.28896	-4.96082	-5.97083	-6.55487	-4.62666	-4.76232	-6.07968	-6.51538	-4.42426	-4.7495	-3.86516	-4.78749	-4.69194	-5.04105	-3.59732	-4.43669	-5.88686	-5.92714	-2.94308	-3.67093	-4.14688	-4.77469
KIT	Yes	Imatinib	D820Y	D	820	Y	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	spindle_and_epithelioid	NS	Unknown	ENST00000288135.5	KIT_D_820	820	KIT	D	820	P10721	D	820	P10721_D_820	P10721	D	820	s	151	D820Y	P10721/D820Y	-4.8403	-5.84134	-6.35055	-6.1242	-7.00734	-3.00094	0.15198	0.23118	-7.14219	-2.61604	0.25196	0.35051	-5.88038	-5.74352	-3.56747	-0.87208	-5.46445	-6.54829	-2.1142	-2.08244	-4.74066	-5.58085	-6.15611	-5.87859
EGFR	Yes	Icotinib	T790M	T	790	M	?	?	NA	lung	carcinoma	hepatoid_adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
MET	Yes	Crizotinib	D1246N	D	1246	N	?	?	NA	lung	carcinoma	sarcomatoid_carcinoma	NS	Unknown	ENST00000318493.10	MET_D_1246	1246	MET	D	1246	P08581	D	1228	P08581_D_1228	P08581	D	1228	e	147	D1228N	P08581/D1228N	-3.89302	-4.01672	-4.87037	-5.99475	-3.93587	-5.76835	-4.83304	-5.73344	-5.48859	-6.01457	-4.16378	-4.89599	NA	-2.44536	-2.44536	-3.29238	-3.56174	-3.76361	-4.83157	-6.00582	-3.56492	-3.74382	-4.8243	-5.69045
EGFR_ENST00000455089	No	Erlotinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	bronchioloalveolar_adenocarcinoma	NS	Unknown	ENST00000455089.5	EGFR_ENST00000455089_T_745	790	EGFR_ENST00000455089	T	745	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
ALK	Yes	Crizotinib	L1196M	L	1196	M	3586C>A	C	A	lung	carcinoma	adenocarcinoma	NS	Homozygous	ENST00000389048.7	ALK_L_1196	1196	ALK	L	1196	Q9UM73	L	1196	Q9UM73_L_1196	Q9UM73	L	1196	l	77	L1196M	Q9UM73/L1196M	-2.10714	-3.04155	-2.93754	-0.65705	1.58653	2.74448	2.99869	3.18813	2.09569	2.92517	3.12183	3.29347	0.72507	0.39472	1.81289	1.8037	-3.29014	-2.42223	-1.1506	0.19169	-1.87869	-2.94667	-3.37793	-3.58831
EGFR	Yes	Osimertinib	T790M	T	790	M	?	?	NA	lung	carcinoma	adenocarcinoma	transformed_to_sarcomatoid_carcinoma	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
FGFR2_ENST00000369061	No	Palbociclib	N437K	N	437	K	1311T>A	T	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000369061.8	FGFR2_ENST00000369061_N_437	549	FGFR2_ENST00000369061	N	437	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549K	P21802/N549K	-3.64811	-4.11211	-4.51203	-2.25892	-2.2117	-3.83119	-2.34387	-2.0932	-2.32326	-3.77184	-2.29823	-2.05102	-4.04513	-2.42111	-3.09061	-2.50446	-3.80625	-4.54717	-3.95835	-1.73318	-3.6234	-4.03561	-4.34609	-2.17698
ALK	Yes	Crizotinib	G1202R	G	1202	R	3604G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000389048.7	ALK_G_1202	1202	ALK	G	1202	Q9UM73	G	1202	Q9UM73_G_1202	Q9UM73	G	1202	g	83	G1202R	Q9UM73/G1202R	-4.81544	-6.73839	-7.96814	-8.23089	-8.99966	-6.51938	-6.67511	-6.18498	-8.99117	-6.52312	-6.66187	-6.17488	-7.73938	-8.17917	-9.69937	-7.04627	-7.18312	-8.85833	-9.94931	-6.31567	-4.34695	-6.57222	-7.32508	-8.42016
EGFR_ENST00000455089	No	Afatinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	bronchioloalveolar_adenocarcinoma	NS	Unknown	ENST00000455089.5	EGFR_ENST00000455089_T_745	790	EGFR_ENST00000455089	T	745	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
FGFR4_ENST00000393648	No	Fisogatinib	V482L	V	482	L	1444G>C	G	C	liver	carcinoma	hepatocellular_carcinoma	NS	Unknown	ENST00000393648.6	FGFR4_ENST00000393648_V_482	550	FGFR4_ENST00000393648	V	482	P22455	V	550	P22455_V_550	P22455	V	550	l	77	V550L	P22455/V550L	-2.4551	-2.99716	-3.082	-1.2076	-3.37839	-3.45376	-2.33025	-1.60496	-3.24753	-3.35757	-2.23668	-1.59437	-2.66871	-3.9419	-3.38869	-1.90248	-2.8906	-3.08134	-3.31301	-1.64314	-2.45229	-2.99361	-3.02446	-1.0623
EGFR_ENST00000454757	No	Afatinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	bronchioloalveolar_adenocarcinoma	NS	Unknown	ENST00000454757.6	EGFR_ENST00000454757_T_745	790	EGFR_ENST00000454757	T	745	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
KIT	Yes	Imatinib	T670I	T	670	I	2009C>T	C	T	soft_tissue	gastrointestinal_stromal_tumour	spindle_and_epithelioid	NS	Unknown	ENST00000288135.5	KIT_T_670	670	KIT	T	670	P10721	T	670	P10721_T_670	P10721	T	670	l	77	T670I	P10721/T670I	-3.21372	-3.61	-4.07085	-3.06475	-1.69942	-0.73517	-0.29682	-0.27338	-1.91451	-0.43354	-0.20002	-0.12691	-4.41323	-0.99524	-0.62606	0.45647	-3.86569	-4.28669	-1.91173	-0.20553	-3.15078	-3.33921	-3.90805	-4.70736
FGFR2_ENST00000358487	No	BGJ398	N549K	N	549	K	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	FGFR2_ENST00000358487_N_549	549	FGFR2_ENST00000358487	N	549	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549K	P21802/N549K	-3.64811	-4.11211	-4.51203	-2.25892	-2.2117	-3.83119	-2.34387	-2.0932	-2.32326	-3.77184	-2.29823	-2.05102	-4.04513	-2.42111	-3.09061	-2.50446	-3.80625	-4.54717	-3.95835	-1.73318	-3.6234	-4.03561	-4.34609	-2.17698
EGFR_ENST00000455089	No	Osimertinib	L747P	L	747	P	2240T>C	T	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	EGFR_ENST00000455089_L_747	792	EGFR_ENST00000455089	L	747	P00533	L	792	P00533_L_792	P00533	L	792	y	79	L792P	P00533/L792P	-5.15844	-5.61755	-5.93526	-6.18939	-6.21444	-6.71833	-6.7635	-6.87896	-6.36391	-6.36826	-6.9507	-6.56556	-3.67888	-4.62437	-5.24789	-4.57306	-5.19961	-5.81396	-7.17777	-7.5768	-5.1311	-5.39869	-5.6449	-6.19451
ABL1	Yes	Tyrosine kinase inhibitor - NS	T334I	T	334	I	1001C>T	C	T	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000372348.6	ABL1_T_334	334	ABL1	T	334	P00519	T	315	P00519_T_315	P00519	T	315	l	77	T315I	P00519/T315I	-3.83824	-3.89394	-4.90879	-4.39264	-5.08085	-3.009	-2.99728	-3.29298	-2.37856	-2.70226	-2.83383	-3.19426	-4.73256	-2.3655	-2.63879	-1.93584	-3.83098	-6.27019	-6.31943	-2.10314	-2.96885	-3.82882	-5.20793	-4.18032
ALK_ENST00000642122	No	Alectinib	I103N	I	103	N	308T>A	T	A	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000642122.1	ALK_ENST00000642122_I_103	1171	ALK_ENST00000642122	I	103	Q9UM73	I	1171	Q9UM73_I_1171	Q9UM73	I	1171	l	52	I1171N	Q9UM73/I1171N	-5.17128	-6.74603	-6.94801	-6.49109	-3.57766	-3.2095	-3.74306	-3.41998	-2.58232	-2.53444	-3.18063	-2.96084	-6.18051	-6.39335	-7.5839	-6.3031	-6.60105	-8.88445	-9.69268	-6.19401	-4.80406	-6.58397	-6.76653	-6.06903
MET	Yes	Crizotinib	D1246H	D	1246	H	?	?	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000318493.10	MET_D_1246	1246	MET	D	1246	P08581	D	1228	P08581_D_1228	P08581	D	1228	e	147	D1228H	P08581/D1228H	-4.67999	-4.83422	-5.78456	-6.90292	-4.73552	-6.68711	-5.99291	-6.78607	-6.46059	-7.04193	-5.23048	-6.00738	NA	-3.02871	-3.02871	-4.09227	-4.31689	-4.56049	-5.75303	-6.93734	-4.32175	-4.53522	-5.74495	-6.58886
PDGFRA	Yes	Sunitinib	D842V	D	842	V	2525A>T	A	T	soft_tissue	gastrointestinal_stromal_tumour	epithelioid	NS	Heterozygous	ENST00000257290.9	PDGFRA_D_842	842	PDGFRA	D	842	P16234	D	842	P16234_D_842	P16234	D	842	e	147	D842V	P16234/D842V	-4.31564	-5.1395	-5.72083	-6.23429	-7.50222	-5.58834	-3.17398	-2.56912	-7.12687	-5.66214	-2.91303	-2.5456	-6.35691	-7.44297	-7.97849	-6.78856	-5.04194	-6.07278	-4.61315	-1.093	-4.28226	-5.10224	-5.65105	-5.81161
FGFR2_ENST00000358487	No	Debio1347	M537I	M	537	I	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	FGFR2_ENST00000358487_M_537	537	FGFR2_ENST00000358487	M	537	P21802	M	537	P21802_M_537	P21802	M	537	i	51	M537I	P21802/M537I	-2.99056	-3.26176	-3.54719	-1.59993	-0.77194	0.11626	0.68981	0.66536	-0.28369	0.31621	0.90742	0.85813	-1.89687	0.16423	-0.00385	0.31813	-3.06905	-3.57002	-2.08512	-1.82669	-2.98845	-3.20731	-3.42516	-1.66566
FGFR2_ENST00000357555	No	BGJ398	L528M	L	528	M	1582T>A	T	A	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000357555.9	FGFR2_ENST00000357555_L_528	617	FGFR2_ENST00000357555	L	528	P21802	L	617	P21802_L_617	P21802	L	617	l	114	L617M	P21802/L617M	-2.1073	-2.37778	-2.56432	-0.58631	-1.99526	-3.16729	-2.95701	-3.49347	-2.54812	-4.03737	-3.19557	-3.71219	-2.13592	-3.11462	-3.57144	-3.87308	-2.20905	-2.58128	-2.17398	-2.00271	-2.08409	-2.33343	-2.49224	-0.51603
EGFR	Yes	Erlotinib	T790M	T	790	M	2369C>T	C	T	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
KIT	Yes	Imatinib	D816G	D	816	G	2447A>G	A	G	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Heterozygous	ENST00000288135.5	KIT_D_816	816	KIT	D	816	P10721	D	816	P10721_D_816	P10721	D	816	e	147	D816G	P10721/D816G	-3.74962	-4.54439	-4.94901	-4.62986	-5.81009	-3.94183	-3.34842	-2.99622	-6.1652	-3.72349	-3.29199	-2.94023	-4.63427	-5.59219	-3.40419	-2.07999	-4.22884	-5.13095	-3.82729	-3.10765	-3.68791	-4.32864	-4.78558	-4.50256
FGFR2_ENST00000478859	No	INCB054828	N321H	N	321	H	961A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000478859.5	FGFR2_ENST00000478859_N_321	549	FGFR2_ENST00000478859	N	321	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549H	P21802/N549H	-3.59202	-4.05283	-4.45204	-1.91687	-3.2987	-5.64347	-3.43921	-3.53355	-3.40495	-5.46205	-3.3852	-3.51414	-4.11275	-4.00667	-4.83075	-4.39536	-3.73976	-4.49588	-3.98204	-1.97595	-3.56699	-3.97335	-4.2944	-1.77593
EGFR_ENST00000455089	No	Gefitinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	squamous_cell_carcinoma	NS	Unknown	ENST00000455089.5	EGFR_ENST00000455089_T_745	790	EGFR_ENST00000455089	T	745	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
KIT	Yes	Imatinib	V654A	V	654	A	1961T>C	T	C	soft_tissue	gastrointestinal_stromal_tumour	spindle_and_epithelioid	NS	Unknown	ENST00000288135.5	KIT_V_654	654	KIT	V	654	P10721	V	654	P10721_V_654	P10721	V	654	v	61	V654A	P10721/V654A	-3.0421	-3.91067	-4.28896	-4.96082	-5.97083	-6.55487	-4.62666	-4.76232	-6.07968	-6.51538	-4.42426	-4.7495	-3.86516	-4.78749	-4.69194	-5.04105	-3.59732	-4.43669	-5.88686	-5.92714	-2.94308	-3.67093	-4.14688	-4.77469
EGFR	Yes	Tyrosine kinase inhibitor - NS	T790M	T	790	M	?	?	NA	lung	carcinoma	micropapillary_adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
KIT	Yes	Imatinib	V654A	V	654	A	1961T>C	T	C	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Homozygous	ENST00000288135.5	KIT_V_654	654	KIT	V	654	P10721	V	654	P10721_V_654	P10721	V	654	v	61	V654A	P10721/V654A	-3.0421	-3.91067	-4.28896	-4.96082	-5.97083	-6.55487	-4.62666	-4.76232	-6.07968	-6.51538	-4.42426	-4.7495	-3.86516	-4.78749	-4.69194	-5.04105	-3.59732	-4.43669	-5.88686	-5.92714	-2.94308	-3.67093	-4.14688	-4.77469
KIT	Yes	Imatinib	D820Y	D	820	Y	2458G>T	G	T	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Heterozygous	ENST00000288135.5	KIT_D_820	820	KIT	D	820	P10721	D	820	P10721_D_820	P10721	D	820	s	151	D820Y	P10721/D820Y	-4.8403	-5.84134	-6.35055	-6.1242	-7.00734	-3.00094	0.15198	0.23118	-7.14219	-2.61604	0.25196	0.35051	-5.88038	-5.74352	-3.56747	-0.87208	-5.46445	-6.54829	-2.1142	-2.08244	-4.74066	-5.58085	-6.15611	-5.87859
ABL1_ENST00000318560	No	Tyrosine kinase inhibitor - NS	T315I	T	315	I	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_T_315	315	ABL1_ENST00000318560	T	315	P00519	T	315	P00519_T_315	P00519	T	315	l	77	T315I	P00519/T315I	-3.83824	-3.89394	-4.90879	-4.39264	-5.08085	-3.009	-2.99728	-3.29298	-2.37856	-2.70226	-2.83383	-3.19426	-4.73256	-2.3655	-2.63879	-1.93584	-3.83098	-6.27019	-6.31943	-2.10314	-2.96885	-3.82882	-5.20793	-4.18032
BTK_ENST00000308731	No	Ibrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Heterozygous	ENST00000308731.7	BTK_ENST00000308731_C_481	481	BTK_ENST00000308731	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
EGFR_ENST00000455089	No	Osimertinib	L747R	L	747	R	2240T>G	T	G	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	EGFR_ENST00000455089_L_747	792	EGFR_ENST00000455089	L	747	P00533	L	792	P00533_L_792	P00533	L	792	y	79	L792R	P00533/L792R	-4.96286	-5.52208	-5.81876	-5.52458	-6.10266	-6.50809	-6.50853	-6.33732	-6.33728	-6.2104	-6.68425	-6.14665	-3.0097	-4.13503	-4.83246	-4.07524	-5.02047	-5.73482	-6.94495	-7.1884	-4.91371	-5.2765	-5.55817	-5.40253
EGFR	Yes	Gefitinib	T790M	T	790	M	?	?	NA	lung	carcinoma	pleomorphic_carcinoma	NS	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
EGFR	Yes	Osimertinib	C797S	C	797	S	2390G>C	G	C	lung	carcinoma	small_cell_carcinoma	NS	Unknown	ENST00000275493.6	EGFR_C_797	797	EGFR	C	797	P00533	C	797	P00533_C_797	P00533	C	797	e	84	C797S	P00533/C797S	-6.10543	-6.64002	-6.96375	-2.21228	-7.28074	-5.17489	-1.99234	-1.36406	-7.39063	-3.56928	-2.02928	-1.47672	-3.7615	-5.10149	-5.84303	-2.46042	-6.15484	-6.83722	-5.65101	-2.29663	-6.04365	-6.40311	-6.66681	-2.05142
EGFR	Yes	Osimertinib	L792R	L	792	R	2375T>G	T	G	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_L_792	792	EGFR	L	792	P00533	L	792	P00533_L_792	P00533	L	792	y	79	L792R	P00533/L792R	-4.96286	-5.52208	-5.81876	-5.52458	-6.10266	-6.50809	-6.50853	-6.33732	-6.33728	-6.2104	-6.68425	-6.14665	-3.0097	-4.13503	-4.83246	-4.07524	-5.02047	-5.73482	-6.94495	-7.1884	-4.91371	-5.2765	-5.55817	-5.40253
EGFR	Yes	Osimertinib	L792V	L	792	V	2374C>G	C	G	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_L_792	792	EGFR	L	792	P00533	L	792	P00533_L_792	P00533	L	792	y	79	L792V	P00533/L792V	-2.87973	-3.29071	-3.04304	-3.68482	-3.24709	-3.81058	-4.1472	-4.17932	-3.88231	-3.81785	-4.39253	-3.84676	-1.6044	-2.37985	-2.86936	-2.526	-2.91342	-3.45256	-4.41504	-4.71537	-2.85288	-3.12469	-3.31329	-4.06925
FGFR2_ENST00000369059	No	INCB054828	N435H	N	435	H	1303A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000369059.5	FGFR2_ENST00000369059_N_435	552	FGFR2_ENST00000369059	N	435	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549H	P21802/N549H	-3.59202	-4.05283	-4.45204	-1.91687	-3.2987	-5.64347	-3.43921	-3.53355	-3.40495	-5.46205	-3.3852	-3.51414	-4.11275	-4.00667	-4.83075	-4.39536	-3.73976	-4.49588	-3.98204	-1.97595	-3.56699	-3.97335	-4.2944	-1.77593
ALK	Yes	Ceritinib	L1196M	L	1196	M	?	?	NA	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000389048.7	ALK_L_1196	1196	ALK	L	1196	Q9UM73	L	1196	Q9UM73_L_1196	Q9UM73	L	1196	l	77	L1196M	Q9UM73/L1196M	-2.10714	-3.04155	-2.93754	-0.65705	1.58653	2.74448	2.99869	3.18813	2.09569	2.92517	3.12183	3.29347	0.72507	0.39472	1.81289	1.8037	-3.29014	-2.42223	-1.1506	0.19169	-1.87869	-2.94667	-3.37793	-3.58831
ABL1_ENST00000318560	No	Dasatinib	G250E	G	250	E	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_G_250	250	ABL1_ENST00000318560	G	250	P00519	G	250	P00519_G_250	P00519	G	250	e	9	G250E	P00519/G250E	-6.10879	-6.25099	-7.27815	-4.42786	-2.11968	1.3822	1.76775	2.03896	1.61495	4.00556	3.01981	3.23876	-1.32824	-0.68916	-0.68473	-0.08813	-6.14112	-5.31538	-2.08641	-2.08598	-4.79607	-6.15321	-7.55871	-6.7245
BTK_ENST00000618050	No	Ibrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Heterozygous	ENST00000618050.4	BTK_ENST00000618050_C_481	481	BTK_ENST00000618050	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
EGFR	Yes	Osimertinib	T790M	T	790	M	?	?	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
ABL1	Yes	Imatinib	T334I	T	334	I	1001C>T	C	T	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	Heterozygous	ENST00000372348.6	ABL1_T_334	334	ABL1	T	334	P00519	T	315	P00519_T_315	P00519	T	315	l	77	T315I	P00519/T315I	-3.83824	-3.89394	-4.90879	-4.39264	-5.08085	-3.009	-2.99728	-3.29298	-2.37856	-2.70226	-2.83383	-3.19426	-4.73256	-2.3655	-2.63879	-1.93584	-3.83098	-6.27019	-6.31943	-2.10314	-2.96885	-3.82882	-5.20793	-4.18032
PDGFRA	Yes	Imatinib	D842V	D	842	V	2525A>T	A	T	soft_tissue	gastrointestinal_stromal_tumour	epithelioid	NS	Heterozygous	ENST00000257290.9	PDGFRA_D_842	842	PDGFRA	D	842	P16234	D	842	P16234_D_842	P16234	D	842	e	147	D842V	P16234/D842V	-4.31564	-5.1395	-5.72083	-6.23429	-7.50222	-5.58834	-3.17398	-2.56912	-7.12687	-5.66214	-2.91303	-2.5456	-6.35691	-7.44297	-7.97849	-6.78856	-5.04194	-6.07278	-4.61315	-1.093	-4.28226	-5.10224	-5.65105	-5.81161
ABL1	Yes	Imatinib	T334I	T	334	I	1001C>T	C	T	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	Heterozygous	ENST00000372348.6	ABL1_T_334	334	ABL1	T	334	P00519	T	315	P00519_T_315	P00519	T	315	l	77	T315I	P00519/T315I	-3.83824	-3.89394	-4.90879	-4.39264	-5.08085	-3.009	-2.99728	-3.29298	-2.37856	-2.70226	-2.83383	-3.19426	-4.73256	-2.3655	-2.63879	-1.93584	-3.83098	-6.27019	-6.31943	-2.10314	-2.96885	-3.82882	-5.20793	-4.18032
FGFR4	Yes	Fisogatinib	V550L	V	550	L	1648G>C	G	C	liver	carcinoma	hepatocellular_carcinoma	NS	Unknown	ENST00000292408.8	FGFR4_V_550	550	FGFR4	V	550	P22455	V	550	P22455_V_550	P22455	V	550	l	77	V550L	P22455/V550L	-2.4551	-2.99716	-3.082	-1.2076	-3.37839	-3.45376	-2.33025	-1.60496	-3.24753	-3.35757	-2.23668	-1.59437	-2.66871	-3.9419	-3.38869	-1.90248	-2.8906	-3.08134	-3.31301	-1.64314	-2.45229	-2.99361	-3.02446	-1.0623
ALK_ENST00000618119	No	Lorlatinib	G825R	G	825	R	2473G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000618119.4	ALK_ENST00000618119_G_825	1202	ALK_ENST00000618119	G	825	Q9UM73	G	1202	Q9UM73_G_1202	Q9UM73	G	1202	g	83	G1202R	Q9UM73/G1202R	-4.81544	-6.73839	-7.96814	-8.23089	-8.99966	-6.51938	-6.67511	-6.18498	-8.99117	-6.52312	-6.66187	-6.17488	-7.73938	-8.17917	-9.69937	-7.04627	-7.18312	-8.85833	-9.94931	-6.31567	-4.34695	-6.57222	-7.32508	-8.42016
MET	Yes	Crizotinib	D1246N	D	1246	N	3736G>A	G	A	breast	carcinoma	basal_(triple-negative)_carcinoma	NS	Unknown	ENST00000318493.10	MET_D_1246	1246	MET	D	1246	P08581	D	1228	P08581_D_1228	P08581	D	1228	e	147	D1228N	P08581/D1228N	-3.89302	-4.01672	-4.87037	-5.99475	-3.93587	-5.76835	-4.83304	-5.73344	-5.48859	-6.01457	-4.16378	-4.89599	NA	-2.44536	-2.44536	-3.29238	-3.56174	-3.76361	-4.83157	-6.00582	-3.56492	-3.74382	-4.8243	-5.69045
ABL1	Yes	Tyrosine kinase inhibitor - NS	D295G	D	295	G	884A>G	A	G	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000372348.6	ABL1_D_295	295	ABL1	D	295	P00519	D	276	P00519_D_276	P00519	D	276	e	35	D276G	P00519/D276G	-4.61113	-4.70641	-4.62081	-4.51285	0.09	-1.38166	-1.42012	-0.98863	0.51515	-1.12016	-1.14944	-0.70223	-0.13093	-0.72866	-0.77165	-0.73963	-4.61302	-3.3239	-1.58787	-2.30446	-3.99384	-4.62544	-4.56025	-5.17359
KIT	Yes	Imatinib	K642E	K	642	E	1924A>G	A	G	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000288135.5	KIT_K_642	642	KIT	K	642	P10721	K	642	P10721_K_642	P10721	K	642	k	50	K642E	P10721/K642E	-2.86871	-3.83495	-4.33693	-5.2914	-6.0895	-0.75961	-1.10055	-1.30422	-6.2368	-0.66001	-1.03398	-1.24659	-4.05048	-5.1073	-1.31724	-0.6052	-3.4613	-4.54826	-2.02884	-1.1982	-2.78518	-3.56152	-4.15965	-5.00163
EGFR	Yes	Osimertinib	C797S	C	797	S	2389T>A	T	A	lung	carcinoma	non_small_cell_carcinoma	NS	Heterozygous	ENST00000275493.6	EGFR_C_797	797	EGFR	C	797	P00533	C	797	P00533_C_797	P00533	C	797	e	84	C797S	P00533/C797S	-6.10543	-6.64002	-6.96375	-2.21228	-7.28074	-5.17489	-1.99234	-1.36406	-7.39063	-3.56928	-2.02928	-1.47672	-3.7615	-5.10149	-5.84303	-2.46042	-6.15484	-6.83722	-5.65101	-2.29663	-6.04365	-6.40311	-6.66681	-2.05142
FGFR2	Yes	Palbociclib	N550K	N	550	K	1650T>A	T	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000457416.6	FGFR2_N_550	552	FGFR2	N	550	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549K	P21802/N549K	-3.64811	-4.11211	-4.51203	-2.25892	-2.2117	-3.83119	-2.34387	-2.0932	-2.32326	-3.77184	-2.29823	-2.05102	-4.04513	-2.42111	-3.09061	-2.50446	-3.80625	-4.54717	-3.95835	-1.73318	-3.6234	-4.03561	-4.34609	-2.17698
BTK	Yes	Ibrutinib	C515R	C	515	R	1543T>C	T	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Homozygous	ENST00000621635.4	BTK_C_515	515	BTK	C	515	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481R	Q06187/C481R	-7.59736	-7.01492	-7.02913	-8.95434	-6.28501	-4.78858	-4.65653	-4.74512	-3.18939	-3.94997	-3.97793	-3.98402	-4.23537	-3.64002	-2.08052	-1.88146	-7.29244	-4.44362	-3.4003	-3.45565	-6.1538	-7.36528	-5.89095	-6.49942
EGFR	Yes	Osimertinib	C797G	C	797	G	?	?	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_C_797	797	EGFR	C	797	P00533	C	797	P00533_C_797	P00533	C	797	e	84	C797G	P00533/C797G	-5.97076	-6.42613	-6.73566	-5.80842	-7.04007	-6.20105	-6.02635	-7.11823	-7.1529	-5.81504	-6.03735	-6.51646	-4.13498	-5.24136	-5.87238	-4.42025	-5.99639	-6.61957	-6.01513	-6.47651	-5.92585	-6.21455	-6.45619	-5.4909
EGFR	Yes	Osimertinib	L792P	L	792	P	2375T>C	T	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_L_792	792	EGFR	L	792	P00533	L	792	P00533_L_792	P00533	L	792	y	79	L792P	P00533/L792P	-5.15844	-5.61755	-5.93526	-6.18939	-6.21444	-6.71833	-6.7635	-6.87896	-6.36391	-6.36826	-6.9507	-6.56556	-3.67888	-4.62437	-5.24789	-4.57306	-5.19961	-5.81396	-7.17777	-7.5768	-5.1311	-5.39869	-5.6449	-6.19451
FGFR1_ENST00000447712	No	Palbociclib	N546K	N	546	K	1638C>A	C	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000447712.6	FGFR1_ENST00000447712_N_546	546	FGFR1_ENST00000447712	N	546	P11362	N	546	P11362_N_546	P11362	N	546	r	62	N546K	P11362/N546K	-3.13103	-3.95788	-5.01381	-2.25003	-2.27094	-3.82251	-2.35447	-2.0932	-2.45129	-3.71966	-2.28948	-2.07549	-4.04513	-2.42111	-3.09498	-2.50446	-3.44124	-4.39563	-4.24681	-1.09163	-3.14929	-3.56415	-4.57374	-2.1373
FGFR2_ENST00000357555	No	Palbociclib	N460K	N	460	K	1380T>A	T	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000357555.9	FGFR2_ENST00000357555_N_460	549	FGFR2_ENST00000357555	N	460	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549K	P21802/N549K	-3.64811	-4.11211	-4.51203	-2.25892	-2.2117	-3.83119	-2.34387	-2.0932	-2.32326	-3.77184	-2.29823	-2.05102	-4.04513	-2.42111	-3.09061	-2.50446	-3.80625	-4.54717	-3.95835	-1.73318	-3.6234	-4.03561	-4.34609	-2.17698
FGFR2_ENST00000369059	No	Palbociclib	N435K	N	435	K	1305T>A	T	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000369059.5	FGFR2_ENST00000369059_N_435	552	FGFR2_ENST00000369059	N	435	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549K	P21802/N549K	-3.64811	-4.11211	-4.51203	-2.25892	-2.2117	-3.83119	-2.34387	-2.0932	-2.32326	-3.77184	-2.29823	-2.05102	-4.04513	-2.42111	-3.09061	-2.50446	-3.80625	-4.54717	-3.95835	-1.73318	-3.6234	-4.03561	-4.34609	-2.17698
KIT	Yes	Imatinib	N822K	N	822	K	2466T>A	T	A	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000288135.5	KIT_N_822	822	KIT	N	822	P10721	N	822	P10721_N_822	P10721	N	822	k	153	N822K	P10721/N822K	-3.43164	-4.65104	-5.21801	-4.95388	-4.84253	-2.03841	-1.844	-1.6082	-4.85631	-1.78246	-1.69447	-1.44971	-4.70887	-4.01165	-3.0352	-0.87894	-4.196	-4.44176	-2.84777	-2.514	-3.33111	-4.31337	-5.02839	-4.78265
ALK_ENST00000618119	No	Crizotinib	F797L	F	797	L	2391C>G	C	G	soft_tissue	inflammatory_myofibroblastic_tumour	NS	NS	Homozygous	ENST00000618119.4	ALK_ENST00000618119_F_797	1174	ALK_ENST00000618119	F	797	Q9UM73	F	1174	Q9UM73_F_1174	Q9UM73	F	1174	l	55	F1174L	Q9UM73/F1174L	-3.81827	-5.2478	-6.47368	-2.31841	-0.60269	0.94324	0.99964	1.10868	-0.25872	1.18764	1.16412	1.25703	-1.33672	-0.58613	-0.00266	-0.21463	-5.69483	-2.46391	-0.84444	-0.12169	-3.46176	-5.10815	-5.76626	-3.17882
ALK	Yes	Alectinib	I1171N	I	1171	N	3512T>A	T	A	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000389048.7	ALK_I_1171	1171	ALK	I	1171	Q9UM73	I	1171	Q9UM73_I_1171	Q9UM73	I	1171	l	52	I1171N	Q9UM73/I1171N	-5.17128	-6.74603	-6.94801	-6.49109	-3.57766	-3.2095	-3.74306	-3.41998	-2.58232	-2.53444	-3.18063	-2.96084	-6.18051	-6.39335	-7.5839	-6.3031	-6.60105	-8.88445	-9.69268	-6.19401	-4.80406	-6.58397	-6.76653	-6.06903
ALK_ENST00000618119	No	Alectinib	I794N	I	794	N	2381T>A	T	A	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000618119.4	ALK_ENST00000618119_I_794	1171	ALK_ENST00000618119	I	794	Q9UM73	I	1171	Q9UM73_I_1171	Q9UM73	I	1171	l	52	I1171N	Q9UM73/I1171N	-5.17128	-6.74603	-6.94801	-6.49109	-3.57766	-3.2095	-3.74306	-3.41998	-2.58232	-2.53444	-3.18063	-2.96084	-6.18051	-6.39335	-7.5839	-6.3031	-6.60105	-8.88445	-9.69268	-6.19401	-4.80406	-6.58397	-6.76653	-6.06903
MAP2K2	Yes	Dabrafenib	C125S	C	125	S	374G>C	G	C	skin	malignant_melanoma	NS	NS	Heterozygous	ENST00000262948.9	MAP2K2_C_125	125	MAP2K2	C	125	P36507	C	125	P36507_C_125	P36507	C	125	l	55	C125S	P36507/C125S	-5.86934	-4.4585	-3.71844	-3.81848	-4.54959	-4.55737	-5.1601	-4.43272	-3.00439	-3.30124	-3.84466	-4.65547	-3.42458	-5.0868	-4.0687	-5.10715	-5.47932	-5.80396	-4.90301	-5.45261	-5.68618	-5.77391	-4.33277	-3.83884
ALK_ENST00000618119	No	Crizotinib	C779Y	C	779	Y	2336G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000618119.4	ALK_ENST00000618119_C_779	1156	ALK_ENST00000618119	C	779	Q9UM73	C	1156	Q9UM73_C_1156	Q9UM73	C	1156	k	36	C1156Y	Q9UM73/C1156Y	-6.16	-8.02876	-5.18122	-3.34554	-4.30317	-4.78336	-3.16122	-2.7816	-3.24014	-3.73867	-2.97655	-2.57337	-3.60733	-3.66879	-4.32301	-3.58122	-8.43152	-7.57398	-7.10224	-4.80166	-5.76175	-7.84685	-4.66663	-3.25208
FGFR1_ENST00000532791	No	Palbociclib	N544K	N	544	K	1632C>A	C	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000532791.5	FGFR1_ENST00000532791_N_544	546	FGFR1_ENST00000532791	N	544	P11362	N	546	P11362_N_546	P11362	N	546	r	62	N546K	P11362/N546K	-3.13103	-3.95788	-5.01381	-2.25003	-2.27094	-3.82251	-2.35447	-2.0932	-2.45129	-3.71966	-2.28948	-2.07549	-4.04513	-2.42111	-3.09498	-2.50446	-3.44124	-4.39563	-4.24681	-1.09163	-3.14929	-3.56415	-4.57374	-2.1373
FLT3	Yes	Quizartinib	D835I	D	835	I	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	Unknown	ENST00000241453.11	FLT3_D_835	835	FLT3	D	835	P36888	D	835	P36888_D_835	P36888	D	835	e	147	D835I	P36888/D835I	-5.23202	-6.5013	-7.36625	-7.41903	-7.95779	-5.71909	-5.75446	-4.75671	-7.90994	-6.17082	-5.74728	-4.71916	-6.57403	-7.66428	-7.22842	-7.04	-6.5013	-7.85745	-4.6006	-4.40022	-5.23202	-6.43955	-7.31004	-7.13714
FGFR2_ENST00000358487	No	Debio1347	N549H	N	549	H	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	FGFR2_ENST00000358487_N_549	549	FGFR2_ENST00000358487	N	549	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549H	P21802/N549H	-3.59202	-4.05283	-4.45204	-1.91687	-3.2987	-5.64347	-3.43921	-3.53355	-3.40495	-5.46205	-3.3852	-3.51414	-4.11275	-4.00667	-4.83075	-4.39536	-3.73976	-4.49588	-3.98204	-1.97595	-3.56699	-3.97335	-4.2944	-1.77593
FGFR2_ENST00000358487	No	BGJ398	L617M	L	617	M	1849T>A	T	A	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	FGFR2_ENST00000358487_L_617	617	FGFR2_ENST00000358487	L	617	P21802	L	617	P21802_L_617	P21802	L	617	l	114	L617M	P21802/L617M	-2.1073	-2.37778	-2.56432	-0.58631	-1.99526	-3.16729	-2.95701	-3.49347	-2.54812	-4.03737	-3.19557	-3.71219	-2.13592	-3.11462	-3.57144	-3.87308	-2.20905	-2.58128	-2.17398	-2.00271	-2.08409	-2.33343	-2.49224	-0.51603
MAP2K2	Yes	Dabrafenib	E207K	E	207	K	619G>A	G	A	skin	malignant_melanoma	NS	NS	Heterozygous	ENST00000262948.9	MAP2K2_E_207	207	MAP2K2	E	207	P36507	E	207	P36507_E_207	P36507	E	207	e	136	E207K	P36507/E207K	-3.04785	-2.45216	-2.83294	-2.2423	-2.70537	-2.22673	-2.99764	-1.36968	-0.82964	-1.02523	-1.03418	-1.21453	-0.84676	-2.62417	-0.95055	-1.63566	-2.75546	-2.49041	-1.52576	-1.6751	-2.869	-2.97328	-3.53505	-1.67787
ALK	Yes	Alectinib	G1202R	G	1202	R	3604G>A	G	A	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000389048.7	ALK_G_1202	1202	ALK	G	1202	Q9UM73	G	1202	Q9UM73_G_1202	Q9UM73	G	1202	g	83	G1202R	Q9UM73/G1202R	-4.81544	-6.73839	-7.96814	-8.23089	-8.99966	-6.51938	-6.67511	-6.18498	-8.99117	-6.52312	-6.66187	-6.17488	-7.73938	-8.17917	-9.69937	-7.04627	-7.18312	-8.85833	-9.94931	-6.31567	-4.34695	-6.57222	-7.32508	-8.42016
KIT	Yes	Crizotinib	D816G	D	816	G	2447A>G	A	G	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000288135.5	KIT_D_816	816	KIT	D	816	P10721	D	816	P10721_D_816	P10721	D	816	e	147	D816G	P10721/D816G	-3.74962	-4.54439	-4.94901	-4.62986	-5.81009	-3.94183	-3.34842	-2.99622	-6.1652	-3.72349	-3.29199	-2.94023	-4.63427	-5.59219	-3.40419	-2.07999	-4.22884	-5.13095	-3.82729	-3.10765	-3.68791	-4.32864	-4.78558	-4.50256
FGFR2_ENST00000369056	No	Palbociclib	N550K	N	550	K	1650T>A	T	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000369056.5	FGFR2_ENST00000369056_N_550	552	FGFR2_ENST00000369056	N	550	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549K	P21802/N549K	-3.64811	-4.11211	-4.51203	-2.25892	-2.2117	-3.83119	-2.34387	-2.0932	-2.32326	-3.77184	-2.29823	-2.05102	-4.04513	-2.42111	-3.09061	-2.50446	-3.80625	-4.54717	-3.95835	-1.73318	-3.6234	-4.03561	-4.34609	-2.17698
FGFR2_ENST00000351936	No	INCB054828	N549H	N	549	H	1645A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000351936.10	FGFR2_ENST00000351936_N_549	551	FGFR2_ENST00000351936	N	549	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549H	P21802/N549H	-3.59202	-4.05283	-4.45204	-1.91687	-3.2987	-5.64347	-3.43921	-3.53355	-3.40495	-5.46205	-3.3852	-3.51414	-4.11275	-4.00667	-4.83075	-4.39536	-3.73976	-4.49588	-3.98204	-1.97595	-3.56699	-3.97335	-4.2944	-1.77593
MET	Yes	Crizotinib	Y1248C	Y	1248	C	3743A>G	A	G	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000318493.10	MET_Y_1248	1248	MET	Y	1248	P08581	Y	1230	P08581_Y_1230	P08581	Y	1230	e	149	Y1230C	P08581/Y1230C	-5.98198	-6.09983	-7.00208	-7.78299	-6.01402	-7.11051	-7.26012	-5.71538	-5.46578	-6.07977	-5.30387	-4.682	NA	-4.41087	-4.41087	-3.7573	-5.66313	-5.86123	-6.97855	-7.02948	-5.66559	-5.83954	-6.97261	-7.3954
BTK_ENST00000618050	No	Ibrutinib	C481Y	C	481	Y	1442G>A	G	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	Unknown	ENST00000618050.4	BTK_ENST00000618050_C_481	481	BTK_ENST00000618050	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481Y	Q06187/C481Y	-7.42147	-6.85939	-7.0678	-9.31334	-6.81445	-6.28611	-6.37594	-7.34037	-3.91449	-5.45128	-5.70888	-6.59455	-4.26101	-4.15799	-2.72652	-2.51016	-7.12058	-4.37441	-5.39488	-6.19902	-6.08369	-7.18425	-6.09403	-6.93796
BTK_ENST00000308731	No	Ibrutinib	C481R	C	481	R	1441T>C	T	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Homozygous	ENST00000308731.7	BTK_ENST00000308731_C_481	481	BTK_ENST00000308731	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481R	Q06187/C481R	-7.59736	-7.01492	-7.02913	-8.95434	-6.28501	-4.78858	-4.65653	-4.74512	-3.18939	-3.94997	-3.97793	-3.98402	-4.23537	-3.64002	-2.08052	-1.88146	-7.29244	-4.44362	-3.4003	-3.45565	-6.1538	-7.36528	-5.89095	-6.49942
FGFR1_ENST00000356207	No	Palbociclib	N457K	N	457	K	1371C>A	C	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000356207.9	FGFR1_ENST00000356207_N_457	546	FGFR1_ENST00000356207	N	457	P11362	N	546	P11362_N_546	P11362	N	546	r	62	N546K	P11362/N546K	-3.13103	-3.95788	-5.01381	-2.25003	-2.27094	-3.82251	-2.35447	-2.0932	-2.45129	-3.71966	-2.28948	-2.07549	-4.04513	-2.42111	-3.09498	-2.50446	-3.44124	-4.39563	-4.24681	-1.09163	-3.14929	-3.56415	-4.57374	-2.1373
FGFR2_ENST00000358487	No	FGFR	M538L	M	538	L	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	FGFR2_ENST00000358487_M_538	538	FGFR2_ENST00000358487	M	538	P21802	M	538	P21802_M_538	P21802	M	538	l	52	M538L	P21802/M538L	-2.64708	-2.92402	-3.21744	-2.99595	-1.88859	-1.93517	-2.36452	-2.40467	-1.68167	-1.81059	-2.3215	-2.36054	-3.07219	-0.56173	-0.84188	-1.30705	-2.7355	-3.24492	-4.19484	-2.7746	-2.64392	-2.87406	-3.09717	-2.80362
EGFR_ENST00000455089	No	Gefitinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	bronchioloalveolar_adenocarcinoma	NS	Unknown	ENST00000455089.5	EGFR_ENST00000455089_T_745	790	EGFR_ENST00000455089	T	745	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
MAP2K1	Yes	Selumetinib	P124L	P	124	L	371C>T	C	T	skin	malignant_melanoma	NS	NS	Heterozygous	ENST00000307102.9	MAP2K1_P_124	124	MAP2K1	P	124	Q02750	P	124	Q02750_P_124	Q02750	P	124	p	58	P124L	Q02750/P124L	-4.32536	-4.96281	-4.83065	-4.70525	-6.41237	-6.74282	-6.69555	-5.45584	-4.46015	-5.05171	-5.09626	-5.63378	-3.42825	-4.60081	-3.50115	-5.33579	-5.06128	-4.69757	-4.29548	-4.61463	-4.70173	-4.19717	-4.77772	-4.30673
EGFR	Yes	HM61713	C797S	C	797	S	2390G>C	G	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_C_797	797	EGFR	C	797	P00533	C	797	P00533_C_797	P00533	C	797	e	84	C797S	P00533/C797S	-6.10543	-6.64002	-6.96375	-2.21228	-7.28074	-5.17489	-1.99234	-1.36406	-7.39063	-3.56928	-2.02928	-1.47672	-3.7615	-5.10149	-5.84303	-2.46042	-6.15484	-6.83722	-5.65101	-2.29663	-6.04365	-6.40311	-6.66681	-2.05142
EGFR_ENST00000455089	No	HM61713	C752S	C	752	S	2255G>C	G	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	EGFR_ENST00000455089_C_752	797	EGFR_ENST00000455089	C	752	P00533	C	797	P00533_C_797	P00533	C	797	e	84	C797S	P00533/C797S	-6.10543	-6.64002	-6.96375	-2.21228	-7.28074	-5.17489	-1.99234	-1.36406	-7.39063	-3.56928	-2.02928	-1.47672	-3.7615	-5.10149	-5.84303	-2.46042	-6.15484	-6.83722	-5.65101	-2.29663	-6.04365	-6.40311	-6.66681	-2.05142
BTK_ENST00000618050	No	Ibrutinib	C481R	C	481	R	1441T>C	T	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Homozygous	ENST00000618050.4	BTK_ENST00000618050_C_481	481	BTK_ENST00000618050	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481R	Q06187/C481R	-7.59736	-7.01492	-7.02913	-8.95434	-6.28501	-4.78858	-4.65653	-4.74512	-3.18939	-3.94997	-3.97793	-3.98402	-4.23537	-3.64002	-2.08052	-1.88146	-7.29244	-4.44362	-3.4003	-3.45565	-6.1538	-7.36528	-5.89095	-6.49942
FLT3	Yes	Crenolanib	D835I	D	835	I	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	Unknown	ENST00000241453.11	FLT3_D_835	835	FLT3	D	835	P36888	D	835	P36888_D_835	P36888	D	835	e	147	D835I	P36888/D835I	-5.23202	-6.5013	-7.36625	-7.41903	-7.95779	-5.71909	-5.75446	-4.75671	-7.90994	-6.17082	-5.74728	-4.71916	-6.57403	-7.66428	-7.22842	-7.04	-6.5013	-7.85745	-4.6006	-4.40022	-5.23202	-6.43955	-7.31004	-7.13714
BTK_ENST00000618050	No	Ibrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	Unknown	ENST00000618050.4	BTK_ENST00000618050_C_481	481	BTK_ENST00000618050	C	481	Q06187	C	481	Q06187_C_481	Q06187	C	481	e	84	C481S	Q06187/C481S	-6.48152	-5.02532	-4.33954	-2.89618	-0.8405	0.30958	0.95577	1.35488	1.83779	1.18898	1.65354	2.11618	-2.48465	-1.947	-0.71273	-0.3022	-6.2429	-2.02189	-1.09369	-0.48925	-5.19612	-6.29907	-2.81561	-2.80383
EGFR	Yes	Osimertinib	L792H	L	792	H	2375T>A	T	A	lung	carcinoma	non_small_cell_carcinoma	NS	Heterozygous	ENST00000275493.6	EGFR_L_792	792	EGFR	L	792	P00533	L	792	P00533_L_792	P00533	L	792	y	79	L792H	P00533/L792H	-4.8254	-5.38517	-5.70241	-4.97976	-5.97338	-5.92185	-5.13719	-5.83715	-6.16791	-4.82256	-5.05571	-5.49757	-2.9369	-4.01774	-4.70132	-3.09963	-4.88608	-5.59856	-5.9826	-6.32968	-4.77562	-5.16063	-5.41901	-4.6062
FGFR2_ENST00000358487	No	FGFR	N549K	N	549	K	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	FGFR2_ENST00000358487_N_549	549	FGFR2_ENST00000358487	N	549	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549K	P21802/N549K	-3.64811	-4.11211	-4.51203	-2.25892	-2.2117	-3.83119	-2.34387	-2.0932	-2.32326	-3.77184	-2.29823	-2.05102	-4.04513	-2.42111	-3.09061	-2.50446	-3.80625	-4.54717	-3.95835	-1.73318	-3.6234	-4.03561	-4.34609	-2.17698
KIT	Yes	Sunitinib	N822K	N	822	K	2466T>A	T	A	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Heterozygous	ENST00000288135.5	KIT_N_822	822	KIT	N	822	P10721	N	822	P10721_N_822	P10721	N	822	k	153	N822K	P10721/N822K	-3.43164	-4.65104	-5.21801	-4.95388	-4.84253	-2.03841	-1.844	-1.6082	-4.85631	-1.78246	-1.69447	-1.44971	-4.70887	-4.01165	-3.0352	-0.87894	-4.196	-4.44176	-2.84777	-2.514	-3.33111	-4.31337	-5.02839	-4.78265
FGFR4_ENST00000502906	No	Fisogatinib	V550M	V	550	M	1648G>A	G	A	liver	carcinoma	hepatocellular_carcinoma	NS	Unknown	ENST00000502906.5	FGFR4_ENST00000502906_V_550	550	FGFR4_ENST00000502906	V	550	P22455	V	550	P22455_V_550	P22455	V	550	l	77	V550M	P22455/V550M	-2.44418	-3.17199	-3.23108	-0.48639	-3.57459	-2.99973	-0.40315	0.13372	-3.14058	-2.29023	-0.33867	0.14108	-2.88083	-4.19547	-3.47476	-2.47998	-3.00659	-3.33739	-3.38134	-0.65289	-2.43951	-3.14519	-3.2612	-0.67212
KIT	Yes	Imatinib	V654A	V	654	A	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	dedifferentiated	anaplastic_and_spindle_and_epithelioid	Homozygous	ENST00000288135.5	KIT_V_654	654	KIT	V	654	P10721	V	654	P10721_V_654	P10721	V	654	v	61	V654A	P10721/V654A	-3.0421	-3.91067	-4.28896	-4.96082	-5.97083	-6.55487	-4.62666	-4.76232	-6.07968	-6.51538	-4.42426	-4.7495	-3.86516	-4.78749	-4.69194	-5.04105	-3.59732	-4.43669	-5.88686	-5.92714	-2.94308	-3.67093	-4.14688	-4.77469
PDGFRA	Yes	Imatinib	D842V	D	842	V	2525A>T	A	T	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Heterozygous	ENST00000257290.9	PDGFRA_D_842	842	PDGFRA	D	842	P16234	D	842	P16234_D_842	P16234	D	842	e	147	D842V	P16234/D842V	-4.31564	-5.1395	-5.72083	-6.23429	-7.50222	-5.58834	-3.17398	-2.56912	-7.12687	-5.66214	-2.91303	-2.5456	-6.35691	-7.44297	-7.97849	-6.78856	-5.04194	-6.07278	-4.61315	-1.093	-4.28226	-5.10224	-5.65105	-5.81161
FGFR2_ENST00000360144	No	INCB054828	N461H	N	461	H	1381A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000360144.7	FGFR2_ENST00000360144_N_461	552	FGFR2_ENST00000360144	N	461	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549H	P21802/N549H	-3.59202	-4.05283	-4.45204	-1.91687	-3.2987	-5.64347	-3.43921	-3.53355	-3.40495	-5.46205	-3.3852	-3.51414	-4.11275	-4.00667	-4.83075	-4.39536	-3.73976	-4.49588	-3.98204	-1.97595	-3.56699	-3.97335	-4.2944	-1.77593
ABL1_ENST00000318560	No	Dasatinib	Y253H	Y	253	H	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	ABL1_ENST00000318560_Y_253	253	ABL1_ENST00000318560	Y	253	P00519	Y	253	P00519_Y_253	P00519	Y	253	f	12	Y253H	P00519/Y253H	-4.89532	-4.98695	-5.85466	-6.40595	-7.04709	-5.54449	-3.47977	-3.44568	-3.6467	-4.56531	-2.75965	-2.89919	-3.78921	-4.06068	-3.91027	-3.18392	-4.90827	-5.82537	-7.37698	-7.52041	-4.13495	-4.92132	-6.08031	-6.33863
EGFR	Yes	Gefitinib	T790M	T	790	M	?	?	NA	lung	carcinoma	micropapillary_adenocarcinoma	NS	Unknown	ENST00000275493.6	EGFR_T_790	790	EGFR	T	790	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
ABL1_ENST00000318560	No	Dasatinib	E255K	E	255	K	?	?	NA	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	Unknown	ENST00000318560.5	ABL1_ENST00000318560_E_255	255	ABL1_ENST00000318560	E	255	P00519	E	255	P00519_E_255	P00519	E	255	k	14	E255K	P00519/E255K	-3.87752	-3.98692	-3.77258	-4.51827	-4.65119	-0.99294	-0.54953	-0.75458	-2.32244	-0.55667	-0.25813	-0.51514	-3.73023	-2.35155	-1.56173	-0.72175	-3.89441	-4.42775	-2.57996	-3.09774	-2.98345	-3.90263	-3.87545	-4.32295
FGFR2_ENST00000358487	No	Pemigatinib	N549H	N	549	H	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	FGFR2_ENST00000358487_N_549	549	FGFR2_ENST00000358487	N	549	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549H	P21802/N549H	-3.59202	-4.05283	-4.45204	-1.91687	-3.2987	-5.64347	-3.43921	-3.53355	-3.40495	-5.46205	-3.3852	-3.51414	-4.11275	-4.00667	-4.83075	-4.39536	-3.73976	-4.49588	-3.98204	-1.97595	-3.56699	-3.97335	-4.2944	-1.77593
KIT	Yes	Imatinib	V654A	V	654	A	1961T>C	T	C	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Heterozygous	ENST00000288135.5	KIT_V_654	654	KIT	V	654	P10721	V	654	P10721_V_654	P10721	V	654	v	61	V654A	P10721/V654A	-3.0421	-3.91067	-4.28896	-4.96082	-5.97083	-6.55487	-4.62666	-4.76232	-6.07968	-6.51538	-4.42426	-4.7495	-3.86516	-4.78749	-4.69194	-5.04105	-3.59732	-4.43669	-5.88686	-5.92714	-2.94308	-3.67093	-4.14688	-4.77469
MET	Yes	Crizotinib	D1246N	D	1246	N	3736G>A	G	A	lung	carcinoma	squamous_cell_carcinoma	NS	Unknown	ENST00000318493.10	MET_D_1246	1246	MET	D	1246	P08581	D	1228	P08581_D_1228	P08581	D	1228	e	147	D1228N	P08581/D1228N	-3.89302	-4.01672	-4.87037	-5.99475	-3.93587	-5.76835	-4.83304	-5.73344	-5.48859	-6.01457	-4.16378	-4.89599	NA	-2.44536	-2.44536	-3.29238	-3.56174	-3.76361	-4.83157	-6.00582	-3.56492	-3.74382	-4.8243	-5.69045
MET	Yes	Capmatinib	D1246N	D	1246	N	3736G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000318493.10	MET_D_1246	1246	MET	D	1246	P08581	D	1228	P08581_D_1228	P08581	D	1228	e	147	D1228N	P08581/D1228N	-3.89302	-4.01672	-4.87037	-5.99475	-3.93587	-5.76835	-4.83304	-5.73344	-5.48859	-6.01457	-4.16378	-4.89599	NA	-2.44536	-2.44536	-3.29238	-3.56174	-3.76361	-4.83157	-6.00582	-3.56492	-3.74382	-4.8243	-5.69045
EGFR_ENST00000454757	No	Erlotinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	non_small_cell_carcinoma	NS	Heterozygous	ENST00000454757.6	EGFR_ENST00000454757_T_745	790	EGFR_ENST00000454757	T	745	P00533	T	790	P00533_T_790	P00533	T	790	l	77	T790M	P00533/T790M	-4.2431	-4.3308	-4.70306	-0.42098	-5.02026	-5.99076	-6.98597	-1.92813	-5.61746	-6.53069	-6.99204	-6.79973	-2.47935	-3.44267	-4.1497	-4.75644	-4.28913	-4.55167	-6.50935	-1.1853	-4.19559	-4.54143	-4.36975	-0.24706
FGFR2_ENST00000351936	No	Palbociclib	N549K	N	549	K	1647T>A	T	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000351936.10	FGFR2_ENST00000351936_N_549	551	FGFR2_ENST00000351936	N	549	P21802	N	549	P21802_N_549	P21802	N	549	r	62	N549K	P21802/N549K	-3.64811	-4.11211	-4.51203	-2.25892	-2.2117	-3.83119	-2.34387	-2.0932	-2.32326	-3.77184	-2.29823	-2.05102	-4.04513	-2.42111	-3.09061	-2.50446	-3.80625	-4.54717	-3.95835	-1.73318	-3.6234	-4.03561	-4.34609	-2.17698
